Phone (USA) +1 212-348-5610
Whatsapp: +1 516-336-9307
WeChat: chembuyersguide
Chemical Search
 


























Molcan Corporation




Country: Canada

70 East Beaver Creek Road #39,
Richmond Hill, Ontario, Canada L4B 3B2


Phone: 905-731-5537
Phone 2: 905-731-6592
FAX: 905-248-3843
E-Mail:E-Mail this Supplier


http://www.molcan.com

Molcan Corporation

Page: Home | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 |
 


Product List

BALSALAZIDE METHYL ESTER ;
BSL51 :
(E)-5-((4-((3-Methoxy-3-oxopropyl)carbamoyl)phenyl)diazenyl)-2-hydroxybenzoic acid ;
BALSALAZIDE USP RC A ;
CAS:1398634-47-3
BSL21N :
(E)-5-[(p-Carboxyphenyl)azo]-2-salicylic acid, disodium salt ;
BALSALAZIDE USP RC B ; BALSALAZIDE META-ISOMER ;
CAS:1798395-96-6
BSL22 :
(E)-5-((m-[(2-Carboxyethyl)carbamoyl]phenyl)azo)-2-salicylic acid ;
BAMBUTEROL EP IMPURITY A ; TERBUTALINE SULFATE ;
CAS:23031-32-5
BBT01S :
(1RS)-1-(3,5-Dihydroxyphenyl)-2-[(1,1-dimethylethyl)-amino]ethanol sulfate salt ;
BAMBUTEROL EP IMPURITY B ;
CAS:112935-92-9
BBT02 :
5-[(1RS)-1,2-Dihydroxyethyl]-1,3-phenylenebis(dimethylcarbamate ;
BAMBUTEROL EP IMPURITY C ; BAMBUTEROL MONOCARBAMATE ;
CAS:81732-52-7
BBT03H :
3-[(1RS)-2-[(1,1-Dimethylethyl)amino]-1-hydroxyethyl]-5-hydroxyphenyl dimethylcarbamate hydrochloride ;
BAMBUTEROL EP IMPURITY D ;
CAS:112935-93-0
BBT04 :
5-[(1RS)-1-Hydroxyethyl]-1,3-phenylene bis(dimethylcarbamate) ;
BAMBUTEROL EP IMPURITY E ;
CAS:81732-48-1
BBT05 :
5-Acetyl-1,3-phenylene bis(dimethylcarbamate) ;
BAMBUTEROL EP IMPURITY F ; 1-KETO BAMBUTEROL ;
CAS:112935-94-1
BBT06H :
5-[[(1,1-Dimethylethyl)amino]acetyl]-1,3-phenylenebis(dimethylcarbamate) hydrochloride ;
BAMBUTEROL HCL ;
CAS:81732-46-9
BBT00H :
5-[(1RS)-2-[(1,1-Dimethylethyl)amino]-1-hydroxyethyl]-1,3-phenylene bis(dimethylcarbamate) hydrochloride ;
BAMIFYLLINE ;
CAS:2016-63-9
BMF00 :
8-Benzyl-7-(2-(ethyl(2-hydroxyethyl)amino)ethyl)-1,3-dimethyl-1H-purine-2,6(3H,7H)-dione ;
BAMIFYLLINE 8-BENZYLTHEOPHYLLINE ;
CAS:2879-15-4
BMF50 :
8-Benzyl-1,3-dimethyl-1H-purine-2,6(3H,7H)-dione ;
BAMIFYLLINE 8-BENZYLTHEOPHYLLINE 2-BROMOETHYL ;
BMF51 :
8-Benzyl-9-(2-bromoethyl)-1,3-dimethyl-1H-purine-2,6(3H,9H)-dione ;
BAMIFYLLINE N-OXIDE ;
BMF52 :
8-Benzyl-7-(2-(ethyl(2-hydroxyethyl)amino)ethyl)-1,3-dimethyl-1H-purine-2,6(3H,7H)-dione N-oxide ;
BAZEDOXIFENE ;
CAS:198481-32-2
BZD00B :
1-[[4-[2-(Hexahydro-1H-azepin-1-yl)ethoxy]phenyl]methyl]-2-(4-hydroxyphenyl)-3-methyl-1H-indol-5-ol ;
BAZEDOXIFENE 5-O-BENZYL IMPURITY ;
CAS:328933-58-0
BZD50 :
4-[1-[[4-[2-(Hexahydro-1H-azepin-1-yl)ethoxy]phenyl]methyl]-3-methyl-5-(phenylmethoxy)-1H-indol-2-yl]phenol ;
BAZEDOXIFENE ACETATE ;
CAS:198481-33-3
BZD00A :
1-[[4-[2-(Hexahydro-1H-azepin-1-yl)ethoxy]phenyl]methyl]-2-(4-hydroxyphenyl)-3-methyl-1H-indol-5-ol acetate ;
BAZEDOXIFENE N-OXIDE ;
CAS:1174289-22-5
BZD51 :
1-[[4-[2-(Hexahydro-1-oxido-1H-azepin-1-yl)ethoxy]phenyl]methyl]-2-(4-hydroxyphenyl)-3-methyl-1H-indol-5-ol ;
BAZEDOXIFENE TRIOL IMPURITY ; DES(1-AZEPANYL)ETHYL BAZEDOXIFENE ;
CAS:104599-10-2
BZD52 :
2-(4-Hydroxyphenyl)-1-[(4-hydroxyphenyl)methyl]-3-methyl-1H-Indol-5-ol;
BECLOMETASONE DIPROPIONATE (ANHYDROUS) ;
CAS:9/8/5534
BCD00 :
9-Chloro-11-hydroxy-16-methyl-3,20-dioxopregna-1,4-diene-17,21-diyl dipropanoate ;
BECLOMETASONE DIPROPIONATE EP IMPURITY A ; BECLOMETASONE 21-PROPIONATE ;
CAS:69224-79-9
BCD01 :
9-Chloro-11,17-dihydroxy-16-methyl-3,20-dioxopregna-1,4-dien-21-yl propanoate ;
BECLOMETASONE DIPROPIONATE EP IMPURITY B ; BECLOMETASONE 21-ACETATE 17-PROPIONATE ;
CAS:8/7/5534
BCD02 :
21-(Acetyloxy)-9-chloro-11-hydroxy-16-methyl-3,20-dioxopregna-1,4-dien-17-yl propanoate ;
BECLOMETASONE DIPROPIONATE EP IMPURITY C ; BECLOMETASONE 21-BUTYRATE 17-PROPIONATE ;
BCD03 :
9-Chloro-11-hydroxy-16-methyl-3,20-dioxo-17-(propanoyloxy)-pregna-1,4-dien-21-yl butanoate ;
BECLOMETASONE DIPROPIONATE EP IMPURITY D ; 9-DESCHLORO-9-BROMO BECLOMETHASONE DIPROPIONATE ;
CAS:52092-14-5
BCD04 :
9-Bromo-11-hydroxy-16-methyl-3,20-dioxopregna-1,4-diene-17,21-diyl dipropanoate ;
BECLOMETASONE DIPROPIONATE EP IMPURITY E ; 6A-CHLORO-BECLOMETHASONE DIPROPIONATE ;
CAS:887130-68-9
BCD05 :
6a,9-Dichloro-11-hydroxy-16-methyl-3,20-dioxopregna-1,4-diene-17,21-diyl dipropanoate ;
BECLOMETASONE DIPROPIONATE EP IMPURITY F ; 6A-BROMO BECLOMETHASONE DIPROPIONATE ;
CAS:887130-69-0
BCD06 :
6a-Bromo-9-chloro-11-hydroxy-16-methyl-3,20-dioxopregna-1,4-diene-17,21-diyl dipropanoate ;
BECLOMETASONE DIPROPIONATE EP IMPURITY H ; BECLOMETASONE 17-PROPIONATE ;
CAS:5534-18-9
BCD08 :
9-Chloro-11,21-dihydroxy-16-methyl-3,20-dioxopregna-1,4-dien-17-yl propanoate ;
BECLOMETASONE DIPROPIONATE EP IMPURITY I ;
CAS:52092-12-3
BCD09 :
16-Methyl-3,20-dioxopregna-1,4,9(11)-triene-17,21-diyl dipropanoate ;
BECLOMETASONE DIPROPIONATE EP IMPURITY J ; BETAMETHASONE 9,11-EPOXIDE 17,21-DIPROPIONATE ; BETAMETHASONE DIPROPIONATE EP IMPURITY F ; BETAMETHASONE DIPROPIONATE USP RC F ;
CAS:66917-44-0
BCD10 :
9,11-Epoxy-16-methyl-3,20-dioxo-9-pregna-1,4-diene-17,21-diyl dipropanoate ;
BECLOMETASONE DIPROPIONATE EP IMPURITY L ; 1,2-DIHYDRO BECLOMETHASONE DIPROPIONATE ;
CAS:114371-33-4
BCD12 :
9-Chloro-11-hydroxy-16-methyl-3,20-dioxopregn-4-ene-17,21-diyl dipropanoate ;
BECLOMETASONE DIPROPIONATE EP IMPURITY M ;
BCD13 :
9-Chloro-11-hydroxy-16-methyl-3,20-dioxopregna-4,6-diene-17,21-diyl dipropanoate ;
BECLOMETASONE DIPROPIONATE EP IMPURITY N ; 2-BROMO BECLOMETHASONE DIPROPIONATE ;
CAS:1204582-47-7
BCD14 :
2-Bromo-9-chloro-11-hydroxy-16-methyl-3,20-dioxopregna-1,4-diene-17,21-diyl dipropanoate ;
BECLOMETASONE DIPROPIONATE EP IMPURITY O ; 11-CHLOROBECLOMETHASONE 17,21-DIPROPIONATE; ;
CAS:14527-61-8
BCD15 :
9,11-Dichloro-16-methyl-3,20-dioxopregna-1,4-diene-17,21-diyl dipropanoate ;
BECLOMETASONE DIPROPIONATE EP IMPURITY Q ; 9-DESCHLORO-11-DESHYDROXY BECLOMETHASONE 17,21-DIPROPIONATE ;
BCD17 :
16-Methyl-3,20-dioxopregna-1,4-diene-17,21-diyl dipropanoate ;
BECLOMETASONE DIPROPIONATE EP IMPURITY R ; BETAMETHASONE EP IMPURITY E ; BETAMETHASONE USP RC E ; BETAMETHASONE 9,11-EPOXY IMPURITY ;
CAS:981-34-0
BCD18 :
9,11-Epoxy-17,21-dihydroxy-16-methyl-9-pregna-1,4-diene-3,20-dione ;
BECLOMETASONE DIPROPIONATE EP IMPURITY S ; BECLOMETASONE TRIPROPIONATE ;
CAS:1709825-83-1
BCD19 :
9-Chloro-16-methyl-3,20-dioxopregna-1,4-diene-11,17,21-triyl tripropanoate ;
BECLOMETASONE DIPROPIONATE EP IMPURITY U ; BETAMETHASONE 9,11-EPOXIDE 17-PROPIONATE ;
CAS:79578-39-5
BCD21 :
9,11-Epoxy-21-hydroxy-16-methyl-3,20-dioxo-9-pregna-1,4-dien-17-yl propanoate ;
BECLOMETASONE DIPROPIONATE EP IMPURITY V ; BETAMETHASONE 9,11-EPOXIDE 21-PROPIONATE ;
CAS:205105-83-5
BCD22 :
9,11-Epoxy-17-hydroxy-16-methyl-3,20-dioxo-9-pregna-1,4-dien-21-yl propanoate ;
BECLOMETASONE DIPROPIONATE MONOHYDRATE ;
BDH00 :
9-Chloro-11-hydroxy-16-methyl-3,20-dioxopregna-1,4-diene-17,21-diyl dipropanoate monohydrate ;
BEDAQUILINE (AR,SSS)-ISOMER ;
CAS:654653-93-7
BDQ51 :
(aR,S)-rel-6-Bromo-a-[2-(dimethylamino)ethyl]-2-methoxy-a-1-naphthalenyl--phenyl-3-quinolineethanol ;
BEDAQUILINE (AS,SSR)-ISOMER ;
CAS:843663-66-1
BDQ52 :
(aS,R)-6-Bromo-a-[2-(dimethylamino)ethyl]-2-methoxy-a-1-naphthalenyl--phenyl-3-quinolineethanol ;
BEDAQUILINE ;
CAS:654655-80-8
BDQ50 :
6-Bromo-a-[2-(dimethylamino)ethyl]-2-methoxy-a-1-naphthalenyl--phenyl-3-quinolineethanol (mixture of diastereomers) ;
BEDAQUILINE N-DESMETHYL RACEMATE ;
CAS:654654-76-9
BDQ53 :
rac-(1R,2S)-1-(6-Bromo-2-methoxyquinolin-3-yl)-4-(methylamino)-2-(naphthalen-1-yl)-1-phenylbutan-2-ol ;
BELINOSTAT ;
CAS:866323-14-0
BLS00 :
N-Hydroxy-3-(3-phenylsulfamoylphenyl)acrylamide ;
BELINOSTAT ACID IMPURITY ;
CAS:866323-87-7
BLS50 :
(2E)-3-[3-[(Phenylamino)sulfonyl]phenyl]-2-propenoic acid ;
BELINOSTAT AMIDE IMPURITY ;
CAS:1485081-57-9
BLS51 :
(2E)-3-[3-[(Phenylamino)sulfonyl]phenyl]-2-propenamide ;
BELINOSTAT METHYL IMPURITY ;
CAS:1485081-34-2
BLS52 :
(2E)-N-Methoxy-3-[3-[(phenylamino)sulfonyl]phenyl]-2-propenamide ;
BENAZEPRIL EP IMPURITY A ; BENAZEPRIL USP RC A ; (1R,3R)-BENAZEPRIL HCL ; BENAZEPRIL HCL ENANTIOMER ;
CAS:215447-89-5
BNZ01H :
[(3R)-3-[[(1R)-1-(Ethoxycarbonyl)-3-phenylpropyl]-amino]-2-oxo-2,3,4,5-tetrahydro-1H-1-benzazepin-1-yl]acetic acid hydrochloride ;
BENAZEPRIL EP IMPURITY B ;
CAS:88372-39-8
BNZ02H :
[(3RS)-3-[[(1SR)-1-(Ethoxycarbonyl)-3-phenylpropyl]-amino]-2-oxo-2,3,4,5-tetrahydro-1H-1-benzazepin-1-yl]acetic acid HCl ;
BENAZEPRIL EP IMPURITY C (DISODIUM) ; BENAZEPRIL USP RC C (DISODIUM) ; BENAZEPRILAT DISODIUM ;
CAS:86541-78-8
BNZ03N :
(3S)-3-[[(1S)-1-Carboxy-3-phenylpropyl]amino-2,3,4,5-tetrahydro-2-oxo-1H-1-benazepine]-1-acetic acid disodium salt ;
BENAZEPRIL EP IMPURITY D ; BENAZEPRIL USP RC D ;
CAS:112110-48-2
BNZ04H :
[(3S)-3-[[(1S)-3-Cyclohexyl-1-(ethoxycarbonyl)propyl]-amino]-2-oxo-2,3,4,5-tetrahydro-1H-1-benzazepin-1-yl]acetic acid HCl ;
BENAZEPRIL EP IMPURITY E ; BENAZEPRIL USP RC E ;
CAS:88372-47-8
BNZ05 :
[(3S)-3-Amino-2-oxo-2,3,4,5-tetrahydro-1H-1-benzazepin-1-yl]acetic acid ;
BENAZEPRIL EP IMPURITY F ; BENAZEPRIL USP RC F ;
CAS:109010-60-8
BNZ06 :
1,1-Dimethylethyl [(3S)-3-amino-2-oxo-2,3,4,5-tetrahydro-1H-1-benzazepin-1-yl]acetate ;
BENAZEPRIL EP IMPURITY G ; BENAZEPRIL USP RC G ; BENAZEPRIL ETHYL ESTER HCL ;
CAS:103129-58-4
BNZ07H :
Ethyl (2S)-2-[[(3S)-1-(2-Ethoxy-2-oxoethyl)-2-oxo-2,3,4,5-tetrahydro-1H-1-benzazepin-3-yl]amino]-4-phenylbutanoate HCl ;
BENAZEPRIL HCL ;
CAS:86541-74-4
BNZ00H :
[(3S)-3-[[(1S)-1-(Ethoxycarbonyl)-3-phenylpropyl]amino]-2-oxo-2,3,4,5-tetrahydro-1H-1-benzazepin-1-yl]acetic acid hydrochloride ;
BENAZEPRIL USP RC B ; BENAZEPRIL HCL (1R,3S)-ISOMER ; (1R,3S)-BENAZEPRIL HCL ;
CAS:86541-77-7
BNZ22H :
(3S)-3-[[(1R)-1-(Ethoxycarbonyl)-3-phenylpropyl]amino]-2,3,4,5-tetrahydro-2-oxo-1H-1-benzazepine-1-acetic acid hydrochloride ;
BENDAMUSTINE 2-HYDROXYPROP-1-YL ESTER ;
BDM52 :
2-Hydroxypropyl 4-(5-(bis(2-chloroethyl)amino)-1-methyl-1H-benzo[d]imidazol-2-yl)butanoate ;
BENDAMUSTINE DESCHLORO ACETOXY IMPURITY ;
BDM53 :
4-(5-((2-Acetoxyethyl)(2-chloroethyl)amino)-1-methyl-1H-benzo[d]imidazol-2-yl)butanoic acid '
BENDAMUSTINE DESCHLORO ETHOXY IMPURITY ;
BDM54 :
4-(5-((2-Chloroethyl)(2-ethoxyethyl)amino)-1-methyl-1H-benzo[d]imidazol-2-yl)butanoic acid ;
BENDAMUSTINE DESCHLOROETHYL ACID ETHYL ESTER ;
BDM32 :
4-(5-((2-Chloroethyl)amino)-1-methyl-1H-benzo[d]imidazol-2-yl)butanoic acid ethyl ester ;
BENDAMUSTINE DIDESCHLOROETHYL ACID ETHYL ESTER ;
CAS:3543-73-5
BDM34 :
4-(5-Amino-1-methyl-1H-benzo[d]imidazol-2-yl)butanoic acid ethyl ester ;
BENDAMUSTINE DIDESCHLOROETHYL ACID IMPURITY ;
BDM33 :
4-(5-Amino-1-methyl-1H-benzo[d]imidazol-2-yl)butanoic acid ;
BENDAMUSTINE DIHYDROXY N-DESMETHYL ETHYL ESTER ;
BDM55 :
Ethyl 4-(5-(bis(2-hydroxyethyl)amino)-1H-benzo[d]imidazol-2-yl)butanoate ;
BENDAMUSTINE DIMER 2-ALLYL ESTER ;
BDM56 :
4-(5-((2-((4-(5-(Bis(2-chloroethyl)amino)-1-methyl-1H-benzo[d]imidazol-2-yl)butanoyl)oxy)ethyl)(2-chloroethyl)amino)-1-methyl-1H-benzo[d]imidazol-2-yl)butanoate allyl ester ;
BENDAMUSTINE HCL ;
CAS:3543-75-7
BDM00H :
4-(5-(Bis(2-chloroethyl)amino)-1-methyl-1H-benzo[d]imidazol-2-yl)butanoic acid HCl ;
BENDAMUSTINE ISOPROPYL ESTER ;
CAS:1313020-25-5
BDM04 :
Isopropyl 4-(5-(bis(2-chloroethyl)amino)-1-methyl-1H-benzo[d]imidazol-2-yl)butanoate ;
BENDAMUSTINE M3 ;
CAS:1258418-50-6
BDM57H :
5-[Bis(2-chloroethyl)amino]-?-hydroxy-1-methyl-1H-benzimidazole-2-butanoic acid hydrochloride ;
BENDAMUSTINE METHYL ESTER ;
CAS:109882-25-9
BDM02 :
Methyl 4-(5-(bis(2-chloroethyl)amino)-1-methyl-1H-benzo[d]imidazol-2-yl)butanoate ;
BENDAMUSTINE MONOHYDROXY ACID ETHYL ESTER ;
CAS:898224-95-8
BDM37 :
5-[(2-Chloroethyl)(2-hydroxyethyl)amino]-1-methyl-1H-benzimidazole-2-butanoic acid ethyl ester ;
BENDAMUSTINE N-DESMETHYL ETHYL ESTER ;
BDM58 :
Ethyl 4-(5-(bis(2-chloroethyl)amino)-1H-benzo[d]imidazol-2-yl)butanoate ;
BENDAMUSTINE N-DESMETHYL IMPURITY ;
CAS:31349-38-9
BDM30H :
4-(5-(Bis(2-chloroethyl)amino)-1H-benzo[d]imidazol-2-yl)butanoic acid HCl ;
BENDAMUSTINE NITRO ETHY ESTER IMPURITY ;
CAS:3543-72-4
BDM44 :
4-(5-Nitro-1-methyl-1H-benzo[d]imidazol-2-yl)butanoic acid ethyl ester ;
BENDAMUSTINE TRIHYDROXYETHYL DIMER IMPURITY ; BENDAMUSTINE DESCHLORO DIMER IMPURITY ;
CAS:1391052-61-1
BDM43 :
4-[-((-((4-(5-(Bis(2-hydroxyethyl)amino)-1-methyl-1H-benzo[d]imidazol-2-yl)butanoyl)oxy)ethyl)(2-hydroxyethyl)amino)-1-methyl-1H-benzo[d]imidazol-2-yl)butanoic acid ;
BENDAMUSTINE USP RC A ; BENDAMUSTINE DIHYDROXY ACID IMPURITY ;
CAS:109882-30-6
BDM21H :
4-(5-(Bis(2-hydroxyethyl)amino)-1-methyl-1H-benzo[d]imidazol-2-yl)butanoic acid HCl ;
BENDAMUSTINE USP RC B ;
CAS:1228552-02-0
BDM22 :
4-(1-Methyl-5-morpholino-1H -benzimidazol-2-yl)butanoic acid ;
BENDAMUSTINE USP RC B ETHYL ESTER ;
BDM59 :
Ethyl 4-(1-methyl-5-morpholino-1H-benzo[d]imidazol-2-yl)butanoate ;
BENDAMUSTINE USP RC C ; BENDAMUSTINE DIHYDROXY ACID ETHYL ESTER ;
CAS:3543-74-6
BDM23 :
4-(5-(Bis(2-hydroxyethyl)amino)-1-methyl-1H-benzo[d]imidazol-2-yl)butanoic acid ethyl ester ;
BENDAMUSTINE USP RC D ; BENDAMUSTINE DESCHLOROETHYL ACID IMPURITY ;
CAS:1219709-86-0
BDM24H :
4-(5-((2-Chloroethyl)amino)-1-methyl-1H-benzo[d]imidazol-2-yl)butanoic acid HCl ;
BENDAMUSTINE USP RC E ; BENDAMUSTINE MONOHYDROXY ACID IMPURITY ;
CAS:109882-27-1
BDM25H :
5-[(2-Chloroethyl)(2-hydroxyethyl)amino]-1-methyl-1H-benzimidazole-2-butanoic acid HCl ;
BENDAMUSTINE USP RC F ; BENDAMUSTINE MANNITOL ESTER ;
CAS:1869075-89-7
BDM26
(2R,3R,4R,5R)-2,3,4,5,6-Pentahydroxyhexyl 4-(5-(bis(2-Chloroethyl)amino)-1-methyl-1H-benzo[d]imidazol-2-yl)butanoate ;
BENDAMUSTINE USP RC G ;
CAS:191939-34-1
BDM27H :
4-[6-(2-Chloroethyl)-3,6,7,8-tetrahydro-3-methylimidazo[4,5-h][1,4]benzothiazin-2-yl]butanoic acid HCl ;
BENDAMUSTINE USP RC H ; BENDAMUSTINE TRICHLOROETHYL DIMER IMPURITY ;
CAS:1228551-91-4
BDM28 :
4-[-((-((4-(5-(Bis(2-Chloroethyl)amino)-1-methyl-1H-benzo[d]imidazol-2-yl)butanoyl)oxy)ethyl)(2-chloroethyl)amino)-1-methyl-1H-benzo[d]imidazol-2-yl)butanoic acid ;
BENDAMUSTINE USP RC I ; BENDAMUSTINE ETHYL ESTER (HCL SALT) ;
CAS:87475-54-5
BDM29H :
Ethyl 4-(5-(bis(2-chloroethyl)amino)-1-methyl-1H-benzo[d]imidazol-2-yl)butanoate hydrochloride ;
BENDROFLUMETHIAZIDE (R)-ISOMER ;
CAS:1087345-31-0
BFT50 :
(3R)-3-Benzyl-6-(trifluoromethyl)-3,4-dihydro-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide ;
BENDROFLUMETHIAZIDE (S)-ISOMER ;
CAS:1245935-40-3
BFT60 :
(3S)-3-Benzyl-6-(trifluoromethyl)-3,4-dihydro-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide ;
BENDROFLUMETHIAZIDE ;
CAS:73-48-3
BFT00 :
(3RS)-3-Benzyl-6-(trifluoromethyl)-3,4-dihydro-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide ;
BENDROFLUMETHIAZIDE 5-TRIFLUOROMETHYL IMPURITY ;
BFT55 :
(3RS)-3-Benzyl-5-(trifluoromethyl)-3,4-dihydro-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide ;
BENDROFLUMETHIAZIDE EP IMPURITY A ;
CAS:654-62-6
BFT01 :
4-Amino-6-(trifluoromethyl)benzene-1,3-disulfonamide ;
BENPERIDOL ;
CAS:2062-84-2
BPD00 :
1-[1-[4-(4-Fluorophenyl)-4-oxobutyl]piperidin-4-yl]-1,3-dihydro-2H-benzimidazol-2-one ;
BENPERIDOL EP IMPURITY A ;
CAS:20662-53-7
BPD01 :
1-(Piperidin-4-yl)-1,3-dihydro-2H-benzimidazol-2-one ;
BENPERIDOL EP IMPURITY B ;
BPD02 :
1-[1-[4-(2-Fluorophenyl)-4-oxobutyl]piperidin-4-yl]-1,3-dihydro-2H-benzimidazol-2-one ;
BENPERIDOL EP IMPURITY C ;
BPD03 :
1-[1-[4-Oxo-4-[4-[4-(2-oxo-2,3-dihydro-1H-benzimidazol-1-yl)piperidin-1-yl]phenyl]butyl]piperidin-4-yl]-1,3-dihydro-2H-benzimidazol-2-one ;
BENPERIDOL EP IMPURITY D ; BENPERIDOL N-OXIDE ; (SUPPLIED AS RACEMATE) ;
CAS:118435-01-1
BPD04 :
cis-1-[1-[4-(4-Fluorophenyl)-4-oxobutyl]piperidin-4-yl-1-oxide]-1,3-dihydro-2H-benzimidazol-2-one ;
BENPERIDOL EP IMPURITY E ; BENPERIDOL N-OXIDE ; (SUPPLIED AS RACEMATE) ;
CAS:118435-01-1
BPD05 :
trans-1-[1-[4-(4-Fluorophenyl)-4-oxobutyl]piperidin-4-yl-1-oxide]-1,3-dihydro-2H-benzimidazol-2-one ;
BENSERAZIDE EP IMPURITY A ; (DL)-SERINE HYDRAZIDE HCL ;
CAS:55819-71-1
BSR01H:
(2RS)-2-Amino-3-hydroxypropanohydrazide HCl ;
BENSERAZIDE EP IMPURITY B ;
BSR02 :
(2RS)-2-Amino-3-hydroxy-2',2'-bis(2,3,4-trihydroxybenzyl) propanohydrazide ;
BENSERAZIDE EP IMPURITY C ;
CAS:787504-88-5
BSR03H :
(2RS)-2-Amino-3-hydroxy-2'-[(1EZ)-(2,3,4-trihydroxybenzylidene)] propanohydrazide HCl ;
BENSERAZIDE HCL ;
CAS:14919-77-8
BSR00 :
(2RS)-2-Amino-3-hydroxy-2'-(2,3,4-trihydroxybenzyl)propanohydrazide hydrochloride ;
BENSERAZIDE TRIHYDROXYBENZYLHYDRAZINE IMPURITY ;
CAS:3614-72-0
BSR31X :
2,3,4-Trihydroxybenzylhydrazine oxalic acid salt ;
BENZAMIDE, 2,6-DIHYDROXY- ;
CAS:145297-98-9
BZM03 :
2,6-Dihydroxybenzamide (DHB) ;
BENZAMIDE, 2-HYDROXY-3-NITRO-6-METHOXY- ;
BZM01 :
2-Hydroxy-3-nitro-6-methoxybenzamide (HNMB) ;
BENZAMIDE, 2-HYDROXY-6-METHOXY- ;
BZM02 :
2-Hydroxy-6-methoxybenzamide (HMB) ;
BENZAMIDE, 3-AMINO-2-HYDROXY-6-METHOXY- ;
CAS:303757-59-7
BZM00 :
3-Amino-2-hydroxy-6-methoxybenzamide (AHMB) ;
BENZBROMARONE ;
CAS:3562-84-3
BZB00 :
(3,5-Dibromo-4-hydroxyphenyl)(2-ethylbenzofuran-3-yl)-methanone ;
BENZBROMARONE 6-HYDROXY IMPURITY ;
CAS:152831-00-0
BZB60 :
(3,5-Dibromo-4-hydroxyphenyl)(2-ethyl-6-hydroxy-3-benzofuranyl)methanone ;
BENZBROMARONE EP IMPURITY A ;
CAS:94729-09-6
BZB01 :
(3-Bromo-4-hydroxyphenyl)(2-ethylbenzofuran-3-yl)methanone ;
BENZBROMARONE EP IMPURITY B ; BENZBROMARONE IMPURITY B ;
CAS:1402819-05-9
BZB02 :
(6-Bromo-2-ethylbenzofuran-3-yl)(3,5-dibromo-4-hydroxyphenyl)methanone ;
BENZBROMARONE EP IMPURITY C ; BENZARONE ;
CAS:1477-19-6
BZB03 :
(2-Ethylbenzofuran-3-yl)(4-hydroxyphenyl)methanone ;
BENZENESULFONIC ACID BUTYL ESTER ;
CAS:80-44-4
BZS04 :
Benzenesulfonic Acid Butyl Ester ;
BENZENESULFONIC ACID ETHYL ESTER ;
CAS:515-46-8
BZS02 :
Benzenesulfonic Acid Ethyl Ester ;
BENZENESULFONIC ACID ISOPROPYL ESTER ;
CAS:6214-18-2
BZS03 :
Benzenesulfonic Acid Isopropyl Ester ;
BENZENESULFONIC ACID METHYL ESTER ;
CAS:80-18-2
BZS01 :
Benzenesulfonic Acid Methyl Ester ;
BENZOCAINE ;
CAS:94-09-7
BZC00 :
Ethyl 4-Aminobenzoate ;
BENZOCAINE EP IMPURITY A ;
CAS:623-04-1
BZC01 :
(4-Aminophenyl)methanol ; 4-Aminobenzyl Alcohol ;
BENZOCAINE EP IMPURITY B ;
CAS:5344-90-1
BZC02 :
(2-Aminophenyl)methanol ;
BENZOCAINE EP IMPURITY C ;
CAS:582-33-2
BZC03 :
Ethyl 3-Aminobenzoate ;
BENZOCAINE EP IMPURITY D ;
CAS:1333-08-0
BZC04 :
Ethyl 2-Aminobenzoate ;
BENZOCAINE EP IMPURITY E ;
CAS:62-23-7
BZC05 :
4-Nitrobenzoic acid ;
BENZOCAINE EP IMPURITY F ;
CAS:1877-77-6
BZC06 :
(3-Aminophenyl)methanol ;
BENZOCAINE EP IMPURITY G ; TETRACAINE EP IMPURITY A ;
CAS:150-13-0
BZC07 :
4-Aminobenzoic acid ;
BENZOCAINE EP IMPURITY H ;
CAS:619-45-4
BZC08 :
Methyl 4-Aminobenzoate ; 4-Aminobenzoic Acid Methyl Ester ;
BENZTHIAZIDE ;
CAS:91-33-8
BZT00 :
6-Chloro-3-[[(phenylmethyl)thio]methyl]-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-Dioxide ;
BENZYDAMINE 5-BENZYL ;
CAS:2196183-71-6
BDN50H :
3-(1,5-Dibenzyl-1H-indazol-3-yloxy)-N,N-dimethylpropan-1-amine hydrochloride ;
BENZYDAMINE 5-HYDROXY ;
CAS:36504-72-0
BDN51 :
1-Benzyl-3-(3-(dimethylamino)propoxy)-1H-indazol-5-ol ;
BENZYDAMINE DESMETHYL ;
CAS:39860-97-4
BDN52H :
3-(1-Benzyl-1H-indazol-3-yloxy)-N-methylpropan-1-amine hydrochloride ;
BENZYDAMINE HYDROCHLORIDE ;
CAS:132-69-4
BDN00H :
3-(1-Benzyl-1H-indazol-3-yloxy)-N,N-dimethylpropan-1-amine hydrochloride ;
BENZYDAMINE N-OXIDE ;
CAS:36504-71-9
BDN53:
3-(1-Benzyl-1H-indazol-3-yloxy)-N,N-dimethylpropan-1-amine N-oxide ;
BENZYLPENICILLIN DL-BENZYLPENICILLENIC ACID ; DL-BENZYLPENICILLENIC ACID ;
CAS:3264-88-8
BZP50 :
(E)-2-((2-Benzyl-5-oxooxazol-4(5H)-ylidene)methylamino)-4-mercapto-4-methylpentanoic acid ;
BENZYLPENICILLIN EP IMPURITY A ; 6-AMINOPENICILLANIC ACID ; 6-APA ;
CAS:551-16-6
BZP01 :
(2S,5R,6R)-6-Amino-3,3-dimethyl-7-oxo-4-thia-1-aza-bicyclo[3.2.0]heptane-2-carboxylic acid ;
BENZYLPENICILLIN EP IMPURITY B ; CYCLOPENTOLATE EP IMPURITY B ; TROPICAMIDE EP IMPURITY D ; TROPICAMIDE USP RC D ;
CAS:103-82-2
BZP02 :
Phenylacetic acid ;
BENZYLPENICILLIN EP IMPURITY C ; PENICILLIN X ;
CAS:525-91-7
BZP03 :
(2S,5R,6R)-6-(2-(4-Hydroxyphenyl)acetamido)-3,3-dimethyl-7-oxo-4-thia-1-aza-bicyclo[3.2.0]heptane-2-carboxylic acid ;
BENZYLPENICILLIN EP IMPURITY D ; PENILLIC ACID OF BENZYLPENICILLIN ;
BZP04 :
(3S,7R,7aR)-5-Benzyl-2,2-dimethyl-2,3,7,7a-tetrahydroimidazo[5,1-b]thiazole-3,7-dicarboxylic acid ;
BENZYLPENICILLIN EP IMPURITY E ; PENICILLOIC ACIDS OF BENZYLPENICILLIN ;
CAS:11039-68-2
BZP05 :
(4S)-2-(Carboxy(2-phenylacetamido)methyl)-5,5-dimethylthiazolidine-4-carboxylic acid ;
BENZYLPENICILLIN EP IMPURITY F ; PENILLOIC ACIDS OF BENZYLPENICILLIN ;
CAS:501-34-8
BZP06 :
(2RS,4S)-5,5-Dimethyl-2-((2-phenylacetamido)methyl)thiazolidine-4-carboxylic acid ;
BENZYLPENICILLIN SODIUM ; PENICILLIN G SODIUM ;
CAS:69-57-8
BZP00N :
Sodium (2S,5R,6R)-3,3-dimethyl-7-oxo-6-[(phenylacetyl)-amino]-4-thia- 1-azabicyclo[3.2.0]heptane-2-carboxylate ;
BEPOTASTINE BESYLATE (R)-ISOMER ; (R)-BEPOTASTINE BESYLATE ;
CAS:190730-42-8
BPT52B :
(R)-4-(4-((4-Chlorophenyl)(pyridin-2-yl)methoxy)piperidin-1-yl)butanoic acid benzenesulfonate ;
BEPOTASTINE BESYLATE ; (S)-BEPOTASTINE BESYLATE ;
CAS:190786-44-8
BPT00B :
(S)-4-(4-((4-Chlorophenyl)(pyridin-2-yl)methoxy)piperidin-1-yl)butanoic acid benzenesulfonate ;
BEPOTASTINE BUTYL ESTER ;
CAS:1807606-59-2
BPT64 :
(S)-Butyl 4-(4-((4-chlorophenyl)(pyridin-2-yl)methoxy)piperidin-1-yl)butanoate ;
BEPOTASTINE DESBUTYRATE IMPURITY (TARTRATE) ;
CAS:210095-58-2
BPT54T :
2-[(S)-(4-Chlorophenyl)(4-piperidinyloxy)methyl]pyridine L-tartrate ;
BEPOTASTINE ETHYL ESTER ;
CAS:190730-39-3
BPT55 :
(S)-Ethyl 4-(4-((4-chlorophenyl)(pyridin-2-yl)methoxy)piperidin-1-yl)butanoate ;
BEPOTASTINE ISOPROPYL ESTER ;
CAS:1807607-93-7
BPT63 :
(S)-Isopropyl 4-(4-((4-chlorophenyl)(pyridin-2-yl)methoxy)piperidin-1-yl)butanoate ;
BEPOTASTINE PYRIDINE N-OXIDE ;
BPT53 :
(S)-4-(4-((4-Chlorophenyl)(N-oxido-pyridin-2-yl)methoxy)piperidin-1-yl)butanoic acid ;
BERBERINE ;
CAS:633-65-8
BBR00 :
5,6-Dihydro-9,10-dimethoxybenzo[g]-1,3-benzodioxolo[5,6-a]quinolizinium chloride ;
BERBERINE DIHYDRO IMPURITY ;
CAS:483-15-8
BBR50 :
13,13a-Didehydro-9,10-dimethoxy-2,3-(methylenedioxy)berbine ;
BESIFLOXACIN (3S)-ISOMER ;
CAS:141388-77-4
BSF53 :
7-[(3S)-3-Aminohexahydro-1H-azepin-1-yl]-8-chloro-1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic Acid ;
BESIFLOXACIN (R)-AZEPAN-3-AMINE IMPURITY ; BESIFLOXACIN IMPURITY G ;
CAS:124932-43-0
BSF57 :
(R)-3-Amino-hexahydroazepine ;
BESIFLOXACIN 8-DECHLORO IMPURITY ;
CAS:141388-69-4
BSF58 :
(R)-7-(3-Aminohexahydro-1H-azepin-1-yl)-1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic Acid ;
BESIFLOXACIN HCL ;
CAS:405165-61-9
BSF00H :
7-[(3R)-3-Aminohexahydro-1H-azepin-1-yl]-8-chloro-1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic Acid Hydrochloride ;
BESIFLOXACIN IMPURITY B ;
CAS:101987-89-7
BSF52 :
8-Chloro-1-cyclopropyl-6,7-difluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid ;
BESIFLOXACIN IMPURITY F ;
CAS:1613314-38-7
BSF56H :
(R)-7-(Azepan-3-ylamino)-8-chloro-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid hydrochloride ;
BETAHISTINE DIHYDROCHLORIDE ;
CAS:5579-84-0
BHT00H :
N-Methyl-2-(pyridin-2-yl)ethanamine dihydrochloride ;
BETAHISTINE EP IMPURITY A ; 2-VINYLPYRIDINE ;
CAS:100-69-6
BHT01 :
2-Ethenylpyridine ;
BETAHISTINE EP IMPURITY B ;
CAS:103-74-2
BHT02 :
2-(Pyridin-2-yl)ethanol ;
BETAHISTINE EP IMPURITY C ;
CAS:5452-87-9
BHT03H :
N-Methyl-2-(pyridin-2-yl)-N-[2-(pyridin-2-yl)ethyl]ethanamine HCl ;
BETAMETHASONE ; BETAMETHASONE VALERATE EP IMPURITY A ; BETAMETHASONE DIPROPIONATE EP IMPURITY A ;
CAS:378-44-9
BMS00 :
9-Fluoro-11,17,21-trihydroxy-16-methylpregna-1,4-diene-3,20-dione ;
BETAMETHASONE 11-OXO 17-PROPIONATE ;
BMS72 :
(8S,9R,10S,13S,14S,16S,17R)-9-Fluoro-17-(2-hydroxyacetyl)-10,13,16-trimethyl-3,11-dioxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-17-yl propionate ;
BETAMETHASONE 11-OXO 21-ACETATE ;
CAS:8/1/4772
BMS73 :
2-((8S,9R,10S,13S,14S,16S,17R)-9-Fluoro-17-hydroxy-10,13,16-trimethyl-3,11-dioxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-17-yl)-2-oxoethyl acetate ;
BETAMETHASONE 11-OXO 21-ACETATE 17-PROPIONATE ;
BMS74 :
(8S,9R,10S,13S,14S,16S,17R)-17-(2-Acetoxyacetyl)-9-fluoro-10,13,16-trimethyl-3,11-dioxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-17-yl propionate ;
BETAMETHASONE 11-OXO IMPURITY ; 11-KETOBETAMETHASONE ; 11-DEHYDROBETAMETHASONE ;
CAS:2282-51-1
BMS71 :
9-Fluoro-17,21-dihydroxy-16-methylpregna-1,4-diene-3,11,20-trione ;
BETAMETHASONE 17-OXO IMPURITY ;
CAS:1/1/3109
BMS75 :
(11,16)- 9-Fluoro-11-hydroxy-16-methyl-androsta-1,4-diene-3,17-dione ;
BETAMETHASONE 6ALPHA-BROMO IMPURITY ;
CAS:1203841-38-6
BMS61 :
6-Bromo-9-Fluoro-11,17,21-trihydroxy-16-methylpregna-1,4-diene-3,20-dione ;
BETAMETHASONE ACETATE ; BETAMETHASONE 21-ACETATE ; BETAMETHASONE ACETATE ; DEXAMETHASONE ACETATE EP IMPURITY D ;
CAS:987-24-6
BMA00 :
9-Fluoro-11,17-dihydroxy-16-methyl-3,20-dioxopregna-1,4-diene-21-yl acetate ;
BETAMETHASONE ACETATE EP IMPURITY A ; BETAMETHASONE ; BETAMETHASONE VALERATE EP IMPURITY A ;
CAS:378-44-9
BMA01 :
9-Fluoro-11,17,21-trihydroxy-16-methylpregna-1,4-diene-3,20-dione ;
BETAMETHASONE ACETATE EP IMPURITY B ; DEXAMETHASONE ACETATE ;
CAS:1177-87-3
BMA02 :
9-Fluoro-11,17-dihydroxy-16a-methyl-3,20-dioxopregna-1,4-dien-21-yl acetate ;
BETAMETHASONE ACETATE EP IMPURITY C ; BETAMETHASONE ACETATE USP RC C ; BETAMETHASONE 11,21-DIACETATE ;
CAS:330157-05-6
BMA03 :
9-Fluoro-17-hydroxy-16-methyl-3,20-dioxopregna-1,4-diene-11,21-diyl diacetate ;
BETAMETHASONE ACETATE EP IMPURITY D ; BETAMETHASONE ACETATE USP RC D ;
CAS:912-38-9
BMA04 :
9,11-Epoxy-17-hydroxy-16-methyl-3,20-dioxo-9-pregna-1,4-diene-21-yl acetate ;
BETAMETHASONE BENZOATE ;
CAS:22298-29-9
BMB00 :
9-Fluoro-11,17,21-trihydroxy-16-methylpregna-1,4-diene-3,20-dione 17-benzoate ;
BETAMETHASONE DIPROPIONATE ; BETAMETHASONE-17,21-DIPROPIONATE ;
CAS:5593-20-4
BMD00 :
9-Fluoro-11-hydroxy-16-methyl-3,20-dioxopregna-1,4-diene-17,21-diyl dipropanoate ;
BETAMETHASONE DIPROPIONATE EP IMPURITY A ; BETAMETHASONE ;
CAS:378-44-9
BMD01 :
9-Fluoro-11,17,21-trihydroxy-16-methylpregna-1,4-diene-3,20-dione ;
BETAMETHASONE DIPROPIONATE EP IMPURITY B ; BETAMETHASONE DIPROPIONATE USP RC B ; BETAMETHASONE 17-PROPIONATE ; CLOBETASOL PROPIONATE EP IMPURITY A ;
CAS:5534-13-4
BMD02 :
9-Fluoro-11,21-dihydroxy-16-methyl-3,20-dioxopregna-1,4-dien-17-yl propanoate ;
BETAMETHASONE DIPROPIONATE EP IMPURITY C ; BETAMETHASONE DIPROPIONATE USP RC C ; BETAMETHASONE 21-PROPIONATE ; CLOBETASOL PROPIONATE EP IMPURITY K ;
CAS:75883-07-7
BMD03 :
9-?uoro-11,17-dihydroxy-16-methyl-3,20-dioxopregna-1,4-dien-21-yl propanoate ;
BETAMETHASONE DIPROPIONATE EP IMPURITY D ; BETAMETHASONE 21-ACETATE 17-PROPIONATE ;
CAS:5514-81-8
BMD04 :
21-(Acetyloxy)-9-?uoro-11-hydroxy-16-methyl-3,20-dioxopregna-1,4-dien-17-yl propanoate ;
BETAMETHASONE DIPROPIONATE EP IMPURITY E ; BECLOMETASONE DIPROPIONATE ;
CAS:9/8/5534
BMD05 :
9-Chloro-11-hydroxy-16-methyl-3,20-dioxopregna-1,4-diene-17,21-diyl dipropanoate ;
BETAMETHASONE DIPROPIONATE EP IMPURITY F ; BETAMETHASONE DIPROPIONATE USP RC F ; BECLOMETASONE DIPROPIONATE EP IMPURITY J ; 9SS,11SS-EPOXY BETAMETHASONE DIPROPIONATE ;
CAS:66917-44-0
BMD06 :
9,11-Epoxy-16-methyl-3,20-dioxo-9-pregna-1,4-diene-17,21-diyl dipropanoate ;
BETAMETHASONE DIPROPIONATE EP IMPURITY G ; BETAMETHASONE TRIPROPIONATE ;
CAS:1186048-33-8
BMD07 :
9-Fluoro-16-methyl-3,20-dioxopregna-1,4-diene-11,17,21-triyl tripropanoate ;
BETAMETHASONE DIPROPIONATE EP IMPURITY H ; BETAMETHASONE DIPROPIONATE USP RC H ; 6A-BROMO-BETAMETHASONE DIPROPIONATE ;
CAS:1186048-34-9
BMD08 :
6a-Bromo-9-?uoro-11-hydroxy-16-methyl-3,20-dioxopregna-1,4-diene-17,21-diyl dipropanoate ;
BETAMETHASONE DIPROPIONATE EP IMPURITY I ; 1,2-DIHYDRO BETAMETHASONE DIPROPIONATE ;
CAS:80163-83-3
BMD09 :
(11,16)-9-Fluoro-11-hydroxy-16-methyl-17,21-bis(1-oxopropoxy)-pregn-4-ene-3,20-dione ;
BETAMETHASONE EP IMPURITY A ; DEXAMETHASONE ;
CAS:50-02-2
BMS01 :
9-Fluoro-11,17,21-trihydroxy-16a-methylpregna-1,4-diene-3,20-dione ;
BETAMETHASONE EP IMPURITY B ; CLOBETASOL ; CLOBETASOL PROPIONATE EP IMPURITY G ;
CAS:25122-41-2
BMS02 :
21-Chloro-9-?uoro-11,17-dihydroxy-16-methylpregna-1,4-diene-3,20-dione ;
BETAMETHASONE EP IMPURITY C ; BETAMETHASONE USP RC C ;
CAS:13504-15-9
BMS03 :
17,21-Dihydroxy-16-methylpregna-1,4,9(11)-triene-3,20-dione ;
BETAMETHASONE EP IMPURITY D ; BETAMETHASONE 21-O-ETHYL CARBONATE ;
CAS:52619-05-3
BMS04 :
9-Fluoro-11,17-dihydroxy-16-methyl-3,20-dioxopregna-1,4-dien-21-yl ethoxycarboxylate ;
BETAMETHASONE EP IMPURITY E ; BETAMETHASONE USP RC E ; BECLOMETASONE DIPROPIONATE EP IMPURITY R ; BETAMETHASONE 9,11-EPOXY IMPURITY ;
CAS:981-34-0
BMS05 :
9,11-Epoxy-17,21-dihydroxy-16-methyl-9-pregna-1,4-diene-3,20-dione ;
BETAMETHASONE EP IMPURITY F ;
CAS:330157-04-5
BMS06 :
17,21-Dihydroxy-16-methylpregna-1,4,11-triene-3,20-dione ;
BETAMETHASONE EP IMPURITY G ;
CAS:85700-75-0
BMS07 :
11a,17,21-Trihydroxy-16-methylpregna-1,4-diene-3,20-dione ;
BETAMETHASONE EP IMPURITY H ; 9-DESFLUORO-14-FLUORO BETAMETHASONE ;
CAS:185613-71-2
BMS08 :
14-Fluoro-11,17,21-trihydroxy-16-methyl-8a,9,14-pregna-1,4-diene-3,20-dione ;
BETAMETHASONE EP IMPURITY I ; 9-DESFLUORO-8-FLUORO BETAMETHASONE ;
CAS:185613-69-8
BMS09 :
8-Fluoro-11,17,21-trihydroxy-16-methyl-8a,9-pregna-1,4-diene-3,20-dione ;
BETAMETHASONE EP IMPURITY J ; 9-DESFLUORO-11-DEOXY BETAMETHASONE ;
CAS:18383-24-9
BMS10 :
17,21-Dihydroxy-16-methylpregna-1,4-diene-3,20-dione ;
BETAMETHASONE SODIUM PHOSPHATE ; BETAMETHASONE 21-PHOSPHATE DISODIUM SALT ; DEXAMETHASONE SODIUM PHOSPHATE EP IMPURITY B ;
CAS:151-73-5
BMP00N :
9-Fluoro-11,17-dihydroxy-16-methyl-3,20-dioxopregna-1,4-dien-21-yl disodium phosphate ;
BETAMETHASONE VALERATE ;
CAS:2152-44-5
BMV00 :
9-Fluoro-11,21-dihydroxy-16-methyl-3,20-dioxopregna-1,4-dien-17-yl pentanoate ;
BETAMETHASONE VALERATE EP IMPURITY A ; BETAMETHASONE DIPROPIONATE EP IMPURITY A ; BETAMETHASONE ;
CAS:378-44-9
BMV01 :
9-Fluoro-11,17,21-trihydroxy-16-methylpregna-1,4-diene-3,20-dione ;
BETAMETHASONE VALERATE EP IMPURITY B ; 21-DEOXY BETAMETHASONE ;
CAS:1879-77-2
BMV02 :
9-Fluoro-11,17-dihydroxy-16-methylpregna-1,4-diene-3,20-dione ;
BETAMETHASONE VALERATE EP IMPURITY C ; DEXAMETHASONE 17-VALERATE ;
CAS:33755-46-3
BMV03 :
9-Fluoro-11,21-dihydroxy-16a-methyl-3,20-dioxopregna-1,4-dien-17-yl pentanoate ;
BETAMETHASONE VALERATE EP IMPURITY D ; 9-BROMO-BETAMETHASONE VALERATE ;
BMV04 :
9-Bromo-11,21-dihydroxy-16-methyl-3,20-dioxopregna-1,4-dien-17-yl pentanoate ;
BETAMETHASONE VALERATE EP IMPURITY E ; BETAMETHASONE VALERATE USP RC A ; BETAMETHASONE 21-VALERATE ;
CAS:2240-28-0
BMV05 :
9-Fluoro-11,17-dihydroxy-16-methyl-3,20-dioxopregna-1,4-dien-21-yl pentanoate ;
BETAMETHASONE VALERATE EP IMPURITY F ; BETAMETHASONE VALERATE D-9(11) ;
CAS:16125-28-3
BMV06 :
21-Hydroxy-16-methyl-3,20-dioxopregna-1,4,9(11)-trien-17-yl pentanoate ;
BETAMETHASONE VALERATE EP IMPURITY G ; 6A-BROMO-BETAMETHASONE VALERATE ;
BMV07 :
6a-Bromo-9-?uoro-11,21-dihydroxy-16-methyl-3,20-dioxopregna-1,4-dien-17-yl pentanoate ;
BETAMETHASONE VALERATE EP IMPURITY H ; BECLOMETHASONE 17-VALERATE ;
CAS:52619-18-8
BMV08 :
9-Chloro-11,21-dihydroxy-16-methyl-3,20-dioxopregna-1,4-dien-17-yl pentanoate ;
BETAMETHASONE VALERATE EP IMPURITY I ; 9-FLUORO-PREDNISOLONE 17-VALERATE ;
CAS:2802-10-0
BMV09 :
9-Fluoro-11,21-dihydroxy-3,20-dioxopregna-1,4-dien-17-yl pentanoate ;
BETAXOLOL (BASE) ;
CAS:63659-18-7
BTX00B :
(2RS)-1-[4-[2-(Cyclopropylmethoxy)ethyl]phenoxy]-3-[(1-methylethyl)amino] propan-2-ol ;
BETAXOLOL EP IMPURITY A ;
CAS:464877-45-0
BTX01H :
(2RS)-1-(4-Ethylphenoxy)-3-[(1-methylethyl)amino] propan-2-ol hydrochloride;
BETAXOLOL EP IMPURITY B ;
CAS:62572-94-5
BTX02:
(2RS)-1-[4-(2-Hydroxyethyl)phenoxy]-3-[(1-methylethyl)amino]propan-2-ol ;
BETAXOLOL EP IMPURITY C ;
CAS:63659-17-6
BTX03:
(2RS)-2-[[4-[2-(Cyclopropylmethoxy)ethyl]phenoxy]-methyl]oxirane ;
BETAXOLOL EP IMPURITY D ;
CAS:63659-16-5
BTX04H :
4-[2-(Cyclopropylmethoxy)ethyl]phenol ;
BETAXOLOL EP IMPURITY E (HCL) ;
CAS:1329613-85-5
BTX05H :
(2RS)-1-[4-(2-Butoxyethyl)phenoxy]-3-[(1-methylethyl)-amino]propan-2-ol hydrochloride ;
BETAXOLOL HYDROCHLORIDE ;
CAS:63659-19-8
BTX00H :
(2RS)-1-[4-[2-(Cyclopropylmethoxy)ethyl]phenoxy]-3-[(1-methylethyl)amino] propan-2-ol hydrochloride ;
BETRIXABAN ;
CAS:330942-05-7
BTB00 :
N-(5-Chloro-2-pyridinyl)-2-[[4-[(dimethylamino)iminomethyl]benzoyl]amino]-5-methoxybenzamide ;
BETRIXABAN 2-AMINO IMPURITY ;
CAS:280773-17-3
BTB52 :
2-Amino-N-(5-chloropyridin-2-yl)-5-methoxybenzamide ;
BETRIXABAN 2-NITRO IMPURITY ;
CAS:280773-16-2
BTB62 :
N-(5-Chloropyridin-2-yl)-5-methoxy-2-nitrobenzamide ;
BETRIXABAN 4-CYANOBENZAMIDO IMPURITY ;
CAS:330942-01-3
BTB54 :
N-(5-Chloropyridin-2-yl)-2-(4-cyanobenzamido)-5-methoxybenzamide ;
BETRIXABAN 4-TRICHLOROMETHYLBENZONITRILE IMPURITY ;
CAS:2179-45-5
BTB64 :
4-(Trichloromethyl)benzenecarbonitrile ;
BEXAROTENE ;
CAS:153559-49-0
BXR00 :
4-[1-(5,6,7,8-Tetrahydro-3,5,5,8,8-pentamethyl-2-naphthalenyl)ethenyl)benzoic acid ;
BEXAROTENE 6-HYDROXY IMPURITY ;
CAS:368451-07-4
BXR50 :
4-[1-(5,6,7,8-Tetrahydro-6-hydroxy-3,5,5,8,8-pentamethyl-2-naphthalenyl) ethenyl]benzoic acid ;
BEXAROTENE 6-OXO IMPURITY ; 6-KETO BEXAROTENE ;
CAS:368451-13-2
BXR51 :
4-[1-(5,6,7,8-Tetrahydro-3,5,5,8,8-pentamethyl-6-oxo-2-naphthalenyl) ethenyl]-benzoic acid ;
BEXAROTENE 7-HYDROXY IMPURITY ;
CAS:368451-10-9
BXR52 :
4-[1-(5,6,7,8-Tetrahydro-7-hydroxy-3,5,5,8,8-pentamethyl-2-naphthalenyl) ethenyl]benzoic acid ;
BEXAROTENE 7-OXO IMPURITY ; 7-KETO BEXAROTENE ;
CAS:368451-15-4
BXR53 :
4-[1-(5,6,7,8-Tetrahydro-3,5,5,8,8-pentamethyl-7-oxo-2-naphthalenyl) ethenyl]-benzoic acid ;
BEXAROTENE ACYL-SS-D-GLUCURONIDE ;
CAS:198700-33-3
BXR60 :
1-[4-[1-(5,6,7,8-Tetrahydro-3,5,5,8,8-pentamethyl-2-naphthalenyl)ethenyl]benzoate] -D-glucopyranuronic acid ;
BEXAROTENE KETONE METHYL ESTER IMPURITY ;
CAS:153559-45-6
BXR54 :
Methyl 4-[(5,6,7,8-tetrahydro-3,5,5,8,8-pentamethyl-2-naphthalenyl) carbonyl] benzoate ;
BEZAFIBRATE ;
CAS:41859-67-0
BZF00 :
2-[4-[2-[(4-Chlorobenzoyl)amino]ethyl]phenoxy]-2-methylpropanoic acid ;
BEZAFIBRATE EP IMPURITY A ;
CAS:41859-57-8
BZF01 :
4-Chloro-N-[2-(4-hydroxyphenyl)ethyl]benzamide ; N-(4-Chlorobenzoyl)tyramine ;
BEZAFIBRATE EP IMPURITY B ; INDOMETHACIN EP IMPURITY A ; INDOMETHACIN USP RC B ; ACEMETACIN EP IMPURITY A ;
CAS:74-11-3
BZF02 :
4-Chlorobenzoic acid ;
BEZAFIBRATE EP IMPURITY C ; BEZAFIBRATE METHYL ESTER ;
CAS:2157488-46-3
BZF03 :
Methyl 2-[4-[2-[(4-Chlorobenzoyl)amino]ethyl]phenoxy]-2-methylpropanoate ;
BEZAFIBRATE EP IMPURITY D ; BEZAFIBRATE ETHYL ESTER ;
CAS:41859-58-9
BZF04 :
Ethyl 2-[4-[2-[(4-Chlorobenzoyl)amino]ethyl]phenoxy]-2-methylpropanoate ;
BEZAFIBRATE EP IMPURITY E ; BEZAFIBRATE BUTYL ESTER ;
BZF05 :
Butyl 2-[4-[2-[(4-Chlorobenzoyl)amino]ethyl]phenoxy]-2-methylpropanoate ;
BEZAFIBRATE ISOPROPYL ESTER ;
CAS:153758-85-1
BZF53 :
Isopropyl 2-[4-[2-[(4-Chlorobenzoyl)amino]ethyl]phenoxy]-2-methylpropanoate ;
BICALUTAMIDE ;
CAS:90357-06-5
BCL00 :
(RS)-N-[4-Cyano-3-(trifluoromethyl)phenyl]-3-[(4-fluorophenyl) sulfonyl]-2-hydroxy-2-methyl-propanamide ;
BICALUTAMIDE EP IMPURITY A ; DESFLUORO BICALUTAMIDE ;
CAS:90357-05-4
BCL01 :
(RS)-N-[4-Cyano-3-(trifluoromethyl)phenyl]-3-phenyl sulfonyl-2-hydroxy-2-methyl-propanamide ;
BICALUTAMIDE EP IMPURITY B ; BICALUTAMIDE 2-FLUORO ISOMER ;
CAS:1159977-36-2
BCL02 :
(RS)-N-[4-Cyano-3-(trifluoromethyl)phenyl]-3-[(2-fluorophenyl) sulfonyl]-2-hydroxy-2-methyl-propanamide ;
BICALUTAMIDE EP IMPURITY C ; BICALUTAMIDE DESHYDROXY IMPURITY ;
CAS:906008-94-4
BCL03 :
(RS)-N-[4-Cyano-3-(trifluoromethyl)phenyl]-3-[(4-fluorophenyl) sulfonyl]-2-methyl-propanamide ;
BICALUTAMIDE EP IMPURITY D ;
CAS:654-70-6
BCL04 :
4-Amino-2-(trifluoromethyl)benzonitrile ;
BICALUTAMIDE EP IMPURITY E ; REL-(R*,R*)-BICALUTAMIDE SULFOXIDE ;
CAS:1080647-25-1
BCL05 :
(2RS)-N-[4-Cyano-3-(trifluoromethyl)phenyl]-3-[(RS)-(4-fluorophenyl) sulfinyl]-2-hydroxy-2-methylpropanamide ;
BICALUTAMIDE EP IMPURITY F ; REL-(R*,S*)-BICALUTAMIDE SULFOXIDE ;
CAS:1080647-26-2
BCL06 :
(2SR)-N-[4-Cyano-3-(trifluoromethyl)phenyl]-3-[(RS)-(4-fluorophenyl) sulfinyl]- 2-hydroxy-2-methylpropanamide ;
BICALUTAMIDE EP IMPURITY G ;
BCL07 :
BICALUTAMIDE EP IMPURITY H ;
BCL08 :
(2RS)-N-[4-Cyano-3-(trifluoromethyl)phenyl]-2-[(4-fluorophenyl)sulfonyl]-3-hydroxy-2-methylpropanamide ;
BICALUTAMIDE EP IMPURITY I ;
BCL09 :
BICALUTAMIDE EP IMPURITY J ; BICALUTAMIDE SULFIDE ;
CAS:90356-78-8
BCL10 :
N-[4-Cyano-3-(trifluoromethyl)phenyl]-3-[(4-fluoro-phenyl)sulfanyl]-2-hydroxy-2-methyl-propanamide ;
BICALUTAMIDE EP IMPURITY K ;
BCL11 :
(2R,2'S)-3,3'-Sulfonyl-bis[N-[4-cyano-3-(trifluoromethyl)phenyl]-2-hydroxy-2-methylpropanamide] ;
BICALUTAMIDE EP IMPURITY L ;
BCL12 :
(2RS,2'RS)-3,3'-Sulfonyl-bis[N-[4-cyano-3-(trifluoromethyl)phenyl]-2-hydroxy-2-methylpropanamide] ;
BICALUTAMIDE EP IMPURITY M ;
CAS:151262-57-6
BCL13 :
(2RS)-3-[(4-Fluorophenyl)sulfonyl]-2-hydroxy-2-methylpropanoic acid ;
BICALUTAMIDE OXIRANE IMPURITY ;
CAS:90357-51-0
BCL50 :
N-[4-Cyano-3-(trifluoromethyl)phenyl]-2-methyl-2-oxiranecarboxamide ;
BICALUTAMIDE R-ISOMER ;
CAS:113299-40-4
BCL33 :
Bicalutamide R-Isomer ;
BICALUTAMIDE S-ISOMER ;
CAS:113299-38-0
BCL34 :
Bicalutamide S-Isomer ;
BICALUTAMIDE USP RC A ; BICALUTAMIDE SULFOXIDE ;
CAS:945419-64-7
BCL21 :
N-[4-Cyano-3-(trifluoromethyl)phenyl]-3-[(4-fluoro-phenyl)sulfinyl]-2-hydroxy-2-methyl-propanamide ;
BICALUTAMIDE USP RC B ; BICALUTAMIDE 3-FLUORO ISOMER ;
CAS:1166228-30-3
BCL22 :
(RS)-N-[4-Cyano-3-(trifluoromethyl)phenyl]-3-[(3-fluorophenyl) sulfonyl]-2-hydroxy-2-methyl-propanamide ;
BIFONAZOLE ;
CAS:60628-96-8
BFN00 :
1-[(RS)-(Biphenyl-4-yl)phenylmethyl]-1H-imidazole ;
BIFONAZOLE EP IMPURITY A ;
CAS:7598-80-3
BFN01 :
(RS)-(Biphenyl-4-yl)phenylmethanol ;
BIFONAZOLE EP IMPURITY B ;
CAS:91679-37-7
BFN02 :
4-[(RS)-(Biphenyl-4-yl)phenylmethyl]-1H-imidazole ;
BIFONAZOLE EP IMPURITY C ; CLOTRIMAZOLE EP IMPURITY D ; ONDANSETRON EP IMPURITY E ; FLUTRIMAZOLE EP IMPURITY A ;
CAS:288-32-4
BFN03 :
1H-Imidazole ;
BIFONAZOLE EP IMPURITY D ;
CAS:66600-13-3
BFN04 :
1,3-Bis[(biphenyl-4-yl)phenylmethyl]-1H-imidazolium chloride ;
BIFONAZOLE EP IMPURITY E ;
BFN05 :
1,4-Bis[(biphenyl-4-yl)phenylmethyl]-1H-imidazole ;
BILIRUBIN ;
CAS:635-65-4
BLR00A :
Bilirubin ;
BILIRUBIN DISODIUM ;
BLR00N :
Bilirubin Disodium ;
BIMATOPROST (5E)-ISOMER ; (5E)-BIMATOPROST ;
CAS:1163135-95-2
BPS70 :
(5E)-7-[(1R,2R,3R,5S)-3,5-Dihydroxy-2-[(1E,3S)-3-hydroxy-5-phenyl-1-penten-1-yl]cyclopentyl]-N-ethyl-5-heptenamide ;
BIMATOPROST ;
CAS:155206-00-1
BPS00 :
(5Z)-7-[(1R,2R,3R,5S)-3,5-Dihydroxy-2-[(1E,3S)-3-hydroxy-5-phenyl-1-penten-1-yl]cyclopentyl]-N-ethyl-5-heptenamide ;
BIMATOPROST 15-EPIMER ; (15R)-BIMATOPROST ;
CAS:1163135-92-9
BPS75 :
(5Z)-7-[(1R,2R,3R,5S)-3,5-Dihydroxy-2-[(1E,3R)-3-hydroxy-5-phenyl-1-penten-1-yl]cyclopentyl]-N-ethyl-5-heptenamide ;
BIMATOPROST 15-KETO IMPURITY ;
CAS:1163135-96-3
BPS71 :
(5Z)-7-[(1R,2R,3R,5S)-3,5-Dihydroxy-2-[(1E)-3-oxo-5-phenyl-1-penten-1-yl]cyclopentyl]-N-ethyl-5-heptenamide ;
BIMATOPROST ACID ;
CAS:38344-08-0
BPS50 :
(5Z)-7-[(1R,2R,3R,5S)-3,5-Dihydroxy-2-[(1E,3S)-3-hydroxy-5-phenyl-1-penten-1-yl]cyclopentyl]-5-heptenoic acid ;
BIMATOPROST ACID 15-EPI ISOPROPYL ESTER ;
CAS:130273-87-9
BPS63 :
(Z)-Isopropyl 7-((1R,2R,3R,5S)-3,5-dihydroxy-2-((R,E)-3-hydroxy-5-phenylpent-1-enyl)cyclopentyl)hept-5-enoate ;
BIMATOPROST ACID 15-EPI METHYL ESTER ;
CAS:122675-28-9
BPS61 :
(Z)-Methyl 7-((1R,2R,3R,5S)-3,5-dihydroxy-2-((R,E)-3-hydroxy-5-phenylpent-1-enyl)cyclopentyl)hept-5-enoate ;
BIMATOPROST ACID 15-EPIMER ; (15R)-BIMATOPROST ACID ;
CAS:41639-71-8
BPS60 :
(5Z)-7-[(1R,2R,3R,5S)-3,5-Dihydroxy-2-[(1E,3R)-3-hydroxy-5-phenyl-1-penten-1-yl]cyclopentyl]-5-heptenoic acid ;
BIMATOPROST ACID ISOPROPYL ESTER ;
CAS:130209-76-6
BPS53 :
(Z)-Isopropyl 7-((1R,2R,3R,5S)-3,5-dihydroxy-2-((S,E)-3-hydroxy-5-phenylpent-1-enyl)cyclopentyl)hept-5-enoate ;
BIMATOPROST ACID METHYL ESTER ;
CAS:38315-47-8
BPS51 :
(5Z)-7-[(1R,2R,3R,5S)-3,5-Dihydroxy-2-[(1E,3S)-3-hydroxy-5-phenyl-1-penten-1-yl]cyclopentyl]-5-heptenoic Acid Methyl Ester ;
BIMATOPROST N-CYCLOPROPYL ;
CAS:1138395-12-6
BPS72 :
(5Z)-N-Cyclopropyl-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(1E,3S)-3-hydroxy-5-phenyl-1-penten-1-yl]cyclopentyl]-5-heptenamide ;
BIOLIMUS ; UMIROLIMUS ;
CAS:851536-75-9
BLM00 :
Biolimus A9 ;
BIOTIN ; VITAMIN H ; D-BIOTIN ;
CAS:58-85-5
BTN00 :
(3aS,4S,6aR)-Hexahydro-2-oxo-1H-thieno[3,4-d]imidazole-4-valeric acid ;
BIOTIN EP IMPURITY A ; D-BIOTIN DIMER ACID ;
CAS:1163708-46-0
BTN01 :
Di[3-[(3aS,4S,6aR)-2-oxohexahydrothieno[3,4-d]imidazol-4-yl]propyl]acetic acid ;
BIOTIN EP IMPURITY B ; BIOTIN DIACID ;
CAS:57671-79-1
BTN02 :
4-[(3aS,4S,6aR)-2-Oxohexahydrothieno[3,4-d]imidazol-4-yl]butane-1,1-dicarboxylic acid ;
BIOTIN EP IMPURITY C ;
CAS:412308-26-0
BTN03H :
5-(3,4-Diamino-2-thienyl)pentanoic acid dihydrochloride ;
BIOTIN EP IMPURITY D ; 9-METHYL BIOTIN ;
CAS:415725-35-8
BTN04 :
2-Methyl-5-[(3aS,4S,6aR)-2-oxohexahydrothieno[3,4-d]imidazol-4-yl]pentanoic acid ;
BIOTIN EP IMPURITY E ; MIXTURE OF N1-BENZYL BIOTIN (BTN51) & N3-BENZYL BIOTIN (BTN53) ;
CAS:76335-62-1
BTN05M :
5-[(3aS,4S,6aR)-3-Benzyl-2-oxohexahydrothieno[3,4-d]imidazol-4-yl]pentanoic acid and 5-[(3aS,4S,6aR)-1-benzyl-2-oxohexahydrothieno[3,4-d]imidazol-4-yl]pentanoic acid ;
BIOTIN N1-BENZYL IMPURITY ; N1-BENZYL BIOTIN ;
CAS:76335-62-1
BTN51 :
(3aS,4S,6aR)-Hexahydro-2-oxo-1-(phenylmethyl)-1H-thieno[3,4-d]imidazole-4-pentanoic acid ;
BIOTIN N3-BENZYL IMPURITY ; N3-BENZYL BIOTIN ;
CAS:57229-92-2
BTN53 :
(3aS,4S,6aR)-Hexahydro-2-oxo-3-(phenylmethyl)-H-thieno[3,4-d]imidazole -4-pentanoic acid ;
BIOTIN SULFONE ;
CAS:40720-05-6
BTN08 :
(3aS,4S,6aR)-Hexahydro-2-oxo-1H-thieno[3,4-d]imidazole-4-pentanoic acid 5,5-dioxide ;
BIOTIN SULFOXIDE ;
CAS:23015-53-4
BTN09M :
(3aS,4S,5RS,6aR)-Hexahydro-2-oxo-1H-thieno[3,4-d]imidazole-4-pentanoic acid 5-oxide ;
BIOTIN SULFOXIDE R-ISOMER ;
CAS:3376-83-8
BTN09R :
(3aS,4S,5R,6aR)-Hexahydro-2-oxo-1H-thieno[3,4-d]imidazole-4-pentanoic acid 5-oxide ;
BIOTIN SULFOXIDE S-ISOMER ;
CAS:10406-89-0
BTN09S :
(3aS,4S,5S,6aR)-Hexahydro-2-oxo-1H-thieno[3,4-d]imidazole-4-pentanoic acid 5-oxide ;
BIPERIDEN EP IMPURITY A ; BIPERIDEN ENDO FORM ;
BRD01 :
(1RS)-1-[(1SR,2SR,4SR)-Bicyclo[2.2.1]hept-5-en-2-yl]-1-phenyl-3-(piperidin-1-yl)propan-1-ol ;
BIPERIDEN EP IMPURITY B ;
BRD02 :
(1RS)-1-[(1SR,2RS,4SR)-Bicyclo[2.2.1]hept-5-en-2-yl]-1-phenyl-3-(piperidin-1-yl)propan-1-ol ;
BIPERIDEN EP IMPURITY C ;
BRD03 :
(1RS)-1-[(1RS,2RS,4RS)-Bicyclo[2.2.1]hept-5-en-2-yl]-1-phenyl-3-(piperidin-1-yl)propan-1-ol ;
BIPERIDEN HCL ;
CAS:514-65-8
BRD00H :
(1RS)-1-[(1RS,2SR,4RS)-Bicyclo[2.2.1]hept-5-en-2-yl]-1-phenyl-3-(piperidin-1-yl)propan-1-ol hydrochloride ;
BIPERIDEN N-OXIDE ;
BRD50 :
(1RS)-1-[(1RS,2SR,4RS)-Bicyclo[2.2.1]hept-5-en-2-yl]-1-phenyl-3-(piperidin-1-yl)propan-1-ol N-oxide ;
BISACODYL ;
CAS:603-50-9
BSC00 :
4,4'-(Pyridin-2-ylmethylene)diphenyl diacetate ;
BISACODYL DESACETYL SS-D-GLUCURONIDE ;
CAS:31050-47-2
BSC50 :
4-[(4-Hydroxyphenyl)-2-pyridinylmethyl]phenyl -D-Glucopyranosiduronic Acid ;
BISACODYL EP IMPURITY A ; BISACODYL USP RC A ; DI-DEACETYL BISACODYL ;
CAS:603-41-8
BSC01 :
4,4'-(Pyridin-2-ylmethylene)diphenol ;
BISACODYL EP IMPURITY B ; BISACODYL USP RC B ;
CAS:16985-05-0
BSC02 :
2-[(RS)-(4-Hydroxyphenyl)(pyridin-2-yl)methyl]phenol ;
BISACODYL EP IMPURITY C ; BISACODYL USP RC C ; MONO-DEACETYL BISACODYL ;
CAS:72901-16-7
BSC03 :
4-[(RS)-(4-Hydroxyphenyl)(pyridin-2-yl)methyl]phenyl acetate ;
BISACODYL EP IMPURITY E ; BISACODYL USP RC E ;
CAS:111664-35-8
BSC05 :
2-[(RS)-[4-(Acetyloxy)-phenyl](pyridin-2-yl)methyl]phenyl acetate ;
BISOPROLOL ALCOHOL IMPURITY ;
CAS:623-05-2
BSP52 :
4-Hydroxybenzyl Alcohol ;
BISOPROLOL CARBOXYLIC ACID IMPURITY ;
CAS:72570-70-8
BSP31L :
4-(2-Hydroxy-3-isopropylaminopropoxy)benzoic acid lithium salt ;
BISOPROLOL EP IMPURITY A ; BISOPROLOL USP RC A ;
CAS:62572-93-4
BSP01 :
(RS)-1-(4-Hydroxymethylphenoxy)-3-isopropylaminopropan-2-ol ;
BISOPROLOL EP IMPURITY B ; BISOPROLOL PROPYL ANALOG ;
CAS:539823-39-7
BSP02 :
(RS)-1-Isopropylamino-3-[4-(2-propoxyethoxymethyl) phenoxy] propan-2-ol ;
BISOPROLOL EP IMPURITY C ;
CAS:1797132-90-1
BSP03 :
(RS)-1-[4-[4-(2-Hydroxy-3-isopropopylaminopropoxy)-benzyl]phenoxy]- 3-isopropylaminopropan-2-ol ;
BISOPROLOL EP IMPURITY D ;
CAS:1225195-71-0
BSP04 :
(RS)-1-[4-[4-(2-Hydroxy-3-isopropylaminopropoxy)benzyloxylmethyl] phenoxy]-3-isopropylaminopropan-2-ol ;
BISOPROLOL EP IMPURITY E ; DEHYDRO BISOPROLOL ; ANHYDRO BISOPROLOL ;
CAS:1217245-60-7
BSP05 :
(EZ)-[3-[4-(2-Isopropoxy-ethoxymethyl)phenoxy]allyl] isopropylamine ;
BISOPROLOL EP IMPURITY F (BASE) ;
CAS:1798418-82-2
BSP06B :
(RS)-2-[4-(2-Isopropoxy-ethoxymethyl)phenoxy]-3-isopropyl amino propan-2-ol ;
BISOPROLOL EP IMPURITY F (FUMARATE SALT) ;
BSP06F :
(RS)-2-[4-(2-Isopropoxy-ethoxymethyl)phenoxy]-3-isopropyl amino propan-2-ol fumarate ;
BISOPROLOL EP IMPURITY G ;
CAS:1215342-36-1
BSP07 :
(2RS)-1-[4-(((2-Isopropoxy-ethoxy)methoxy)methyl)phenoxy]-3- (isopropyl-amino)-2-propanol ;
BISOPROLOL EP IMPURITY H ;
BSP08 :
Bisoprolol EP Impurity H ;
BISOPROLOL EP IMPURITY I ;
BSP09 :
Bisoprolol EP Impurity I ;
BISOPROLOL EP IMPURITY J ;
CAS:1797024-50-0
BSP10 :
(2RS)-3-[4-((2-Isopropoxyethoxy)methyl)phenoxy]-1,2-propanediol ;
BISOPROLOL EP IMPURITY K ; BISOPROLOL ESTER IMPURITY ; KETO BISOPROLOL ;
CAS:864544-37-6
BSP11M :
2-Isopropoxyethyl 4-[((2RS)-2-Hydroxy-3-(isopropylamino)propyl)-oxy]benzoate maleate ;
BISOPROLOL EP IMPURITY L ; METOPROLOL EP IMPURITY C (= USP RC C) ;
CAS:29122-74-5
BSP12H :
4-[((2RS)-2-Hydroxy-3-(isopropylamino)-propyl)oxy]benzaldehyde hydrochloride ;
BISOPROLOL EP IMPURITY M ;
CAS:177034-57-0
BSP13 :
4-[(2-Isopropoxyethoxy)methyl]phenol ;
BISOPROLOL EP IMPURITY N ;
CAS:1346601-75-9
BSP14F :
(2RS)-1-[4-((2-Ethoxyethoxy)methyl)phenoxy]-3-(isopropylamino)-2-propanol fumarate salt ;
BISOPROLOL EP IMPURITY O ;
BSP15 :
Bisoprolol EP Impurity O ;
BISOPROLOL EP IMPURITY P ;
BSP16 :
Bisoprolol EP Impurity P ;
BISOPROLOL EP IMPURITY Q ;
CAS:1346604-00-9
BSP17F :
(2RS)-1-Isopropylamino-3-[4-(2-methoxyethoxy)methyl]-phenoxy-2-propanol fumarate ;
BISOPROLOL EP IMPURITY R ; BISOPROLOL USP RC C ;
CAS:5790-46-5
BSP18F :
(2RS)-1-(Isopropylamino)-3-(4-methylphenoxy)propan-2-ol fumarate ;
BISOPROLOL EP IMPURITY S ;
CAS:123-08-0
BSP19 :
4-Hydroxybenzaldehyde ;
BISOPROLOL EPOXIDE IMPURITY ;
CAS:66722-57-4
BSP22 :
2-[4-(2-Isopropoxyethoxymethyl)phenoxymethyl]oxirane ;
BISOPROLOL FUMARATE ;
CAS:104344-23-2
BSP00F :
1-[4-[[2-(1-Methylethoxy)ethoxy]methyl]phenoxy]-3-[(1-methylethyl) amino]-2-propanol fumarate salt ;
BISOPROLOL HYDROXYETHYL ESTER IMPURITY ;
CAS:1346601-19-1
BSP51F :
2-Hydroxyethyl 4-(2-hydroxy-3-(isopropylamino)propoxy)benzoate hemifumarate ;
BISOPROLOL HYDROXYMETHYL OXIRAN IMPURITY ;
CAS:4204-78-8
BSP47 :
(4-(Oxiran-2-ylmethoxy)phenyl)methanol ;
BISOPROLOL USP RC E ; BISOPROLOL DIMER ;
BSP25 :
3,3'-(Isopropylazanediyl)bis(1-(4-((2-isopropoxyethoxy)methyl)phenoxy)propan-2-ol) ;
BOCEPREVIR ;
CAS:394730-60-0
BPV00 :
(1R,2S,5S)-N-[3-Amino-1-(cyclobutylmethyl)-2,3-dioxopropyl]-3-[(2S)-2-[[[(1,1-dimethylethyl)amino]carbonyl]amino]-3,3-dimethyl-1-oxobutyl]-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide ;
BOCEPREVIR 2-DIHYDRO IMPURITY ;
BPV72 :
(1R,2S,5S)-N-[3-Amino-1-(cyclobutylmethyl)-2-hydroxy-3-oxopropyl]-3-[(2S)-2-[[[(1,1-dimethylethyl)amino]carbonyl]amino]-3,3-dimethyl-1-oxobutyl]-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide ;
BOCEPREVIR METABOLITE M15 ;
CAS:1351791-45-1
BPV65 :
(1R,2S,5S)-3-[(2S)-2-[[[[1,1-Dimethylethyl]amino]carbonyl]amino]-3,3-dimethyl-1-oxobutyl]-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carbamide ;
BOCEPREVIR METABOLITE M4 ;
CAS:816444-90-3
BPV54 :
(1R,2S,5S)-3-[(2S)-2-[[[[1,1-Dimethylethyl]amino]carbonyl]amino]-3,3-dimethyl-1-oxobutyl]-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxylic Acid ;
BORTEZOMIB (1S, 2R)-ISOMER ; BORTEZOMIB ENANTIOMER ;
CAS:1132709-16-0
BTZ43 :
[(1S)-3-Methyl-1-({(2R)-3-phenyl-2-[(pyrazin-2-ylcarbonyl)amino]propanoyl} amino)butyl]boronic acid ;
BORTEZOMIB ; (1R, 2S)-BORTEZOMIB ;
CAS:179324-69-7
BTZ00 :
[(1R)-3-Methyl-1-({(2S)-3-phenyl-2-[(pyrazin-2-ylcarbonyl)amino]propanoyl} amino)butyl]boronic acid ;
BORTEZOMIB ACID METHYL ESTER ;
CAS:73058-37-4
BTZ44 :
(2S)-3-Phenyl-2-[(pyrazin-2-ylcarbonyl)amino]propanoic acid methyl ester ;
BORTEZOMIB ACID R-ISOMER ;
CAS:1608986-16-8
BTZ81 :
(2R)-3-Phenyl-2-[(pyrazin-2-ylcarbonyl)amino]propanoic acid ;
BORTEZOMIB ACID R-ISOMER METHYL ESTER ;
BTZ82 :
(2R)-3-Phenyl-2-[(pyrazin-2-ylcarbonyl)amino]propanoic acid methyl ester ;
BORTEZOMIB DESBORONIC IMPURITY ;
CAS:1446194-56-4
BTZ48 :
(S)-N-(1-(Isopentylamino)-1-oxo-3-phenylpropan-2-yl)pyrazine-2-carboxamide ;
BORTEZOMIB HYDROXY (1R, 2R)-ISOMER ;
BTZ76 :
N-[(2R)-1-{[(1R)-1-Hydroxy-3-methyl butyl]amino}-1-oxo-3-phenylpropan-2-yl]pyrazine-2-carboxamide ;
BORTEZOMIB HYDROXY (1S, 2R)-ISOMER ;
BTZ77 :
N-[(2R)-1-{[(1S)-1-Hydroxy-3-methyl butyl]amino}-1-oxo-3-phenylpropan-2-yl]pyrazine-2-carboxamide ;
BORTEZOMIB METHOXY (1R, 2R)-ISOMER ;
BTZ71 :
N-[(2R)-1-{[(1R)-1-Methoxy-3-methyl butyl]amino}-1-oxo-3-phenylpropan-2-yl]pyrazine-2-carboxamide ;
BORTEZOMIB METHOXY (1R, 2S)-ISOMER ;
BTZ70 :
N-[(2S)-1-{[(1R)-1-Methoxy-3-methyl butyl]amino}-1-oxo-3-phenylpropan-2-yl]pyrazine-2-carboxamide ;
BORTEZOMIB METHOXY (1S, 2R)-ISOMER ;
BTZ72 :
N-[(2R)-1-{[(1S)-1-Methoxy-3-methyl butyl]amino}-1-oxo-3-phenylpropan-2-yl]pyrazine-2-carboxamide ;
BORTEZOMIB METHOXY (1S, 2S)-ISOMER ;
BTZ73 :
N-[(2S)-1-{[(1S)-1-Methoxy-3-methyl butyl]amino}-1-oxo-3-phenylpropan-2-yl]pyrazine-2-carboxamide ;
BORTEZOMIB N-HEXYL IMPURITY ;
BTZ46 :
B-[(1R)-1-[[(2S)-1-Oxo-3-phenyl-2-[(2-pyrazinylcarbonyl)amino]propyl]amino] hexyl]boronic acid ;
BORTEZOMIB N-PENTYL IMPURITY ;
CAS:1104011-35-9:
BTZ45 :
B-[(1R)-1-[[(2S)-1-Oxo-3-phenyl-2-[(2-pyrazinylcarbonyl)amino]propyl]amino] pentyl]boronic acid ;
BORTEZOMIB PINANEDIOL IMPURITY ;
CAS:205393-22-2
BTZ42 :
N-[(1S)-2-[[(1R)-1-[(3aS,4S,6S,7aR)-Hexahydro-3a,5,5-trimethyl-4,6-methano-1,3,2-benzodioxaborol-2-yl]-3-methylbutyl]amino]-2-oxo-1-(phenylmethyl)ethyl]-2-pyrazinecarboxamide ;
BORTEZOMIB USP IMPURITY A ; BORTEZOMIB DESPHENYLALANYL ANALOG (USP) ;
BTZ51 :
(R)-[3-Methyl-1-(pyrazine-2-carboxamido)butyl]boronic acid ;
BORTEZOMIB USP IMPURITY B ; BORTEZOMIB AMIDE ANALOG (USP) ; BORTEZOMIB AMIDE IMPURITY ;
CAS:289472-80-6
BTZ52 :
(2S)-3-Phenyl-2-[(pyrazin-2-ylcarbonyl)amino]propanamide ;
BORTEZOMIB USP IMPURITY C ; HYDROXY BORTEZOMIB (USP) ; BORTEZOMIB 3-HYDROXY IMPURITY ;
BTZ53 :
{(R)-3-Hydroxy-3-methyl-1-[(S)-3-phenyl-2-(pyrazine-2-carboxamido)propanamido]butyl}boronic acid ;
BORTEZOMIB USP IMPURITY D ; BORTEZOMIB ACID ANALOG (USP) ;
CAS:114457-94-2
BTZ54 :
(2S)-3-Phenyl-2-[(pyrazin-2-ylcarbonyl)amino]propanoic acid ; N-(2-Pyrazinyl carbonyl)-L-phenylalanine ; (S)-3-Phenyl-2-(pyrazine-2-carboxamido)propanoic acid ;
BORTEZOMIB USP IMPURITY E ; BORTEZOMIB N-FORMYL ANALOG (USP) ;
BTZ55 :
(S)-N-(1-Formamido-1-oxo-3-phenylpropan-2-yl)pyrazine-2-carboxamide ;
BORTEZOMIB USP IMPURITY F ; BORTEZOMIB HYDROXYKETONE ANALOG (USP) ;
BTZ56 :
(S)-N-(1-(3-Hydroxy-3-methylbutanamido)-1-oxo-3-phenylpropan-2-yl)pyrazine-2-carboxamide ;
BORTEZOMIB USP IMPURITY G ; BORTEZOMIB (S,S)-DIASTEREOMER (USP) ; BORTEZOMIB (1S, 2S)-ISOMER ; BORTEZOMIB 1-EPIMER ;
CAS:1132709-14-8
BTZ57 :
[(1S)-3-Methyl-1-({(2S)-3-phenyl-2-[(pyrazin-2-ylcarbonyl)amino]propanoyl} amino)butyl]boronic acid ;
BORTEZOMIB USP IMPURITY I ; (S,R)-BORTEZOMIB HYDROXYISOPENTYL AMIDE ANALOG (USP) ; BORTEZOMIB HYDROXY (1R, 2S)-ISOMER ;
CAS:289472-78-2
BTZ59 :
N-[(S)-1-{[(R)-1-Hydroxy-3-methylbutyl]amino}-1-oxo-3-phenylpropan-2-yl]pyrazine-2-carboxamide ;
BORTEZOMIB USP IMPURITY J ; (S,S)-BORTEZOMIB HYDROXYISOPENTYL AMIDE ANALOG (USP) ; BORTEZOMIB HYDROXY (1S, 2S)-ISOMER ;
CAS:289472-81-7
BTZ60 :
N-[(S)-1-{[(S)-1-Hydroxy-3-methylbutyl]amino}-1-oxo-3-phenylpropan-2-yl]pyrazine-2-carboxamide ;
BORTEZOMIB USP IMPURITY L ; BORTEZOMIB R-HYDROXYPEROXIDE (USP) ; (R)-HYDROPEROXY DES(BORIC ACID) BORTEZOMIB ;
CAS:886979-78-8
BTZ62 :
N-((S)-1-(((R)-1-Hydroperoxy-3-methylbutyl)amino)-1-oxo-3-phenylpropan-2-yl)pyrazine-2-carboxamide ;
BORTEZOMIB USP IMPURITY M ; BORTEZOMIB S-HYDROXYPEROXIDE (USP) ; (S)-HYDROPEROXY DES(BORIC ACID) BORTEZOMIB ;
CAS:886979-81-3
BTZ63 :
N-((S)-1-(((S)-1-Hydroperoxy-3-methylbutyl)amino)-1-oxo-3-phenylpropan-2-yl)pyrazine-2-carboxamide ;
BORTEZOMIB USP IMPURITY O ; BORTEZOMIB L-PHENYLALANYL ANALOG (USP) ;
CAS:1194235-41-0
BTZ65 :
((R)-3-Methyl-1-((S)-3-phenyl-2-((S)-3-phenyl-2-(pyrazine-2-carboxamido) propanamido)propanamido)butyl)boronic Acid ;
BORTEZOMIB USP IMPURITY P ; BORTEZOMIB D-PHENYLALANYL ANALOG (USP) ;
BTZ66 :
((R)-3-Methyl-1-((S)-3-phenyl-2-((R)-3-phenyl-2-(pyrazine-2-carboxamido) propanamido)propanamido)butyl)boronic Acid ;
BORTEZOMIB USP RC A ; BORTEZOMIB (1R, 2R)-ISOMER ; BORTEZOMIB (R,R)-DIASTEREOMER (USP) ; BORTEZOMIB USP IMPURITY H ;
CAS:1132709-15-9
BTZ21 :
[(1R)-3-Methyl-1-({(2R)-3-phenyl-2-[(pyrazin-2-ylcarbonyl)amino]propanoyl} amino)butyl]boronic acid ;
BOSENTAN ;
CAS:157212-55-0
BSN00 :
4-(1,1-Dimethylethyl)-N-[6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)[2,2-bipyrimidin]-4-yl]benzenesulfonamide ;
BOSENTAN HYDROXYMETHYL IMPURITY ;
CAS:253688-60-7
BSN31 :
4-(2-Hydroxy-1,1-dimethylethyl)-N-[6-(2-hydroxyethoxy)-5-(2-methoxy phenoxy)[2,2'-bipyrimidin]-4-yl]-benzenesulfonamide ;
BOSENTAN HYDROXYMETHYL O-DESMETHYL IMPURITY ;
CAS:253688-62-9
BSN32 :
4-(2-Hydroxy-1,1-dimethylethyl)-N-[6-(2-hydroxyethoxy)-5-(2-hydroxy phenoxy) [2,2'-bipyrimidin]-4-yl]benzenesulfonamide ;
BOSENTAN O-DESMETHYL IMPURITY ;
CAS:253688-61-8
BSN33 :
O-Desmethyl Bosentan ; 4-(1,1-Dimethylethyl)-N-[6-(2-hydroxyethoxy)-5-(2-hydroxyphenoxy)[2,2-bipyrimidin]-4-yl]benzenesulfonamide ;
BOSENTAN SULFIDE ;
BSN41 :
2-(6-(4-tert-Butylphenylthioamino)-5-(2-methoxyphenoxy)-2-(pyrimidin-2-yl) pyrimidin-4-yloxy)ethanol ;
BOSENTAN SULFOXIDE ;
BSN42 :
4-tert-Butyl-N-(6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-2-(pyrimidin-2-yl) pyrimidin-4-yl)benzenesulfinamide ;
BOSENTAN USP RC A ;
CAS:150727-06-3
BSN21 :
4-(tert-Butyl)-N-[6-chloro-5-(2-methoxyphenoxy)-(2,2'-bipyrimidin)-4-yl] benzenesulfonamide ;
BOSENTAN USP RC B ;
CAS:174227-14-6
BSN22 :
4-(tert-Butyl)-N-[6-hydroxy-5-(2-methoxyphenoxy)-(2,2'-bipyrimidin)-4-yl]benzenesulfonamide ;
BOSENTAN USP RC C ;
CAS:1097263-60-9
BSN23 :
1,2-bis({6-[4-(tert-Butyl)phenylsulfonamido]-5-(2-methoxyphenoxy)-[2,2'-bipyrimidin]-4-yl}oxy)ethane ;
BOSENTAN USP RC D ;
CAS:150728-13-5
BSN24 :
4,6-Dichloro-5-(2-methoxyphenoxy)-2,2'-bipyrimidine ;
BOSENTAN USP RC E ;
CAS:6292-59-7
BSN25 :
4-(tert-Butyl)benzenesulfonamide ;
BOSUTINIB ;
CAS:380843-75-4
BST00 :
4-[(2,4-Dichloro-5-methoxyphenyl)amino]-6-methoxy-7-[3-(4-methyl-1-piperazinyl)propoxy]-3-quinolinecarbonitrile ;
BOSUTINIB 2,4-DICHLORO-5-METHOXYBENZENAMINE IMPURITY ;
CAS:98446-49-2
BST55 :
2,4-Dichloro-5-methoxybenzenamine ;
BOSUTINIB 4-CHLORO 7-CHLOROPROPOXY IMPURITY ;
CAS:214470-68-5
BST56 :
4-Chloro-7-(3-chloropropoxy)-6-methoxyquinoline-3-carbonitrile ;
BOSUTINIB 4-HYDROXY 7-CHLOROPROPOXY IMPURITY ;
CAS:214470-66-3
BST57 :
4-Hydroxy-7-(3-chloropropoxy)-6-methoxyquinoline-3-carbonitrile ;
BOSUTINIB 7-CHLOROPROPOXY IMPURITY ;
CAS:380844-49-5
BST58 :
7-(3-Chloropropoxy)-4-(2,4-dichloro-5-methoxyphenylamino)-6-methoxyquinoline-3-carbonitrile ;
BOSUTINIB IMPURITY 1 ;
CAS:492444-39-0
BST51 :
4-Chloro-6-methoxy-7-(3-(4-methylpiperazin-1-yl)propoxy)quinoline-3-carbonitrile ;
BOSUTINIB IMPURITY 2 ; N-DESMETHYL BOUSUTINIB ;
CAS:380843-81-2
BST52 :
4-(2,4-Dichloro-5-methoxyphenylamino)-6-methoxy-7-(3-(piperazin-1-yl)propoxy)quinoline-3-carbonitrile ;
BOSUTINIB IMPURITY 3 ;
CAS:1460227-29-5
BST53 :
4-(2,4-Dichloro-5-methoxyphenylamino)-7-hydroxy-6-methoxyquinoline-3-carbonitrile ;
BOSUTINIB IMPURITY 4 ;
CAS:380843-12-9
BST54 :
4-(2,4-Dichloro-5-methoxyphenylamino)-6,7-dimethoxyquinoline-3-carbonitrile ;
BREMELANOTIDE ACETATE ;
CAS:189691-06-3
BMT00 :
PT141 Acetate ;
BREXPIPRAZOLE ;
CAS:913611-97-9
BRX00 :
7-[4-(4-(Benzo[b]thien-4-yl)-piperazin-1-yl)butoxy]-1H-quinolin-2-one ;
BREXPIPRAZOLE BENZOTHIOPHENE IMPURITY ;
BRX54 :
7-(4-(4-(2-(Benzo[b]thiophen-4-yl)benzo[b]thiophen-4-yl)piperazin-1-yl)butoxy)quinolin-2(1H)-one ;
BREXPIPRAZOLE BUTOXYQUINOLINONE IMPURITY ;
BRX67 :
4-(Benzo[b]thiophen-4-yl)-1,1-bis(4-((2-oxo-1,2-dihydroquinolin-7-yl)oxy)butyl)piperazin-1-ium iodide ;
BREXPIPRAZOLE CHLOROBUTOXYQUINOLINOL IMPURITY ;
BRX53 :
2-(4-Chlorobutoxy)quinolin-7-ol ;
BREXPIPRAZOLE DESQUINOLINONYL IMPURITY ;
CAS:913614-15-0
BRX49 :
4-(4-(Benzo[b]thiophen-4-yl)piperazin-1-yl)butan-1-ol ;
BREXPIPRAZOLE IMPURITY 1 ;
BRX61 :
7-(4-(7-(4-Chlorobutoxy)quinolin-2-yloxy)butoxy)quinolin-2(1H)-one ;
BREXPIPRAZOLE IMPURITY 2 ;
BRX62 :
7-(4-(7-(4-Chlorobutoxy)-2-oxoquinolin-1(2H)-yl)butoxy)quinolin-2(1H)-one ;
BREXPIPRAZOLE IMPURITY 3 ;
BRX63 :
2,7-bis(4-Chlorobutoxy)quinoline ;
BREXPIPRAZOLE IMPURITY 4 ;
CAS:2059954-32-2
BRX64 :
7-(4-Chlorobutoxy)-1-(4-chlorobutyl)quinolin-2(1H)-one ;
BREXPIPRAZOLE IMPURITY 5 ;
CAS:2094559-58-5
BRX65 :
7-(4-(4-(Benzo[b]thiophen-4-yl)piperazin-1-yl)butoxy)-1-(4-((2-oxo-1,2-dihydroquinolin-7-yl)oxy)butyl)quinolin-2(1H)-one ;
BREXPIPRAZOLE IMPURITY 6 ;
BRX66 :
1-(4-Chlorobutyl)-7-hydroxyquinolin-2(1H)-one ;
BREXPIPRAZOLE N-OXIDE ;
CAS:1191900-58-9
BRX50 :
7-[4-(4-Benzo[b]thien-4-yl-1-oxido-1-piperazinyl)butoxy]-2(1H)-quinolinone ;
BREXPIPRAZOLE SULFONE ;
BRX52 :
7-[4-(4-(Benzo[b]thien-4-yl)-piperazin-1-yl)butoxy]-1H-quinolin-2-one sulfone ;
BREXPIPRAZOLE SULFOXIDE ;
CAS:1191900-51-2
BRX51 :
7-[4-(4-(Benzo[b]thien-4-yl)-piperazin-1-yl)butoxy]-1H-quinolin-2-one sulfoxide ;
BRIMONIDINE ;
CAS:59803-98-4
BRM00 :
5-Bromo-N-(4,5-dihydro-1H-imidazol-2-yl)-6-quinoxalinamine ;
BRIMONIDINE 2,3-DIONE IMPURITY ;
CAS:182627-95-8
BRM50 :
5-Bromo-6-[(4,5-dihydro-1H-imidazol-2-yl)amino]-1,4-dihydro-2,3-quinoxalinedione ;
BRIMONIDINE CARBAMOTHIOATE IMPURITY ;
CAS:842138-75-4
BRM51 :
O-Ethyl (5-bromoquinoxalin-6-yl)carbamothioate ; (5-Bromo-6-quinoxalinyl) carbamothioic acid O-ethyl ester ;
BRIMONIDINE EP IMPURITY A ; DESBROMO BRIMONIDINE ;
CAS:91147-43-2
BRM01 :
N-(Imidazolidin-2-ylidene)quinoxalin-6-amine ;
BRIMONIDINE EP IMPURITY B ; BRIMONIDINE USP RC A ;
CAS:50358-63-9
BRM02 :
6-Amino-5-bromoquinoxaline ;
BRIMONIDINE EP IMPURITY C ;
CAS:6298-37-9
BRM03 :
Quinoxalin-6-amine ;
BRIMONIDINE EP IMPURITY D ; BRIMONIDINE USP RC B ;
CAS:842138-74-3
BRM04 :
5-Bromoquinazolin-6-ylthiourea ; N-(5-Bromo-6-quinoxalinyl)thiourea ;
BRIMONIDINE EP IMPURITY E ;
CAS:168329-48-4
BRM05 :
2-(5-Bromoquinoxalin-6-yl)guanidine ;
BRIMONIDINE EP IMPURITY F ; 4,5-DIDEHYDRO BRIMONIDINE ;
CAS:151110-15-5
BRM06 :
5-Bromo-N-1H-imidazol-2-yl-6-quinoxalinamine ;
BRIMONIDINE EP IMPURITY G ; HYDROXY BRIMONIDINE TRIFLUOROACETIC ACID SALT ;
CAS:1216379-05-3
BRM07T :
1-(2-Aminoethyl)-3-(5-bromoquinoxalin-6-yl)urea trifluoroacetic acid salt ;
BRIMONIDINE EP IMPURITY H ;
CAS:91147-46-5
BRM08 :
5-Chloro-N-(4,5-dihydro-1H-imidazol-2-yl)-6-quinoxalinamine ;
BRINZOLAMIDE (4R)-HYDROXY ANALOG ;
CAS:165117-54-4
BRZ52 :
(R)-4-Hydroxy-3,4-dihydro-2-(3-methoxypropyl)-2H-thieno[3,2-e]-1,2-thiazine-6-sulfonamide 1,1-Dioxide ;
BRINZOLAMIDE (4S)-HYDROXY ANALOG ;
CAS:154127-42-1
BRZ53 :
(S)-4-Hydroxy-3,4-dihydro-2-(3-methoxypropyl)-2H-thieno[3,2-e]-1,2-thiazine-6-sulfonamide 1,1-Dioxide ;
BRINZOLAMIDE ;
CAS:138890-62-7
BRZ00 :
(R)-4-(Ethylamino)-3,4-dihydro-2-(3-methoxypropyl)-2H-thieno[3,2-e]-1,2-thiazine-6-sulfonamide 1,1-Dioxide ;
BRINZOLAMIDE METHANESULFONYL AMIDE ;
BRZ50 :
(R)-4-(N-ethylmethan-6-ylsulfonamido)-2-(3-methoxypropyl)-3,4-dihydro-2H-thieno[3,2-e][1,2]thiazine-6-sulfonamide 1,1-Dioxide ;
BRINZOLAMIDE O-DESMETHYL IMPURITY ;
CAS:186377-56-0
BRZ51 :
(R)-4-(Ethylamino)-3,4-dihydro-2-(3-hydroxypropyl)-2H-thieno[3,2-e]-1,2-thiazine-6-sulfonamide 1,1-Dioxide ;
BRINZOLAMIDE USP RC A ; BRINZOLAMIDE (S)-ISOMER ;
CAS:154127-19-2
BRZ21 :
(S)-4-(Ethylamino)-3,4-dihydro-2-(3-methoxypropyl)-2H-thieno[3,2-e]-1,2-thiazine-6-sulfonamide 1,1-Dioxide ;
BRINZOLAMIDE USP RC B ; BRINZOLAMIDE N-DESETHYL IMPURITY ;
CAS:404034-55-5
BRZ22 :
(4R)-4-Amino-3,4-dihydro-2-(3-methoxypropyl)-2H-thieno[3,2-e]-1,2-thiazine-6-sulfonamide 1,1-Dioxide ;
BRIVANIB ; BMS-540215 ;
CAS:649735-46-6
BVN00 :
(1R)-2-[[4-[(4-Fluoro-2-methyl-1H-indol-5-yl)oxy]-5-methylpyrrolo [2,1-f] [1,2,4]triazin-6-yl]oxy]-1-methylethanol ;
BRIVANIB ALANINATE ; BMS-582664 ;
CAS:649735-63-7
BVN00A :
L-Alanine (1R)-2-[[4-[(4-fluoro-2-methyl-1H-indol-5-yl)oxy]-5-methylpyrrolo [2,1-f][1,2,4]triazin-6-yl]oxy]-1-methylethyl ester ;
BROMFENAC ACYL-SS-D-GLUCURONIDE ;
BRF50 :
2-Amino-3-(4-bromobenzoyl)benzeneacetyl -D-glucopyranosiduronic acid ;
BROMFENAC ETHYL ESTER ;
CAS:102414-22-2
BRF52 :
2-Amino-3-(4-bromobenzoyl)benzeneacetic acid ethyl ester ;
BROMFENAC METHYL ESTER ;
BRF51 :
2-Amino-3-(4-bromobenzoyl)benzeneacetic acid methyl ester ;
BROMFENAC N-SS-D-GLUCOSIDE ;
CAS:212266-82-5
BRF60 :
3-(4-Bromobenzoyl)-2-(-D-glucopyranosylamino)benzeneacetic acid ;
BROMFENAC SODIUM ;
CAS:120638-55-3
BRF00N :
2-[2-Amino-3-(4-bromobenzoyl)phenyl]acetic acid sodium salt ;
BROMHEXINE ACID ; AMBROXOL ACID ;
CAS:609-85-8
BHX31 :
2-Amino-3,5-dibromobenzoic acid ;
BROMHEXINE EP IMPURITY A ; AMBROXOL EP IMPURITY A ;
CAS:50739-76-9
BHX01 :
(2-Amino-3,5-dibromophenyl)methanol ;
BROMHEXINE EP IMPURITY B ; AMBROXOL EP IMPURITY E ;
CAS:50910-55-9
BHX02 :
2-Amino-3,5-dibromobenzaldehyde ;
BROMHEXINE EP IMPURITY C ; DIDESBROMO BROMOHEXINE ;
CAS:57365-08-9
BHX03 :
N-(2-Aminobenzyl)-N-methylcyclohexanamine ;
BROMHEXINE EP IMPURITY D ; MONODESBROMO BROMOHEXINE DIHYDROCHLORIDE ;
CAS:10076-98-9
BHX04H :
N-(2-Amino-5-bromobenzyl)-N-methylcyclohexanamine dihydrochloride ;
BROMHEXINE EP IMPURITY E ;
CAS:1661064-00-1
BHX05 :
(3RS)-6,8-Dibromo-3-cyclohexyl-3-methyl-1,2,3,4-tetrahydroquinazolin-3-ium ;
BROMHEXINE HCL ;
CAS:611-75-6
BHX00H:
N-(2-Amino-3,5-dibromobenzyl)-N-methylcyclohexanamine hydrochloride ;
BUDESONIDE (22R)-ISOMER ; DEXBUDESONIDE ;
CAS:51372-29-3
BDS50 :
(11,16a)-16,17-[(1R)-Butylidenebis(oxy)]-11,21-dihydroxypregna-1,4-diene-3,20-dione ;
BUDESONIDE (22S)-ISOMER ;
CAS:51372-28-2
BDS51 :
(11,16a)-16,17-[(1S)-Butylidenebis(oxy)]-11,21-dihydroxypregna-1,4-diene-3,20-dione ;
BUDESONIDE ;
CAS:51333-22-3
BDS00 :
16a,17-[(1RS)-Butylidenebis(oxy)]-11,21-dihydroxypregna-1,4-diene-3,20-dione ;
BUDESONIDE 1,4,14-TRIENE TRIOL IMPURITY ;
CAS:131918-72-4
BDS42 :
(11,16a)-21-(Acetyloxy)-11,16,17-trihydroxypregna-1,4,14-triene-3,20-dione ;
BUDESONIDE 1,4,16-TRIENE IMPURITY ;
CAS:3044-42-6
BDS43 :
21-Acetoxy-11-hydroxypregna-1,4,16-triene-3,20-dione ;
BUDESONIDE 17,21-DIACETYLOXY IMPURITY ;
CAS:17652-24-3
BDS45 :
11,17,21-Trihydroxypregna-1,4-diene-3,20-dione; (11)-17,21-Bis(acetyl oxy)-11-hydroxypregna-1,4-diene-3,20-dione ;
BUDESONIDE 17-CARBOXYLIC ACID IMPURITY ;
CAS:192057-49-1
BDS44 :
(11,16a,17a)-16,17-[Butylidenebis(oxy)]-11-hydroxy-3-oxo-androsta-1,4-diene-17-carboxylic acid ;
BUDESONIDE 21-BUTYRATE IMPURITY ;
BDS64 :
16a,17-[(1RS)-Butylidenebis(oxy)]-11,21-dihydroxypregna-1,4-diene-3,20-dione-21-butyrate ;
BUDESONIDE 6-ALPHA-HYDROXY IMPURITY ;
CAS:577777-51-6
BDS61 :
(6a,11,16a)-16,17-[Butylidenebis(oxy)]-6,11,21-trihydroxypregna-1,4-diene-3,20-dione ;
BUDESONIDE 6-BETA-HYDROXY IMPURITY ;
CAS:88411-77-2
BDS62 :
(6,11,16a)-16,17-[Butylidenebis(oxy)]-6,11,21-trihydroxypregna-1,4-diene-3,20-dione ;
BUDESONIDE ACID ;
BDS52 :
16a,17-[(1RS)-Butylidenebis(oxy)]-11-hydroxy-21-carboxy-pregna-1,4-diene-3,20-dione ;
BUDESONIDE EP IMPURITY A ; 16A-HYDROXYPREDNISOLONE (USP) ;
CAS:13951-70-7
BDS01 :
11,16a,17,21-Tetrahydroxypregna-1,4-diene-3,20-dione ;
BUDESONIDE EP IMPURITY B ; BUDESONIDE ACETYLALDEHYDE ACETAL IMPURITY (USP) ;
CAS:1040085-98-0
BDS02 :
16a,17-[(1RS)-Ethylidenebis(oxy)]-11,21-dihydroxypregna-1,4-diene-3,20-dione ;
BUDESONIDE EP IMPURITY C ; D-HOMO BUDESONIDE (USP) ;
CAS:1040085-99-1
BDS03 :
16a,17-[(1RS)-Butylidenebis(oxy)]-11-hydroxy-17-(hydroxymethyl)-D-homoandrosta-1,4-diene-3,17a-dione ;
BUDESONIDE EP IMPURITY D ; 21-DEHYDROBUDESONIDE ; BUDESONIDE GLYOXAL IMPURITY ; BUDESONIDE ALDEHYDE IMPURITY ;
CAS:85234-63-5
BDS04 :
16a,17-[(1RS)-Butylidenebis(oxy)]-11-hydroxy-3,20-dioxopregna-1,4-dien-21-aldehyde ;
BUDESONIDE EP IMPURITY E ( = USP RC E ) ; 14,15-DEHYDRO BUDESONIDE ;
CAS:131918-64-4
BDS05 :
16a,17-[(1RS)-Butylidenebis(oxy)]-11,21-dihydroxypregna-1,4,14-triene-3,20-dione ;
BUDESONIDE EP IMPURITY F ; DESONIDE ;
CAS:638-94-8
BDS06 :
16a,17-[1-Methylethylidenebis(oxy)]-11,21-dihydroxypregna-1,4-diene-3,20-dione ;
BUDESONIDE EP IMPURITY G ( = USP RC G ) ; 1,2-DIHYDRO BUDESONIDE ;
CAS:137174-25-5
BDS07 :
16a,17-[(1RS)-Butylidenebis(oxy)]-11,21-dihydroxypregn-4-ene-3,20-dione ;
BUDESONIDE EP IMPURITY H ; 9,11-ANHYDRO BUDESONIDE ;
CAS:313474-58-7
BDS08 :
16a,17-[(1RS)-Butylidenebis(oxy)]-21-hydroxypregna-1,4,9(11)-triene-3,20-dione ;
BUDESONIDE EP IMPURITY I ; 16A-BUTYLOXY PREDNISOLONE ;
CAS:113930-13-5
BDS09 :
11,17,21-Trihydroxy-3,20-dioxopregna-1,4-dien-16a-yl butanoate ;
BUDESONIDE EP IMPURITY J ; 9A-BROMO BUDESONIDE ;
CAS:313474-59-8
BDS10 :
16a,17-[(1RS)-Butylidenebis(oxy)]-9a-bromo-11,21-dihydroxypregna-1,4-diene-3,20-dione ;
BUDESONIDE EP IMPURITY K ; BUDESONIDE 21-ACETATE ;
CAS:51333-05-2
BDS11 :
16a,17-[(1RS)-Butylidenebis(oxy)]-11,21-dihydroxypregna-1,4-diene-3,20-dione-21-acetate ;
BUDESONIDE EP IMPURITY L ( = USP RC L ) ; 11-KETO BUDESONIDE ;
CAS:216453-74-6
BDS12 :
16a,17-[(1RS)-Butylidenebis(oxy)]-21-hydroxypregna-1,4-diene-3,11,20-trione ;
BUFEXAMAC ;
CAS:2438-72-4
BFX00 :
2-(4-Butoxyphenyl)-N-hydroxyacetamide ;
BUFEXAMAC EP IMPURITY A ;
CAS:4547-57-3
BFX01 :
2-(4-Butoxyphenyl)acetic acid ;
BUFEXAMAC EP IMPURITY B ;
CAS:29056-06-2
BFX02 :
Methyl 2-(4-butoxyphenyl)acetate ;
BUFEXAMAC EP IMPURITY C ;
CAS:1185726-73-1
BFX03 :
Butyl 2-(4-butoxyphenyl)acetate ;
BUFEXAMAC EP IMPURITY D ;
CAS:3413-59-0
BFX04 :
2-(4-Butoxyphenyl)acetamide ;
BUFLOMEDIL EP IMPURITY A ;
CAS:70585-57-8
BFM01H :
1-(2-Hydroxy-4,6-dimethoxyphenyl)-4-(pyrrolidin-1-yl)butan-1-one hydrochloride ;
BUFLOMEDIL EP IMPURITY B ;
CAS:79967-07-0
BFM02 :
1-(4-Hydroxy-2,6-dimethoxyphenyl)-4-(pyrrolidin-1-yl)butan-1-one ;
BUFLOMEDIL EP IMPURITY C ;
BFM03 :
1-(2,4-Dihydroxy-6-methoxyphenyl)-4-(pyrrolidin-1-yl)butan-1-one ;
BUFLOMEDIL HCL ;
CAS:35543-24-9
BFM00H :
4-(Pyrrolidin-1-yl)-1-(2,4,6-trimethoxyphenyl)butan-1-one hydrochloride ;
BUFLOMEDIL N-OXIDE ;
BFM50H :
4-(Pyrrolidin-1-yl)-1-(2,4,6-trimethoxyphenyl)butan-1-one N-oxide hydrochloride ;
BUMETANIDE ;
CAS:28395-03-1
BMM00 :
3-(Aminosulfonyl)-5-(butylamino)-4-phenoxy-benzoic Acid ; 3-(Butylamino)-4-phenoxy-5-sulfamoylbenzoic acid ;
BUMETANIDE EP IMPURITY A ; BUMETANIDE USP RC B ;
CAS:28328-53-2
BMM01 :
3-Nitro-4-phenoxy-5-sulfamoylbenzoic acid ; 3-(Aminosulfonyl)-5-nitro-4-phenoxy-benzoic Acid ;
BUMETANIDE EP IMPURITY B ; BUMETANIDE USP RC A ; DESBUTYL BUMETANIDE ;
CAS:28328-54-3
BMM02 :
3-Amino-4-phenoxy-5-sulfamoylbenzoic acid ; 3-Amino-5-(aminosulfonyl)-4-phenoxy-benzoic Acid ;
BUMETANIDE EP IMPURITY C ; BUMETANIDE BUTYL ESTER ;
CAS:32643-00-8
BMM03 :
Butyl 3-(Butylamino)-4-phenoxy-5-sulfamoylbenzoate ; 3-(Aminosulfonyl)-5-(butylamino)-4-phenoxybenzoic Acid Butyl Ester ;
BUMETANIDE EP IMPURITY D ;
CAS:153012-65-8
BMM04 :
3-[[(2RS)-2-Ethylhexyl]amino]-4-phenoxy-5-sulfamoylbenzoic acid ; N-Desbutyl-N-(2-ethylhexyl) Bumetanide ;
BUMETANIDE SS-D-GLUCURONIDE ;
CAS:102623-14-3
BMM60 :
1-[3-(Aminosulfonyl)-5-(butylamino)-4-phenoxybenzoate]--D-glucopyranuronic Acid ;
BUPIVACAINE 4-HYDROXY N-DESBUTYL IMPURITY ;
CAS:51989-48-1
BVC54 :
N-(4-Hydroxy-2,6-dimethylphenyl)-2-piperidinecarboxamide ;
BUPIVACAINE EP IMPURITY A ; MEPIVACAINE EP IMPURITY C ; 2,6-PICOLINOXYLIDIDE ;
CAS:39627-98-0
BVC01 :
N-(2,6-Dimethylphenyl)pyridine-2-carboxamide ;
BUPIVACAINE EP IMPURITY B ; BUPIVACAINE USP RC B ; N-DESBUTYL BUPIVACAINE ;
CAS:15883-20-2
BVC02 :
(2RS)-N-(2,6-Dimethylphenyl)piperidine-2-carboxamide ;
BUPIVACAINE EP IMPURITY C ; LEVOBUPIVACAINE IMPURITY C ;
CAS:1797894-80-4
BVC03 :
1-(2,6-Dimethylphenyl)-1,5,6,7-tetrahydro-2H-azepin-2-one ;
BUPIVACAINE EP IMPURITY D ; LEVOBUPIVACAINE IMPURITY D ; ROPIVACAINE DICHLORO IMPURITY (RPV54) ;
CAS:1037184-07-8
BVC04 :
(2RS)-2,6-Dichloro-N-(2,6-dimethylphenyl)hexanamide ;
BUPIVACAINE EP IMPURITY E ; BUPIVACAINE USP RC A ;
CAS:1330172-81-0
BVC05 :
6-(Butylamino)-N-(2,6-dimethylphenyl)hexanamide ;
BUPIVACAINE EP IMPURITY F ; LIDOCAINE EP IMPURITY A ; ROPIVACAINE EP IMPURITY H ; ROPIVACAINE USP RC A ; LIDOCAINE BP IMPURITY A ; LIDOCAINE USP IMPURITY A ;
CAS:87-62-7
BVC06H :
2,6-Dimethylaniline HCl ;
BUPIVACAINE HCL ;
CAS:18010-40-7
BVC00H :
(2RS)-1-Butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide hydrochloride ;
BUPIVACAINE N-OXIDE HCL ;
CAS:1796927-05-3
BVC50H :
1-Butyl-1-oxido-N-(2,6-dimethylphenyl)-2-piperidinecarboxamide hydrochloride ;
BUPROPION (5R,6R)-THIOMORPHOLINE ACID (USP) ;
BPP33 :
(3S,5R,6R)-6-(3-Chlorophenyl)-6-hydroxy-5-methyl-3-thiomorpholine carboxylic acid ;
BUPROPION (5RS,6RS)-THIOMORPHOLINE ACID ;
CAS:1246812-57-6
BPP31 :
(3R,5RS,6RS)-6-(3-Chlorophenyl)-6-hydroxy-5-methyl-3-thiomorpholine carboxylic acid ;
BUPROPION (5S,6S)-THIOMORPHOLINE ACID (USP) ;
BPP32 :
(3S,5S,6S)-6-(3-Chlorophenyl)-6-hydroxy-5- methyl-3-thiomorpholine carboxylic acid ;
BUPROPION (R)-ISOMER ; (R)-BUPROPION D-TARTARIC ACID SALT ;
CAS:437723-96-1
BPP40T :
(2R)-(t-Butylamino)-3'-chloropropiophenone D-tartaric acid salt ;
BUPROPION (S)-HYDROXY PROPANONE IMPURITY ;
CAS:287477-53-6
BPP43 :
(S)-1-(3-Chlorophenyl)-2-hydroxy-1-propanone ;
BUPROPION (S)-ISOMER ; (S)-BUPROPION L-TARTARIC ACID SALT ;
CAS:324548-43-8
BPP41T :
(2S)-(t-Butylamino)-3'-chloropropiophenone L-tartaric acid salt ;
BUPROPION 2'-CHLORO ANALOG (HCL SALT) ;
CAS:1049718-57-1
BPP08H :
2-(t-Butylamino)-2'-chloropropiophenone hydrochloride ;
BUPROPION 2-AMINO IMPURITY (HCL SALT) ;
CAS:119802-69-6
BPP13H :
2-Amino-1-(3-chlorophenyl)-1-propanone HCl ;
BUPROPION 2-BROMO IMPURITY ;
CAS:34911-51-8
BPP10 :
2-Bromo-3'-chloropropiophenone ;
BUPROPION 2-OXIME IMPURITY ;
CAS:56472-71-0
BPP45 :
1-(3-Chlorophenyl)-1,2-propanedione 2-oxime ;
BUPROPION 3',4'-DICHLORO IMPURITY (HCL SALT) ; 4-CHLORO BUPROPION HCL ;
CAS:1193779-34-8
BPP11H :
2-(tert-Butylamino)-1-(3,4-dichlorophenyl)propan-1-one HCl ;
BUPROPION 3',5'-DICHLORO IMPURITY ; 5-CHLORO BUPROPION ;
CAS:1193779-48-4
BPP12 :
2-(tert-Butylamino)-1-(3,5-dichlorophenyl)propan-1-one ;
BUPROPION 3-CHLOROBENZOIC ACID IMPURITY ;
CAS:535-80-8
BPP54 :
3-Chlorobenzoic Acid ;
BUPROPION DES-T-BUTYLAMINO IMPURITY ; BUPROPION MCPP IMPURITY ;
CAS:34841-35-5
BPP09 :
m-Chloropropiophenone ;
BUPROPION DIHYDRO (R,R)-ISOMER ; (R,R)-DIHYDRO BUPROPION HCL ;
CAS:357637-18-4
BPP51H :
(aR)?-3-Chloro-?a-?[(1R)?-?1-?[(1,?1-?dimethylethyl)?amino]?ethyl]?-?benzenemethanol hydrochloride ;
BUPROPION DIHYDRO (R,S)-ISOMER ; (R,S)-DIHYDRO BUPROPION HCL ;
CAS:357628-62-7
BPP52H :
(aR)?-3-Chloro-?a-?[(1S)?-?1-?[(1,?1-?dimethylethyl)?amino]?ethyl]?-?benzenemethanol hydrochloride ;
BUPROPION DIHYDRO (S,S)-ISOMER ; (S,S)-DIHYDRO BUPROPION HCL ;
CAS:92264-82-9
BPP53H :
(aS)?-3-Chloro-?a-?[(1S)?-?1-?[(1,?1-?dimethylethyl)?amino]?ethyl]?-?benzenemethanol hydrochloride ;
BUPROPION HCL ;
CAS:31677-93-7
BPP00H :
2-(tert-Butylamino)-1-(3-chlorophenyl)propan-1-one hydrochloride ;
BUPROPION HYDROXYMETHYL IMPURITY ;
BPP14 :
2-[(1-Hydroxymethyl-1-methyl)ethylamino]-3'-chloropropiophenone ;
BUPROPION MBPP IMPURITY ;
CAS:19829-31-3
BPP59 :
m-Bromopropiophenone ;
BUPROPION MORPHOLINOL (2R,3R)-ISOMER ; (2R,3R)-HYDROXY BUPROPION HCL ; ENTI-RADAFAXINE HYDROCHLORIDE ;
CAS:192374-15-5
BPP17H :
(2R,3R)-2-(3-Chlorophenyl)-3,5,5-trimethyl-2-morpholinol hydrochloride ;
BUPROPION MORPHOLINOL (2S,3S)-ISOMER ; (2S,3S)-HYDROXY BUPROPION HCL ; RADAFAXINE HYDROCHLORIDE ;
CAS:106083-71-0
BPP16H :
(2S,3S)-2-(3-Chlorophenyl)-3,5,5-trimethyl-2-morpholinol hydrochloride ;
BUPROPION MORPHOLINOL RACEMATE ; BUPROPION HYDROXY IMPURITY ;
CAS:357399-43-0
BPP15 :
2-(3-Chlorophenyl)-3,5,5-trimethyl-2-morpholinol ;
BUPROPION USP RC A (HCL SALT) ; BUPROPION 4-CHLORO ANALOG ;
CAS:1049718-72-0
BPP01H :
2-(tert-Butylamino)-1-(4-chlorophenyl)propan-1-one hydrochloride ;
BUPROPION USP RC B (HCL SALT) ; BUPROPION 3'-BROMO ANALOG ;
CAS:1049718-43-5
BPP02H :
2-(tert-Butylamino)-1-(3-bromophenyl)propan-1-one hydrochloride ;
BUPROPION USP RC C ;
CAS:152943-33-4
BPP03 :
1-(3-Chlorophenyl)-2-hydroxy-1-propanone ;
BUPROPION USP RC D (HCL SALT) ;
CAS:63199-74-6
BPP04H :
2-(t-Butylamino)propiophenone hydrochloride ;
BUPROPION USP RC E ; BUPROPION DIONE DERIVATIVE (USP) ;
CAS:10557-17-2
BPP05 :
1-(3-Chlorophenyl)-1,2-propanedione ;
BUPROPION USP RC F ;
CAS:857233-13-7
BPP06 :
1-(3-Chlorophenyl)-1-hydroxy-2-propanone ;
BUPROPRION 3-CHLOROPROPIOPHENONE IMPURITY ;
CAS:936-59-4
BPP56 :
3-Chloropropiophenone ;
BUPROPRION PROPIOPHENONE IMPURITY ;
CAS:93-55-0
BPP55 :
1-Phenyl-1-propanone ;
BUSPIRONE 5-HYDROXY METABOLITE ;
CAS:105496-33-1
BPR31 :
8-[4-[4-(5-Hydroxy-2-pyrimidinyl)-1-piperazinyl]butyl]-8-azaspiro[4.5]decane-7,9-dione ;
BUSPIRONE 6-HYDROXY METABOLITE ; 6'-HYDROXY BUSPIRONE ;
CAS:125481-61-0
BPR32 :
6-Hydroxy-8-[4-[4-(2-pyrimidinyl)-1-piperazinyl]butyl]-8-azaspiro[4.5]decane-7,9- dione ;
BUSPIRONE EP IMPURITY A ; BUSPIRONE USP RC A ;
CAS:20980-22-7
BPR01 :
2-(Piperazin-1-yl)pyrimidine ;
BUSPIRONE EP IMPURITY B ; BUSPIRONE SPIROAMMONIUM SALT IMPURITY (USP) ;
CAS:81461-73-6
BPR02 :
8-(Pyrimidin-2-yl)-8-aza-5-azoniaspiro[4.5]decane bromide ;
BUSPIRONE EP IMPURITY C ; BUSPIRONE BISPYRIMIDINYLPIPERAZINYL BUTANE IMPURITY (USP) ;
CAS:257877-45-5
BPR03 :
2,2'-[Butane-1,4-diylbis(piperazine-1,4-diyl)]dipyrimidine ;
BUSPIRONE EP IMPURITY D ; BUSPIRONE BISPYRIMIDINYLPIPERAZINYLBUTYL ETHER IMPURITY (USP) ;
BPR04H :
2,2'-[Oxybis[butane-1,4-diyl(piperazine-1,4-diyl)]]dipyrimidine HCl ;
BUSPIRONE EP IMPURITY E ; BUSPIRONE BUSPIRONE OPEN RING IMPURITY (USP) ;
CAS:257877-46-6
BPR05 :
[1-[2-Oxo-2-[[4-[4-(pyrimidin-2-yl)piperazin-1-yl]butyl]amino]ethyl] cyclopentyl]acetic acid ;
BUSPIRONE EP IMPURITY F ; BUSPIRONE OPEN RING DIMER IMPURITY (USP) ;
BPR06X :
4-(4-(Pyrimidin-2-yl)piperazin-1-yl)butyl 2-(1-(2-Oxo-2-((4-(4-(pyrimidin-2-yl)piperazin-1-yl)butyl)amino)ethyl)cyclopentyl)acetate oxalate ;
BUSPIRONE EP IMPURITY G ; BUSPIRONE USP RC G ;
CAS:84746-24-7
BPR07 :
2,2'-(Piperazine-1,4-diyl)dipyrimidine ;
BUSPIRONE EP IMPURITY H ; BUSPIRONE DIESTER DIMER (USP) ;
BPR08 :
bis{[4-[4-(Pyrimidin-2-yl)piperazin-1-yl]butyl]}2,2'-(cyclopentane-1,1-diyl)diacetate ;
BUSPIRONE EP IMPURITY I ; 5-CHLORO BUSPIRONE HCL (USP) ;
BPR09H :
8-[4-[4-(5-Chloropyrimidin-2-yl)piperazin-1-yl]butyl]-8-azaspiro[4.5]decane-7,9-dione HCl ;
BUSPIRONE EP IMPURITY J ; BUSPIRONE OPEN RING SPIRODIMER IMPURITY (USP) ;
BPR10X :
4-(7,9-Dioxo-8-azaspiro[4.5]dec-8-yl)butyl [1-[2-oxo-2-[[4-[4-(pyrimidin-2-yl)piperazin-1-yl]butyl]amino]ethyl]-cyclopentyl]acetate oxalate ;
BUSPIRONE EP IMPURITY K ; BUSPIRONE USP RC K ;
CAS:1075-89-4
BPR11 :
8-Azaspiro[4.5]decane-7,9-dione ;
BUSPIRONE EP IMPURITY L ; BUSPIRONE USP RC L ; BUSPIRONE CHLOROBUTYL IMPURITY ;
CAS:21098-11-3
BPR12 :
8-(4-Chlorobutyl)-8-azaspiro[4.5]decane-7,9-dione ;
BUSPIRONE EP IMPURITY M ; BUSPIRONE BROMOBUTYL IMPURITY (USP) ;
CAS:80827-62-9
BPR13 :
8-(4-Bromobutyl)-8-azaspiro[4.5]decane-7,9-dione ;
BUSPIRONE EP IMPURITY N ; BUSPIRONE USP RC N ;
CAS:257877-44-4
BPR14 :
8,8'-(Butane-1,4-diyl)bis(8-azaspiro[4.5]decane-7,9-dione) ;
BUSPIRONE HCL ;
CAS:33386-08-2
BPR00H :
8-[4-[4-(Pyrimidin-2-yl)piperazin-1-yl]butyl]-8-azaspiro[4.5]-decane-7,9-dione hydrochloride ;
BUSPIRONE N-OXIDE (OXALATE) ;
CAS:220747-81-9
BPR33X :
8-[4-[4-(Pyrimidin-2-yl)piperazin-1-yl]butyl]-8-azaspiro[4.5]-decane-7,9-dione N-oxide oxalate ;
BUSULFAN ;
CAS:55-98-1
BUF00 :
4-(Methylsulfonyloxy)butyl methanesulfonate ;
BUSULFAN HYDROXYBUTYL METHANESULFONATE IMPURITY ;
CAS:42729-95-3
BUF51 :
4-Hydroxybutyl methanesulfonate ;
BUSULFAN HYDROXYBUTYL SULFONATE SODIUM ;
CAS:31465-25-5
BUF52N :
4-Hydroxybutane-1-sulfonic acid sodium salt ;
BUSULFAN METHYLSULFINYLOXY ANALOG ;
CAS:1797106-48-9
BUF53 :
4-(Methylsulfinyloxy)butyl methanesulfonate ;
BUSULFAN METHYLSULFONYLOXYBUTYL ANALOG ;
BUF54:
4-(Methylsulfonyloxy)butyl 4-(methylsulfonyloxy)butane-1-sulfonate ;
BUSULFAN O-ACETYL ANALOG ;
CAS:19859-00-8
BUF55 :
4-(Methylsulfonyloxy)butyl acetate ;
BUTAMIRATE (BASE) ;
CAS:18109-80-3
BTM00B :
2-(2-(Diethylamino)ethoxy)ethyl 2-phenylbutanoate ;
BUTAMIRATE BUTYRIC ACID R-ISOMER ;
CAS:938-79-4
BTM50 :
(R)-2-Phenylbutanoic Acid ;
BUTAMIRATE CITRATE ;
CAS:18109-81-4
BTM00C :
2-(2-(Diethylamino)ethoxy)ethyl 2-phenylbutanoate, 2-hydroxypropane-1,2,3-tricarboxylic acid ;
BUTAMIRATE IMPURITY A ; OXELADIN EP IMPURITY A ;
CAS:140-82-9
BTM01 :
2-[2-(Diethylamino)ethoxy]ethanol ;
BUTAMIRATE IMPURITY B ; BUTAMIRATE BUTYRIC ACID IMPURITY ;
CAS:90-27-7
BTM02 :
(RS)-2-Phenylbutanoic Acid ;
BUTAMIRATE IMPURITY C ; BUTAMIRATE DESETHYL IMPURITY ;
CAS:47092-75-1
BTM03 :
2-(2-(Diethylamino)ethoxy)ethyl 2-phenylacetate ;
BUTAMIRATE IMPURITY D ;
CAS:92321-53-4
BTM04 :
N,N-diethyl-2-phenylbutanamide ;
BUTAMIRATE IMPURITY E ; CYCLOPENTOLATE EP IMPURITY B ; TROPICAMIDE EP IMPURITY D ; TROPICAMIDE USP RC D ;
CAS:103-82-2
BTM05 :
Phenylacetic acid ;
BUTAMIRATE METHYL BUTANOATE IMPURITY ;
CAS:2294-71-5
BTM52 :
Methyl 2-phenylbutanoate ;
BUTENAFINE HCL ;
CAS:101827-46-7
BTF00H :
N-[[4-(1,1-Dimethylethyl)phenyl]methyl]-N-methyl-1-naphthalenemethanamine Hydrochloride ;
BUTENAFINE N-DESMETHYL HCL ;
CAS:101828-08-4
BTF50H :
N-[[4-(1,1-Dimethylethyl)phenyl]methyl]-1-naphthalenemethanamine Hydrochloride ;
BUTOCONAZOLE NITRATE ;
CAS:64872-77-1
BCZ00N :
1-[4-(4-Chlorophenyl)-2-[(2,6-dichlorophenyl)thio]butyl]-1H-imidazole nitrate ;
BUTOCONAZOLE SULFONE ;
BCZ52 :
1-(4-(4-Chlorophenyl)-2-(2,6-dichlorophenylsulfonyl)butyl)-1H-imidazole ;
BUTOCONAZOLE SULFOXIDE ;
BCZ51H :
1-(4-(4-Chlorophenyl)-2-(2,6-dichlorophenylsulfinyl)butyl)-1H-imidazole hydrochloride ;
BUTYLHYDROXYANISOLE ;
CAS:25013-16-5
BHA00 :
3-t-Butyl-4-hydroxyanisole ; 2-(1,1-Dimethylethyl)-4-methoxyphenol ;
BUTYLHYDROXYANISOLE EP IMPURITY A ; HYDROQUINONE ; ETAMSYLATE EP IMPURITY A ; BUTYLHYDROXYANISOLE EP IMPURITY A ;
CAS:123-31-9
BHA01 :
1,4-Dihydroxybenzene ;
BUTYLHYDROXYANISOLE O-DESMETHYL IMPURITY ;
CAS:1948-33-0
BHA30 :
2-(1,1-Dimethylethyl)-1,4-dihydroxybenzene ; t-Butylhydroquinone ;
CABAZITAXEL (2S,3R)-ISOMER ;
CAS:1714967-27-7
CZT60 :
(2S,3R)--[[(1,1-Dimethylethoxy)carbonyl]amino]-a-hydroxybenzenepropanoic acid (2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-12b-(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-11-hydroxy-4,6-dimethoxy-4a,8,13,13-tetramethyl-5-oxo-7,11-met
CABAZITAXEL ;
CAS:183133-96-2
CZT00 :
(2R,3S)--[[(1,1-Dimethylethoxy)carbonyl]amino]-a-hydroxybenzenepropanoic acid (2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-12b-(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-11-hydroxy-4,6-dimethoxy-4a,8,13,13-tetramethyl-5-oxo-7,11-met
CABAZITAXEL AMINE ; CABAZITAXEL DES-T-BOC IMPURITY ;
CAS:1638286-64-2
CZT63 :
(2R,3S)-3-Amino-2-hydroxy-3-phenylpropanoic acid (2aR,4S,4aS,6R,9S, 11S,12S,12aR,12bS)-12b-(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10, 11,12,12a,12b-dodecahydro-11-hydroxy-4,6-dimethoxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca[3,4]benz[1
CABAZITAXEL DEACYL IMPURITY ;
CAS:183133-94-0
CZT61 :
(2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-12b-(Acetyloxy)-12-(benzoyloxy)-1,2a,3,4,4a,6,9,10,11,12,12a,12b-dodecahydro-9,11-dihydroxy-4,6-dimethoxy-4a,8,13,13-tetramethyl-7,11-methano-5H-cyclodeca[3,4]benz[1,2-b]oxet-5-one ;
CABAZITAXEL DECTROC OXAZOLIDINE IMPURITY ;
CAS:159262-93-8
CZT62 :
(4S,5R)-2,2-Dimethyl-4-phenyl-3,5-oxazolidinedicarboxylic acid 5-[(2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-12b-(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,6,11-trihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca[3,
CABAZITAXEL OXAZOLIDINE IMPURITY ;
CAS:1373171-12-0
CZT64:
(4S,5R)-2,2-Dimethyl-4-phenyl-3,5-oxazolidinedicarboxylic acid 5-[(2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-12b-(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-11-hydroxy-4,6-dimethoxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclo
CABOZANTINIB (BASE) ;
CAS:849217-68-1
CZN00B :
N-[4-[(6,7-Dimethoxy-4-quinolinyl)oxy]phenyl]-N-(4-fluorophenyl)-1,1-cyclopropanedicarboxamide ;
CABOZANTINIB (S)-MALATE SALT ; CABOZANTINIB L-MALATE SALT ;
CAS:1140909-48-3
CZN00M :
N-[4-[(6,7-Dimethoxy-4-quinolinyl)oxy]phenyl]-N-(4-fluorophenyl)-1,1-cyclopropanedicarboxamide (2S)-2-hydroxybutanedioic acid ;
CABOZANTINIB IMPURITY 1 ;
CAS:849217-48-7
CZN51 :
1-((4-Fluorophenyl)carbamoyl)cyclopropanecarboxylic acid ;
CABOZANTINIB IMPURITY 2 ;
CAS:190728-25-7
CZN52 :
4-(6,7-Dimethoxyquinolin-4-yloxy)benzenamine ;
CABOZANTINIB N-OXIDE ;
CAS:1621681-63-7
CZN50 :
N-[4-[(6,7-Dimethoxy-4-quinolinyl)oxy]phenyl]-N-(4-fluorophenyl)-1,1-cyclopropanedicarboxamide ;
CALCIFEDIOL ; 25-HYDROXY CHOLECALCIFEROL ; 25-HYDROXY VITAMIN D ; 25-HYDROXY VITAMIN D3 ; CALCIDIOL ; HIDROFEROL ;
CAS:63283-36-3
CDF00 :
(5Z,7E)-9,10-Secocholesta-5,7,10(19)-triene-3,25-diol ;
CALCIFEDIOL EP IMPURITY A ;
CAS:61585-29-3
CDF01 :
9,10a-Cholesta-5,7-diene-3,25-diol ;
CALCIFEDIOL EP IMPURITY B ; 25-HYDROXY PROVITAMIN D3 ;
CAS:22145-68-2
CDF02 :
Cholesta-5,7-diene-3,25-diol ;
CALCIFEDIOL EP IMPURITY C ;
CAS:39932-44-0
CDF03 :
(6E)-9,10-Secocholesta-5(10),6,8-triene-3,25-diol ;
CALCIFEDIOL EP IMPURITY D ;
CDF04 :
(5E,7E)-9,10-Secocholesta-5,7,10(19)-triene-3,25-diol ;
CALCIPOTRIOL ; CALCIPOTRIENE ;
CAS:112965-21-6
CCP00 :
(5Z,7E,22E,24S)-24-Cyclopropyl-9,10-secochola-5,7,10(19),22-tetraene-1a,3,24-triol ;
CALCIPOTRIOL EP IMPURITY A ; 24-OXO CALCIPOTRIOL ;
CAS:126860-83-1
CCP01 :
(5Z,7E,22E)-24-Cyclopropyl-1a,3-dihydroxy-9,10-secochola-5,7,10(19),22-tetraen-24-one ;
CALCIPOTRIOL EP IMPURITY B ; (7Z)-CALCIPOTRIOL ;
CCP02 :
(5Z,7Z,22E,24S)-24-Cyclopropyl-9,10-secochola-5,7,10(19),22-tetraene-1a,3,24-triol ;
CALCIPOTRIOL EP IMPURITY C ; (5E)-CALCIPOTRIOL ; (5E)-CALCIPOTRIENE ;
CAS:113082-99-8
CCP03 :
(5E,7E,22E,24S)-24-Cyclopropyl-9,10-secochola-5,7,10(19),22-tetraene-1a,3,24-triol ;
CALCIPOTRIOL EP IMPURITY D ; 24-EPI-CALCIPOTRIOL ; (24R)-CALCIPOTRIENE ;
CAS:112827-99-3
CCP04 :
(5Z,7E,22E,24R)-24-Cyclopropyl-9,10-secochola-5,7,10(19),22-tetraene-1a,3,24-triol ;
CALCIPOTRIOL EP IMPURITY E ; DEHYDRO CALCIPOTRIOL ;
CCP05 :
rac-(5Z,7E,24S)-24-Cyclopropyl-9,10-secochola-5,7,10(19)-triene-1a,3,24-triol ;
CALCIPOTRIOL EP IMPURITY F ;
CAS:112875-61-3
CCP06 :
(5Z,7E,22E,24S)-24-Cyclopropyl-1a,3-bis[[(1,1-dimethylethyl)dimethylsilyl]oxy]-9,10-secochola-5,7,10(19),22-tetraen-24-ol ; 1,3-Bis-O-(tert-butyldimethylsilyl)calcipotriene ;
CALCIPOTRIOL EP IMPURITY G ;
CCP07 :
24,24'-Oxybis[(5Z,7E,22E,24S)-24-cyclopropyl-9,10-secochola-5,7,10(19),22-tetraene-1a,3-diol] ;
CALCIPOTRIOL EP IMPURITY H ;
CCP08 :
(5Z,7E,22E,24R)-24-Cyclopropyl-24-[[(5Z,7E,22E,24S)-24-cyclopropyl-1a,3-dihydroxy-9,10-secochola-5,7,10(19),22-tetraen-24-yl]oxy]-9,10-secochola-5,7,10(19),22-tetraene-1a,3-diol ;
CALCIPOTRIOL EP IMPURITY I ; SUPRASTEROL OF CALCIPOTRIOL ;
CCP09 :
(6S,7R,8R,22E,24S)-24-Cyclopropyl-6,8:7,19-dicyclo-9,10-secochola-5(10),22-diene-1a,3,24-triol ;
CALCITRIOL ;
CAS:32222-06-3
CCT00 :
(1R,3S,5Z)-4-Methylene-5-[(2E)-2-[(1R,3aS,7aS)-octahydro-1-[(1R)-5-hydroxy-1,5-dimethylhexyl]-7a-methyl-4H-inden-4-ylidene]ethylidene]-1,3-cyclohexanediol ;
CALCITRIOL EP IMPURITY A ; TRANS-CALCITRIOL ;
CAS:73837-24-8
CCT01 :
(5E,7E)-9,10-Secocholesta-5,7,10(19)-triene-1a,3,25-triol ;
CALCITRIOL EP IMPURITY B ; 1SS-CALCITRIOL ; 1-EPI-CALCITRIOL ;
CAS:66791-71-7
CCT02 :
(5Z,7E)-9,10-Secocholesta-5,7,10(19)-triene-1,3,25-triol ;
CALCITRIOL EP IMPURITY C ; PRE-CALCITRIOL TRIAZOLINE ADDUCT ; PRE-CALCITRIOL PTAD ADDUCT ;
CAS:86307-44-0
CCT03 :
(6aR,7R,9aR)-11-[(3S,5R)-3,5-Dihydroxy-2-methylcyclohex-1-enyl]-7-[(1R)-5-hydroxy-1,5-dimethylhexyl]-6a-methyl-2-phenyl-5,6,6a,7,8,9,9a,11-octahydro-1H,4aH-cyclopenta[f][1,2,4]triazolo[1,2a]cinnoline-1,3(2H)-dione ;
CAMPTOTHECIN ; IRINOTECAN EP IMPURITY D ; TOPOTECAN USP RC C ;
CAS:7689-03-4
CPT01 :
(S)-4-Ethyl-4-hydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14 (4H,12H)-dione ;
CAMPTOTHECIN 10-HYDROXY IMPURITY ; IRINOTECAN USP RC A ; 10-HYDROXY CAMPTOTHECIN ;
CAS:19685-09-7
CPT04 :
(4S)-4-Ethyl-4,9-dihydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b] quinoline-3,14(4H,12H)-dione ;
CAMPTOTHECIN 7-ETHYL IMPURITY ; 7-ETHYL CAMPTOTHECIN ;
CAS:78287-27-1
CPT02 :
(S)-4,11-Diethyl-4-hydroxy-1H-pyrano(3',4':6,7)indolizino(1,2-b) quinoline-3,14(4H,12H)-dione ;
CAMPTOTHECIN 7-ETHYL-10-HYDROXY IMPURITY ; IRINOTECAN USP RC B ; IRINOTECAN IMPURITY E ;
CAS:86639-52-3
CPT03 :
(S)-4,11-Diethyl-4,9-dihydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b] quinoline-3,14(4H,12H)-dione ;
CANAGLIFLOZIN ;
CAS:842133-18-0
CNG00 :
(1S)-1,5-Anhydro-1-C-[3-[[5-(4-fluorophenyl)-2-thienyl]methyl]-4-methyl phenyl]-D-glucitol ;
CANAGLIFLOZIN 1-EPIMER ; CANAGLIFLOZIN ALPHA-ANOMER ;
CAS:1589590-87-3
CNG60 :
(1R)-1,5-Anhydro-1-[3-[[5-(4-fluorophenyl)thiophen-2-yl]methyl]-4-methylphenyl]-D-glucitol ;
CANAGLIFLOZIN 1-METHOXY IMPURITY ;
CAS:1358581-37-9
CNG51 :
Methyl 1-C-[3-[[5-(4-Fluorophenyl)-2-thienyl]methyl]-4-methylphenyl]-a-D-glucopyranoside ;
CANAGLIFLOZIN BROMO IMPURITY ;
CAS:1030825-20-7
CNG54 :
2-[(5-Bromo-2-methylphenyl)methyl]-5-(4-fluorophenyl)-thiophene ;
CANAGLIFLOZIN DESFLUORO IMPURITY ;
CAS:842133-16-8
CNG55 :
(1S)-1,5-Anhydro-1-C-[3-[[5-phenyl-2-thienyl]methyl]-4-methyl phenyl]-D-glucitol ;
CANAGLIFLOZIN DIMER ;
CNG66 :
(2S,3R,4S,5S,6R)-2-(3-((5-(4-Fluorophenyl)thiophen-2-yl)methyl)-4-methylphenyl)-2-(((2R,3S,4R,5R,6S)-6-(3-((5-(4-fluorophenyl)thiophen-2-yl)methyl)-4-methylphenyl)-3,4,5-trihydroxytetrahydro-2H-pyran-2-yl)methoxy)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,
CANAGLIFLOZIN HYDROPEROXIDE ;
CNG61 :
2-(3-((5-(4-Fluorophenyl)thiophen-2-yl)(hydroperoxy)methyl)-4-methylphenyl)-6-(hydroxymethyl)-tetrahydro-2H-pyran-3,4,5-triol ;
CANAGLIFLOZIN TETRAACETATE ;
CAS:866607-35-4
CNG64 :
(1S)-1,5-Anhydro-1-C-[3-[[5-(4-fluorophenyl)-2-thienyl]methyl]-4-methylphenyl]-D-glucitol 2,3,4,6-Tetraacetate ;
CANDESARTAN ACID METHOXY ANALOG ;
CAS:139481-76-8
CST87 :
2-Methoxy-1-({4-[2-(2H-1,2,3,4-tetrazol-5-yl)phenyl]phenyl}methyl)-1H-1,3-benzodiazole-7-carboxylic acid ;
CANDESARTAN BENZIMIDAZOLE ETHOXY METHYL ESTER ;
CAS:150058-27-8
CST33 :
2-Ethoxy-3H-benzimidazole-4-carboxylic acid methyl ester ;
CANDESARTAN BENZIMIDAZOLE METHOXY METHYL ESTER ;
CAS:1246817-06-0
CST43 :
2-Methoxy-3H-benzimidazole-4-carboxylic acid methyl ester ;
CANDESARTAN BROMO N2-TRITYL IMPURITY ; LOSARTAN BROMO N2-TRITYL IMPURITY ; CANDESARTAN TTBB IMPURITY ;
CAS:133051-88-4
CST45 :
5-(4'-(Bromomethyl)(1,1'-biphenyl)-2-yl)-2-trityl-2H-tetrazole ;
CANDESARTAN CILEXETIL ;
CAS:145040-37-5
CST00 :
2-Ethoxy-1-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-1H-benz imidazole-7-carboxylic acid 1-[[(Cyclohexyloxy)carbonyl]oxy]ethyl ester ;
CANDESARTAN CILEXETIL DESETHYL N2-TRITYL ANALOG ; O-DESETHYL N2-TRITYL CANDESARTAN CILEXETIL ;
CAS:1798004-41-7
CST54 :
2,3-Dihydro-2-oxo-3-[[2'-[2-(triphenylmethyl)-2H-tetrazol-5-yl][1,1'-biphenyl]-4-yl]methyl]-1H-benzimidazole-4-carboxylic acid 1-[[(cyclohexyloxy) carbonyl]oxy]ethyl ester ;
CANDESARTAN CILEXETIL EP IMPURITY A ; CANDESARTAN CILEXETIL USP RC A ; CANDESARTAN ETHYL ESTER ;
CAS:139481-58-6
CST01 :
Ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]-1H-benzimi dazole-7-carboxylate ;
CANDESARTAN CILEXETIL EP IMPURITY B ; CANDESARTAN CILEXETIL USP RC B ; CANDESARTAN CILEXETIL O-DESETHYL ANALOG ; CANDESARTAN CILEXETIL KETONE ;
CAS:869631-11-8
CST02 :
2,3-Dihydro-2-oxo-3-[[2-(2H-tetrazol-5-yl)[1,1-biphenyl]-4-yl] methyl]-1H-benzimidazole-4-carboxylic acid 1-[[(cyclohexyloxy)carbonyl]oxy]ethyl ester ;
CANDESARTAN CILEXETIL EP IMPURITY C (= CANDESARTAN CILEXETIL N1-ETHYL AMIDE) ;
CAS:1185255-99-5
CST03 :
(1RS)-1-[[(Cyclohexyloxy)carbonyl]oxy]ethyl 3-[[2'-(1-ethyl-1H-tetrazol-5-yl)biphenyl-4-yl]methyl]-2-oxo-2,3-dihydro-1H-benzimidazole-4-carboxylate ;
CANDESARTAN CILEXETIL EP IMPURITY D ; CANDESARTAN CILEXETIL USP RC D ; CANDESARTAN CILEXETIL N2-ETHYL AMIDE ;
CAS:1185256-03-4
CST04 :
(1RS)-1-[[(Cyclohexyloxy)carbonyl]oxy]ethyl 3-[[2'-(2-ethyl-2H-tetrazol-5-yl)biphenyl-4-yl]methyl]-2-oxo-2,3-dihydro-1H-benzimidazole-4-carboxylate ;
CANDESARTAN CILEXETIL EP IMPURITY E (= CANDESARTAN CILEXETIL N1-ETHYL IMPURITY) ;
CAS:914613-35-7
CST05 :
2-Ethoxy-1-[[2'-[1-ethyl-1H-tetrazol-5-yl][1,1'-biphenyl]-4-yl]methyl]-1H-benzimidazole-7-carboxylic acid 1-[[(cyclohexyloxy) carbonyl]oxy]ethyl ester ;
CANDESARTAN CILEXETIL EP IMPURITY F ; CANDESARTAN CILEXETIL USP RC F ; CANDESARTAN CILEXETIL N2-ETHYL IMPURITY ;
CAS:914613-36-8
CST06 :
(1RS)-1-[[(Cyclohexyloxy)carbonyl]oxy]ethyl-2-ethoxy-1-[[2'-(2-ethyl-2H-tetrazol-5-yl)biphenyl-4-yl]methyl]-1H-benzimidazole-7-carboxylate ;
CANDESARTAN CILEXETIL EP IMPURITY G ; CANDESARTAN CILEXETIL USP RC G ; CANDESARTAN ACID ;
CAS:139481-59-7
CST07 :
2-Ethoxy-1-({4-[2-(2H-1,2,3,4-tetrazol-5-yl)phenyl]phenyl}methyl)-1H-1,3-benzodiazole-7-carboxylic acid ;
CANDESARTAN CILEXETIL EP IMPURITY H ; CANDESARTAN CILEXETIL N1-TRITYL ANALOG ;
CAS:170791-09-0
CST08 :
2-Ethoxy-1-[[2'-[1-(triphenylmethyl)-1H-tetrazol-5-yl][1,1'-biphenyl]-4-yl]methyl]-1H-benzimidazole-7-carboxylic acid 1-[[(cyclohexyloxy) carbonyl]oxy]ethyl ester ;
CANDESARTAN CILEXETIL EP IMPURITY I ; CANDESARTAN METHYL ESTER ;
CAS:139481-69-9
CST09 :
2-Ethoxy-1-({4-[2-(2H-1,2,3,4-tetrazol-5-yl)phenyl]phenyl}methyl)-1H-1,3-benzodiazole-7-carboxylic acid methyl ester ;
CANDESARTAN CILEXETIL METHOXY ANALOG ;
CAS:1026042-12-5
CST37 :
2-Methoxy-1-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-1H-benz imidazole-7-carboxylic acid 1- [[(cyclohexyloxy) carbonyl] oxy] ethyl ester ;
CANDESARTAN CILEXETIL N2-TRITYL ANALOG ; N2-TRITYL CANDESARTAN CILEXETIL ;
CAS:886999-34-4
CST48 :
2-Ethoxy-1-[[2'-[2-(triphenylmethyl)-2H-tetrazol-5-yl][1,1'-biphenyl]-4-yl]methyl]-1H-benzimidazole-7-carboxylic acid 1-[[(cyclohexyloxy) carbonyl]oxy]ethyl ester ;
CANDESARTAN CILEXETIL N2-TRITYL METHOXY ANALOG ; N2-TRITYL CANDESARTAN CILEXETIL METHOXY ANALOG ;
CAS:1797867-82-3
CST57 :
2-Methoxy-1-[[2'-[2-(triphenylmethyl)-2H-tetrazol-5-yl][1,1'-biphenyl]-4-yl]methyl]-1H-benzimidazole-7-carboxylic acid 1-[[(cyclohexyloxy) carbonyl]oxy]ethyl ester ;
CANDESARTAN DIBROMO N2-TRITYL IMPURITY (= LOSARTAN DIBROMO N2-TRITYL IMPURITY) ; CANDESARTAN DIBROMO TTBB IMPURITY ;
CAS:151052-34-5
CST46 :
5-(4'-(Dibromomethyl)(1,1'-biphenyl)-2-yl)-2-trityl-2H-tetrazole ;
CANDESARTAN ETHYL ESTER DESETHYL ANALOG ;
CAS:1225044-20-1
CST24 :
2,3-Dihydro-2-oxo-3-[[2-(2H-tetrazol-5-yl)[1,1-biphenyl]-4-yl]methyl]-1H-benzimidazole-4-carboxylic acid ethyl ester ;
CANDESARTAN ETHYL ESTER DESETHYL N1-CILEXETIL ANALOG ; O-DESETHYL CANDESARTAN N1-CILEXETIL ETHYL ESTER ;
CST20 :
Ethyl 1-({2'-[1-(1-{[(cyclohexyloxy) carbonyl] oxy} ethyl)-1H-tetrazol-5-yl] biphenyl-4-yl} methyl)-2-hydroxy-1H-benzimidazole-7-carboxylate ;
CANDESARTAN ETHYL ESTER DESETHYL N2-CILEXETIL ANALOG ; O-DESETHYL CANDESARTAN N2-CILEXETIL ETHYL ESTER ;
CST21 :
Ethyl 1-({2'-[2-(1-{[(cyclohexyloxy) carbonyl] oxy} ethyl)-1H-tetrazol-5-yl] biphenyl-4-yl} methyl)-2-hydroxy-1H-benzimidazole-7-carboxylate ;
CANDESARTAN ETHYL ESTER N1-CILEXETIL ANALOG ;
CAS:1391054-45-7
CST34 :
Ethyl 1-({2'-[1-(1-{[(cyclohexyloxy) carbonyl] oxy} ethyl)-1H-tetrazol-5-yl] biphenyl-4-yl} methyl)-2-ethoxy-1H-benzimidazole-7-carboxylate ;
CANDESARTAN ETHYL ESTER N2-CILEXETIL ANALOG ; CANDESARTAN N2-CILEXETIL ETHYL ESTER ;
CST44 :
Ethyl 1-({2'-[1-(1-{[(cyclohexyloxy) carbonyl] oxy} ethyl)-2H-tetrazol-5-yl] biphenyl-4-yl} methyl)-2-ethoxy-1H-benzimidazole-7-carboxylate ;
CANDESARTAN ETHYL ESTER N2-TRITYL ANALOG ; N2-TRITYL CANDESARTAN ETHYL ESTER ;
CAS:1797985-81-9
CST40 :
2-Ethoxy-1-[[2'-[2-(triphenylmethyl)-2H-tetrazol-5-yl][1,1'-biphenyl]-4-yl]methyl]-1H-benzimidazole-7-carboxylic acid ethyl ester ;
CANDESARTAN ETHYL ESTER N2-TRITYL METHOXY ANALOG ;
CST47 :
2-Methoxy-1-[[2'-[2-(triphenylmethyl)-2H-tetrazol-5-yl][1,1'-biphenyl]-4-yl]methyl]-1H-benzimidazole-7-carboxylic acid ethyl ester ;
CANDESARTAN HYDROXY IMPURITY ; LOSARTAN EP IMPURITY B ;
CAS:160514-13-6
CST16 :
p-(o-1H-Tetrazol-5-ylphenyl)benzyl alcohol ; 2'-(1H-Tetrazol-5-yl)-[1,1'-biphenyl]-4-methanol ;
CANDESARTAN HYDROXY N2-TRITYL IMPURITY ; LOSARTAN N2-TRITYL IMPURITY ;
CAS:154709-18-9
CST36 :
5-(4'-(Hydroxymethyl)(1,1'-biphenyl)-2-yl)-2-trityl-2H-tetrazole ;
CANDESARTAN ISOPROPYL ESTER ;
CST10 :
2-Ethoxy-1-({4-[2-(2H-1,2,3,4-tetrazol-5-yl)phenyl]phenyl}methyl)-1H-1,3-benzodiazole-7-carboxylic acid isopropyl ester ;
CANDESARTAN METHYL ESTER DESETHYL ANALOG ;
CAS:1203674-06-9
CST23 :
2,3-Dihydro-2-oxo-3-[[2-(2H-tetrazol-5-yl)[1,1-biphenyl]-4-yl]methyl]-1H-benzimidazole-4-carboxylic acid methyl ester ;
CANDESARTAN METHYL ESTER METHOXY ANALOG ;
CAS:139481-75-7
CST39 :
2-Methoxy-1-({4-[2-(2H-1,2,3,4-tetrazol-5-yl)phenyl]phenyl}methyl)-1H-1,3-benzodiazole-7-carboxylic acid methyl ester ;
CANDESARTAN METHYL ESTER N2-TRITYL ANALOG ; N2-TRITYL CANDESARTAN METHYL ESTER ;
CAS:1796932-77-8
CST49 :
2-Ethoxy-1-[[2'-[2-(triphenylmethyl)-2H-tetrazol-5-yl][1,1'-biphenyl]-4-yl]methyl]-1H-benzimidazole-7-carboxylic acid methyl ester ;
CANDESARTAN METHYL ESTER N2-TRITYL METHOXY ANALOG ; N2-TRITYL CANDESARTAN METHYL ESTER METHOXY ANALOG ;
CAS:1797136-91-4
CST50 :
2-Methoxy-1-[[2'-[2-(triphenyl methyl)-2H-tetrazol-5-yl][1,1'-biphenyl]-4-yl]methyl]-1H-benzimidazole-7-carboxylic acid methyl ester ;
CANDESARTAN METHYL IMPURITY ; IRBESARTAN METHYL IMPURITY ; LOSARTAN METHYL IMPURITY ; LOSARTAN EP IMPURITY E ;
CAS:120568-11-8
CST17 :
5-(4'-Methyl-(1,1'-biphenyl)-2-yl)-1H-tetrazole ;
CANDESARTAN N1-ETHYL IMPURITY ; N1-ETHYL CANDESARTAN ;
CAS:1246817-38-8
CST31 :
2-Ethoxy-1-[[2'-(1-ethyl-1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-1H-benzimidazole-7-carboxylic acid ;
CANDESARTAN N2-ETHYL IMPURITY ; N2-ETHYL CANDESARTAN ;
CAS:1246819-02-2
CST32 :
2-Ethoxy-1-[[2'-(2-ethyl-2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-1H-benzimidazole-7-carboxylic acid ;
CANDESARTAN N2-TRITYL IMPURITY ; N2-TRITYL CANDESARTAN ;
CAS:894806-43-0
CST58 :
2-Ethoxy-1-[[2'-(2-trityl-2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-1H-benzimidazole-7-carboxylic acid ;
CANDESARTAN N2-TRITYL METHOXY ANALOG ;
CAS:1797918-38-7
CST77 :
2-Methoxy-1-[[2'-[2-(triphenyl methyl)-2H-tetrazol-5-yl][1,1'-biphenyl]-4-yl]methyl]-1H-benzimidazole-7-carboxylic acid ;
CANDESARTAN NITRO IMPURITY ;
CAS:136285-67-1
CST51 :
Ethyl 2-[N-[(2'-Cyanobiphenyl-4-yl)methyl]amino]-3-nitrobenzoate ;
CANDESARTAN O-DESETHYL ANALOG ; CANDESARTAN DESETHYL ANALOG ;
CAS:168434-02-4
CST35 :
2,3-Dihydro-2-oxo-3-[[2-(2H-tetrazol-5-yl)[1,1-biphenyl]-4-yl]methyl]-1H-benzimidazole-4-carboxylic acid ;
CANDESARTAN TRITYL ALCOHOL IMPURITY ; ZIDOVUDINE EP IMPURITY D ; CANDESARTAN TRITYL ALCOHOL IMPURITY ;
CAS:76-84-6
CST18 :
Triphenylmethanol ;
CANDESARTAN TRITYL ESTER N2-TRITYL ANALOG ; N2-TRITYL CANDESARTAN TRITYL ESTER ;
CAS:1797113-00-8
CST68 :
2-Ethoxy-1-[[2'-(1-trityl-1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-1H-benzimidazole-7-carboxylic acid trityl ester ;
CANDESARTAN TRITYL METHYL ETHER IMPURITY ; LOSARTAN TRITYL METHYL ETHER IMPURITY ;
CAS:596-31-6
CST19 :
Triphenylmethyl Methyl Ether ;
CANERTINIB (BASE) ;
CAS:267243-28-7
CNT00B :
N-[4-[(3-Chloro-4-fluorophenyl)amino]-7-[3-(4-morpholinyl)propoxy]-6-quinazolinyl]-2-propenamide ;
CANERTINIB 3-CHLORO-4-FLUOROBENZENAMINE IMPURITY ;
CAS:367-21-5
CNT51 :
3-Chloro-4-fluorobenzenamine ; 4-Fluoro-3-chloroaniline ;
CANERTINIB 4,6-DIAMINO IMPURITY ;
CNT52 :
7-(3-Morpholinopropoxy)quinazoline-4,6-diamine ;
CANERTINIB 4-AMINO IMPURITY ;
CNT53 :
N-(4-Amino-7-(3-morpholinopropoxy)quinazolin-6-yl)acrylamide ;
CANERTINIB DIAMINOQUINAZOLINOL IMPURITY ;
CNT54 :
4,6-Diaminoquinazolin-7-ol ;
CANERTINIB DIHYDROCHLORIDE ;
CAS:289499-45-2
CNT00H :
N-[4-[(3-Chloro-4-fluorophenyl)amino]-7-[3-(4-morpholinyl)propoxy]-6-quinazolinyl]-2-propenamide dihydrochloride ;
CANERTINIB N-DESPROPENYL IMPURITY ;
CAS:267243-68-5
CNT55 :
N4-(3-Chloro-4-fluorophenyl)-7-(3-morpholinopropoxy)quinazoline-4,6-diamine ;
CANERTINIB NITRO IMPURITY ;
CAS:267243-64-1
CNT56 :
N-(3-Chloro-4-fluorophenyl)-7-(3-morpholinopropoxy)-6-nitroquinazolin-4-amine ;
CAPECITABINE ;
CAS:154361-50-9
CPC00 :
Pentyl 1-(5-deoxy--D-ribofuranosyl)-5-fluoro-1,2-dihydro-2-oxo-4-pyrimidinecarbamate ;
CAPECITABINE 2-O-BDR IMPURITY (USP) ; 2-O-(5-DEOXY-SS-D-RIBOFURANOSYL) CAPECITABINE ; CAPECITABINE USP IMPURITY H ; CAPECITABINE IMPURITY I ;
CAS:1262133-66-3
CPC52 :
[1-[5-Deoxy-2-O-(5-deoxy--D-ribofuranosyl)--D-ribofuranosyl]-5-fluoro-2-oxo-1,2-dihydropyrimidin-4-yl]-carbamic acid pentyl ester ;
CAPECITABINE 3-O-BDR IMPURITY (USP) ; 3-O-(5-DEOXY-SS-D-RIBOFURANOSYL) CAPECITABINE ; CAPECITABINE USP IMPURITY G ; CAPECITABINE IMPURITY H ;
CAS:1262133-64-1
CPC53 :
[1-[5-Deoxy-3-O-(5-deoxy--D-ribofuranosyl)--D-ribofuranosyl]-5-fluoro-2-oxo-1,2-dihydropyrimidin-4-yl]-carbamic acid pentyl ester ;
CAPECITABINE ALPHA-ISOMER ;
CPC50 :
Pentyl 1-(5-deoxy-a-D-ribofuranosyl)-5-fluoro-1,2-dihydro-2-oxo-4-pyrimidinecarbamate ;
CAPECITABINE DESCARBAMATE DIACETYL ALPHA-ISOMER ; DESCARBAMATE DIACETYL CAPECITABINE ALPHA-ISOMER ;
CPC65 :
4-Amino-5-fluoro-1-(2,3-di-O-acetyl-a-D-ribofuranosyl)-2(1H)-pyrimidinone ;
CAPECITABINE EP IMPURITY A ; CAPECITABINE USP RC A ; DOXIFLURIDINE 5-FLUOROCYTOSINE IMPURITY ;
CAS:66335-38-4
CPC01 :
5'-Deoxy-5-fluorocytidine ;
CAPECITABINE EP IMPURITY B ; CAPECITABINE USP RC B ; DOXIFLURIDINE ;
CAS:9/5/3094
CPC02 :
5'-Deoxy-5-fluorouridine ;
CAPECITABINE EP IMPURITY C ; CAPECITABINE DIACETYL AMINO IMPURITY (USP) ;
CAS:161599-46-8
CPC03 :
2',3'-Di-O-acetyl-5'-deoxy-5-fluorocytidine ;
CAPECITABINE EP IMPURITY D ; CAPECITABINE 2-METHYLBUTYLOXY IMPURITY (USP) ;
CAS:910129-15-6
CPC04 :
5'-Deoxy-5-fluoro-N4-(2-methylbutyloxycarbonyl)cytidine ;
CAPECITABINE EP IMPURITY E ; CAPECITABINE 3-METHYLBUTYLOXY IMPURITY (USP) ;
CAS:162204-30-0
CPC05 :
5'-Deoxy-5-fluoro-N4-(3-methylbutyloxycarbonyl)cytidine ;
CAPECITABINE EP IMPURITY F ; CAPECITABINE USP RC C ;
CAS:921769-65-5
CPC06 :
2',3'-O-Carbonyl-5'-deoxy-5-fluoro-N4-(pentyloxycarbonyl)cytidine ;
CAPECITABINE EP IMPURITY G ; CAPECITABINE DIACETYL IMPURITY (USP) ;
CAS:162204-20-8
CPC07 :
4-Amino-5-fluoro-1-(2,3-di-O-acetyl--D-ribofuranosyl)-2(1H)-pyrimidinone ; 2',3'-Di-O-acetyl-5'-deoxy-5-fluoro-N4- (pentyloxycarbonyl) cytidine ;
CAPECITABINE METHOXY ANALOG ; CAPECITABINE IMPURITY M ;
CPC33 :
(1-(5-Deoxy-beta-D-ribofuranosyl)-5-fluoro-1,2-dihydro-2-oxo-4-pyrimidinyl)-carbamic acid methyl ester ;
CAPECITABINE USP RC I ; CAPECITABINE USP IMPURITY I ; 3-O-(5-DEOXY-A-D-RIBOFURANOSYL) CAPECITABINE ;
CAS:1262133-68-5
CPC29 :
1-[5-Deoxy-3-O-(5-deoxy-a-D-ribofuranosyl)--D-ribofuranosyl]-5-fluoro-2-oxo-1,2-dihydropyrimidin-4-yl]carbamic acid pentyl ester ;
CAPTOPRIL ;
CAS:62571-86-2
CPR00 :
(2S)-1-[(2S)-2-Methyl-3-sulphanylpropanoyl]pyrrolidine-2-carboxylic acid ;
CAPTOPRIL EP IMPURITY A (= USP RC A) ; CAPTOPRIL DISULFIDE ;
CAS:64806-05-9
CPR01 :
(2S,2'S)-1,1'-[Disulphanediylbis[(2S)-2-methyl-1-oxopropane-3,1-diyl]-bis[pyrrolidine-2-carboxylic] acid ;
CAPTOPRIL EP IMPURITY B (= USP RC B) ; CAPTOPRIL BROMO ANALOG ;
CAS:80629-35-2
CPR02 :
(2S)-1-[(2S)-2-Methyl-3-bromopropanoyl]pyrrolidine-2-carboxylic acid ;
CAPTOPRIL EP IMPURITY C (= USP RC C) ;
CAS:26473-47-2
CPR03A :
3-Mercapto-2-methylpropanoic acid ;
CAPTOPRIL EP IMPURITY D (= USP RC D) ; CAPTOPRIL BROMO ACID ;
CAS:56970-78-6
CPR04 :
3-Bromo-2-methylpropanoic acid ;
CAPTOPRIL EP IMPURITY E (= USP RC E) ; CAPTOPRIL DESMERCAPTO IMPURITY ;
CAS:23500-15-4
CPR05 :
(2S)-1-(2-Methylpropanoyl)pyrrolidine-2-carboxylic acid ;
CAPTOPRIL EP IMPURITY F ; EPI-CAPTOPRIL ;
CAS:63250-36-2
CPR06 :
(2S)-1-[(2R)-2-Methyl-3-sulphanylpropanoyl]pyrrolidine-2-carboxylic acid ;
CAPTOPRIL EP IMPURITY G ;
CAS:33325-40-5
CPR07 :
3-Acetylsulfanyl-2-methylpropanoic acid ;
CAPTOPRIL EP IMPURITY H ;
CPR08 :
(2S)-1-[(2S)-3-[[(2R)-3-(Acetylsulfanyl)-2-methylpropanoyl]sulfanyl]-2-methylpropanoyl]pyrrolidine-2-carboxylic acid ;
CAPTOPRIL EP IMPURITY I ;
CPR09 :
(2S)-1-[(2S)-3-[[[(2S)-1-[(2S)-2-Methyl-3-sulfanylpropanoyl]pyrrolidin-2-yl]carbonyl]sulfanyl]-2-methylpropanoyl]pyrrolidine-2-carboxylic acid ;
CAPTOPRIL EP IMPURITY J ; CAPTOPRIL ACETYLTHIO IMPURITY ;
CAS:64838-55-7
CPR10 :
(2S)-1-[(2S)-3-(Acetylsulfanyl)-2-methylpropanoyl]pyrrolidine-2-carboxylic acid ;
CAPTOPRIL EP IMPURITY K ;
CPR11 :
CAPTOPRIL EP IMPURITY L ; CAPTOPRIL METHYLENEBIS IMPURITY ;
CPR12 :
1,1'-[Methylenebis[sulfanediyl[(2S)-2-methyl-1-oxopropane-3,1-diyl]]]bis[(2S)-pyrrolidine-2-carboxylic]acid ;
CAPTOPRIL EP IMPURITY M ;
CPR13 :
(2S)-1-[(2S)-3-[[(2S)-2-Carboxypropyl]disulfanyl]-2-methylpropanoyl] pyrrolidine-2-carboxylic acid ;
CAPTOPRIL EP IMPURITY N ;
CAS:65134-74-9
CPR14 :
3,3'-Disulfanediylbis[(2S)-2-methylpropanoic] acid ;
CAPTOPRIL EP IMPURITY O ;
CPR15 :
1,1'-[Propane-2,2-diylbis[sulfanediyl[(2S)-2-methyl-1-oxopropane-3,1-diyl]]]bis[(2S)-pyrrolidine-2-carboxylic]acid ;
CAPTOPRIL ETHYL ESTER ;
CAS:86938-12-7
CPR32 :
(2S)-1-[(2S)-2-Methyl-3-sulphanylpropanoyl]pyrrolidine-2-carboxylic acid ethyl ester ;
CAPTOPRIL METHYL ESTER ;
CAS:176036-41-2
CPR31 :
(2S)-1-[(2S)-2-Methyl-3-sulphanylpropanoyl]pyrrolidine-2-carboxylic acid methyl ester ;
CARBACHOL CHLORIDE ;
CAS:51-83-2
CRB00 :
2-(Carbamoyloxy)-N,N,N-trimethylethanaminium chloride ;
CARBACHOL CHLORIDE EP IMPURITY A ; CHOLINE CHLORIDE ;
CAS:67-48-1
CRB01 :
2-Hydroxy-N,N,N-trimethylethanaminium chloride ;
CARBAMAZEPINE ; OXCARBAZEPINE EP IMPURITY A ;
CAS:298-46-4
CBM00 :
5H-Dibenzo[b,f]azepine-5-carboxamide ;
CARBAMAZEPINE 10-ACETOXY IMPURITY ;
CAS:952740-00-0
CBM50 :
10-Acetoxy-5H-dibenz[b,f]azepine-5-carboxamide ;
CARBAMAZEPINE 3-CHLOROIMINODIBENZYL IMPURITY ; CLOMIPRAMINE EP IMPURITY F ;
CAS:32943-25-2
CBM53 :
3-Chloro-10,11-dihydro-5H-dibenz[b,f]azepine ;
CARBAMAZEPINE DIHYDRO CHLOROCARBONYL IMPURITY ; IMINODIBENZYL 5-CARBONYL CHLORIDE ;
CAS:33948-19-5
CBM46 :
5-Chlorocarbonyl-10,11-dihydro-5H-dibenz[b,f]azepine ;
CARBAMAZEPINE DIHYDRO N-CARBAMOYL IMPURITY ;
CBM43 :
10,11-Dihydro-5H-Dibenzo[b,f]azepin-5-ylcarbonyl)urea ; 10,11-Dihydro-N-Carbamoyl Carbamazepine ;
CARBAMAZEPINE EP IMPURITY A ; CARBAMAZEPINE USP RC A ;
CAS:3564-73-6
CBM01 :
10,11-Dihydro-5H-dibenzo[b,f]azepine-5-carboxamide ; 10,11-Dihydro Carbamazepine ;
CARBAMAZEPINE EP IMPURITY B ; CARBAMAZEPINE USP IMPURITY D ;
CAS:611-64-3
CBM02 :
9-Methylacridine ;
CARBAMAZEPINE EP IMPURITY C ; CARBAMAZEPINE USP IMPURITY C ;
CAS:1219170-51-0
CBM03 :
5H-Dibenzo[b,f]azepin-5-ylcarbonyl)urea ; N-Carbamoyl Carbamazepine ;
CARBAMAZEPINE EP IMPURITY D ; CARBAMAZEPINE USP RC B ; OXCARBAZEPINE EP IMPURITY E ; IMINOSTILBENE ;
CAS:256-96-2
CBM04 :
5H-Dibenzo[b,f]azepine ;
CARBAMAZEPINE EP IMPURITY E ; TRIMIPRAMINE EP IMPURITY F ; TRIMIPRAMINE BP IMPURITY F ; IMINODIBENZYL ;
CAS:494-19-9
CBM05 :
10,11-Dihydro-5H-dibenzo[b,f]azepine ;
CARBAMAZEPINE EP IMPURITY F ; CARBAMAZEPINE USP IMPURITY F ;
CAS:33948-22-0
CBM06 :
5H-Dibenzo[b,f]azepine-5-carbonyl chloride ;
CARBAMAZEPINE EP IMPURITY G ; CARBAMAZEPINE USP IMPURITY G ; 10-BROMOCARBAMAZEPINE ;
CAS:59690-97-0
CBM07 :
10-Bromo-5H-dibenzo[b,f]azepine-5-carboxamide ;
CARBAMAZEPINE N-BROMOCARBONYL IMPURITY ;
CAS:40421-05-4
CBM56 :
5H-Dibenzo[b,f]azepine-5-carbonyl bromide ;
CARBASALATE CALCIUM ;
CAS:5749-67-7
CRL00U :
Calcium di[2-(acetyloxy)benzoate] and urea ;
CARBASALATE EP IMPURITY A ; ACETYLSALICYLIC ACID EP IMPURITY F ; ACETYLSALICYLIC ANHYDRIDE ;
CAS:1466-82-6
CRL01 :
2-(Acetyloxy)benzoic anhydride ;
CARBASALATE EP IMPURITY B ; ACETYLSALICYLIC ACID EP IMPURITY D ; ACETYLSALICYLSALICYLIC ACID ;
CAS:530-75-6
CRL02 :
2-[[2-(Acetyloxy)benzoyl]oxy]benzoic acid ;
CARBASALATE EP IMPURITY C ; LAMIVUDINE EP IMPURITY C ; MESALAZINE EP IMPURITY H ; SULFASALAZINE EP IMPURITY H ; SALICYLIC ACID ; DEFERASIROX BENZOIC IMPURITY ;
CAS:69-72-7
CRL03 :
2-Hydroxybenzenecarboxylic acid ;
CARBASALATE EP IMPURITY D ; ACETYLSALICYLIC ACID EP IMPURITY E ; SALICYLSALICYLIC ACID ; SALSALATE ;
CAS:552-94-3
CRL04 :
2-[(2-Hydroxybenzoyl)oxy]benzoic acid ;
CARBIDOPA ;
CAS:38821-49-7
CBD00 :
(2S)-3-(3,4-Dihydroxyphenyl)-2-hydrazino-2-methylpropanoic acid monohydrate ;
CARBIDOPA EP IMPURITY A ; L-METHYLDOPA ;
CAS:555-30-6
CBD01 :
(2S)-2-Amino-3-(3,4-dihydroxyphenyl)-2-methylpropanoic acid ;
CARBIDOPA EP IMPURITY B ; A-METHYLDOPA METHYL ESTER ;
CAS:18181-08-3
CBD02 :
Methyl (2S)-2-Amino-3-(3,4-dihydroxyphenyl)-2-methylpropanoate ;
CARBIDOPA EP IMPURITY C ; CARBIDOPA USP RC A ; 3-O-METHYL CARBIDOPA ;
CAS:85933-19-3
CBD03 :
a-Hydrazino-4-hydroxy-3-methoxy-a-methylbenzenepropanoic acid ;
CARBIDOPA EP IMPURITY D ; N-CYCLOHEXYLIDENE CARBIDOPA METHYL ESTER ;
CAS:934371-48-9
CBD04 :
Methyl (2S)-2-(2-Cyclohexylidenehydrazino)-3-(3,4-dihydroxyphenyl)-2-methylpropanoate ;
CARBIDOPA EP IMPURITY E ; (S)-CARBIDOPA METHYL ESTER ;
CAS:52514-63-3
CBD05 :
Methyl (2S)-3-(3,4-Dihydroxyphenyl)-2-hydrazino-2-methylpropanoate ;
CARBIDOPA EP IMPURITY F ; (S)-CARBIDOPA ETHYL ESTER HCL ;
CAS:96115-88-7
CBD06H :
Ethyl (2S)-3-(3,4-Dihydroxyphenyl)-2-hydrazino-2-methylpropanoate hydrochloride ;
CARBIDOPA EP IMPURITY G ;
CAS:2503-44-8
CBD07 :
1-(3,4-Dihydroxyphenyl)propan-2-one ;
CARBIDOPA EP IMPURITY H ; 4-O-METHYLCARBIDOPA ;
CBD08 :
(2S)-2-Hydrazino-3-(3-hydroxy-4-methoxyphenyl)-2-methylpropanoic acid ;
CARBIDOPA EP IMPURITY I ; 3-BROMO (S)-CARBIDOPA ;
CAS:1246819-09-9
CBD09 :
(2S)-3-(3-Bromo-4,5-dihydroxyphenyl)-2-hydrazino-2-methylpropanoic acid ;
CARBIDOPA EP IMPURITY J ; 2-BROMO (S)-CARBIDOPA ;
CAS:43197-33-7
CBD10 :
(2S)-3-(2-Bromo-4,5-dihydroxyphenyl)-2-hydrazino-2-methylpropanoic acid ;
CARBIDOPA METHYL ESTER RACEMATE ;
CAS:91431-01-5
CBD55 :
a-Hydrazinyl-3,4-dihydroxy-a-methylbenzenepropanoic acid methyl ester ;
CARBIMAZOLE EP IMPURITY A ; THIAMAZOLE ; METHIMAZOLE ;
CAS:60-56-0
CMA01 :
1-Methyl-1H-imidazole-2-thiol ;
CARBIMAZOLE ;
CAS:22232-54-8
CMA00 :
Ethyl 3-methyl-2-thioxo-2,3-dihydro-1H-imidazole-1-carboxylate ;
CARBINOXAMINE MALEATE ;
CAS:3505-38-2
CNX00M :
2-((4-Chlorophenyl)(pyridin-2-yl)methoxy)-N,N-dimethylethanamine maleate ;
CARBINOXAMINE N-OXIDE ;
CAS:1256285-70-7
CNX50 :
2-((4-Chlorophenyl)(pyridin-2-yl)methoxy)-N,N-dimethylethanamine N-oxide ;
CARBINOXAMINE USP RC A ;
CAS:6318-51-0
CNX21 :
(4-Chlorophenyl)(pyridin-2-yl)methanone ;
CARBINOXAMINE USP RC B ;
CAS:27652-89-7
CNX22 :
(4-Chlorophenyl)(pyridin-2-yl)methanol ;
CARBINOXAMINE USP RC C ; DESCHLORO CARBINOXAMINE OXALATE ;
CNX23X :
N,N-Dimethyl-2-[phenyl(pyridin-2-yl)methoxy]ethan-1-amine oxalate ;
CARBOCISTEINE ; S-CARBOXYMETHYL-L-CYSTEINE;
CAS:638-23-3
CCS00 :
(2R)-2-Amino-3-[(carboxymethyl)thio]propionic acid ;
CARBOCISTEINE LACTAM IMPURITY ;
CAS:62305-89-9
CCS50N :
(3R)-5-Oxo-3-thiomorpholinecarboxylic acid sodium salt ;
CARBOCISTEINE SULFOXIDE ;
CAS:5439-87-2
CCS51 :
3-[(Carboxymethyl)sulfinyl]-L-alanine ;
CARBOVIR ;
CAS:118353-05-2
CBV00 :
rel-2-Amino-1,9-dihydro-9-[(1R,4S)-4-(hydroxymethyl)-2-cyclopenten-1-yl]-6H-purin-6-one ;
CARBOVIR DIPHOSPHATE ;
CAS:144606-03-1
CBV52 :
Diphosphoric acid rel-mono[[(1R,4S)-4-(2-amino-1,6-dihydro-6-oxo-9H-purin-9-yl)-2-cyclopenten-1-yl]methyl] ester ;
CARBOVIR MONOPHOSPHATE ;
CAS:144490-73-3
CBV51 :
rel-2-Amino-1,9-dihydro-9-[(1R,4S)-4-[(phosphonooxy)methyl]-2-cyclopenten-1-yl]-6H-purin-6-one ;
CARFILZOMIB (2R,4R)-2-HYDROXY O-ACETATYL IMPURITY ;
CZM61 :
(2R,4R)-2-Hydroxy-2,6-dimethyl-4-((S)-2-((S)-4-methyl-2-((S)-2-(2-morpholinoacetamido)-4-phenylbutanamido)pentanamido)-3-phenylpropanamido)-3-oxoheptyl acetate ;
CARFILZOMIB (2R,4R)-DIOL (7R)-ISOMER ;
CAS:868540-17-4
CZM65 :
(S)-N-((R)-1-((2R,4R)-1,2-Dihydroxy-2,6-dimethyl-3-oxoheptan-4-ylamino)-1-oxo-3-phenylpropan-2-yl)-4-methyl-2-((S)-2-(2-morpholinoacetamido)-4-phenylbutanamido)pentanamide ;
CARFILZOMIB (2R,4R)-DIOL ;
CZM60 :
(S)-N-((S)-1-((2R,4R)-1,2-Dihydroxy-2,6-dimethyl-3-oxoheptan-4-ylamino)-1-oxo-3-phenylpropan-2-yl)-4-methyl-2-((S)-2-(2-morpholinoacetamido)-4-phenylbutanamido)pentanamide ;
CARFILZOMIB (2R,4S)-2-HYDROXY O-ACETYL IMPURITY ;
CAS:1541171-69-0
CZM62 :
(2R,4S)-2-Hydroxy-2,6-dimethyl-4-((S)-2-((S)-4-methyl-2-((S)-2-(2-morpholinoacetamido)-4-phenylbutanamido)pentanamido)-3-phenylpropanamido)-3-oxoheptyl acetate ;
CARFILZOMIB (2R,4S)-DIOL (7R)-ISOMER ;
CAS:868540-17-4
CZM66 :
(S)-N-((R)-1-((2R,4S)-1,2-Dihydroxy-2,6-dimethyl-3-oxoheptan-4-ylamino)-1-oxo-3-phenylpropan-2-yl)-4-methyl-2-((S)-2-(2-morpholinoacetamido)-4-phenylbutanamido)pentanamide ;
CARFILZOMIB (2R,4S)-DIOL ;
CAS:1541172-75-1
CZM51 :
(S)-N-((S)-1-((2R,4S)-1,2-dihydroxy-2,6-dimethyl-3-oxoheptan-4-ylamino)-1-oxo-3-phenylpropan-2-yl)-4-methyl-2-((S)-2-(2-morpholinoacetamido)-4-phenylbutan amido)pentanamide ;
CARFILZOMIB (2S,4R)-2-HYDROXY O-ACETYL IMPURITY ;
CZM63 :
(2S,4R)-2-Hydroxy-2,6-dimethyl-4-((S)-2-((S)-4-methyl-2-((S)-2-(2-morpholinoacetamido)-4-phenylbutanamido)pentanamido)-3-phenylpropanamido)-3-oxoheptyl acetate ;
CARFILZOMIB (2S,4R)-DIOL (7R)-ISOMER ;
CAS:868540-17-4
CZM67 :
(S)-N-((R)-1-((2S,4R)-1,2-Dihydroxy-2,6-dimethyl-3-oxoheptan-4-ylamino)-1-oxo-3-phenylpropan-2-yl)-4-methyl-2-((S)-2-(2-morpholinoacetamido)-4-phenylbutanamido)pentanamide ;
CARFILZOMIB (2S,4R)-DIOL ;
CZM52 :
(S)-N-((S)-1-((2S,4R)-1,2-Dihydroxy-2,6-dimethyl-3-oxoheptan-4-ylamino)-1-oxo-3-phenylpropan-2-yl)-4-methyl-2-((S)-2-(2-morpholinoacetamido)-4-phenylbutan amido)pentanamide ;
CARFILZOMIB (2S,4S)-2-HYDROXY O-ACETYL IMPURITY ;
CZM64 :
(2S,4S)-2-Hydroxy-2,6-dimethyl-4-((S)-2-((S)-4-methyl-2-((S)-2-(2-morpholinoacetamido)-4-phenylbutanamido)pentanamido)-3-phenylpropanamido)-3-oxoheptyl acetate ;
CARFILZOMIB (2S,4S)-DIOL (7R)-ISOMER ;
CAS:868540-17-4
CZM68 :
(S)-N-((R)-1-((2S,4S)-1,2-Dihydroxy-2,6-dimethyl-3-oxoheptan-4-ylamino)-1-oxo-3-phenylpropan-2-yl)-4-methyl-2-((S)-2-(2-morpholinoacetamido)-4-phenylbutanamido)pentanamide ;
CARFILZOMIB (2S,4S)-DIOL HYDROCHLORIDE ;
CZM53H :
(S)-N-((S)-1-((2S,4S)-1,2-Dihydroxy-2,6-dimethyl-3-oxoheptan-4-ylamino)-1-oxo-3-phenylpropan-2-yl)-4-methyl-2-((S)-2-(2-morpholinoacetamido)-4-phenylbutan amido)pentanamide hydrochloride ;
CARFILZOMIB ;
CAS:868540-17-4
CZM00 :
(aS)-a-[[2-(4-Morpholinyl)acetyl]amino]benzenebutanoyl-L-leucyl-N-[(1S)-3-methyl-1-[[(2R)-2-methyl-2-oxiranyl]carbonyl]butyl]-L-phenylalaninamide ;
CARFILZOMIB 3-PHENYLPROPANOIC ACID ;
CAS:868540-16-3
CZM69 :
(S)-2-((S)-4-Methyl-2-((S)-2-(2-morpholinoacetamido)-4-phenylbutanamido)pentanamido)-3-phenylpropanoic acid ;
CARFILZOMIB DIMER-1 ;
CZM70 :
(S)-2-((2S,5S,8S,11S)-5-Benzyl-8-isobutyl-14-morpholino-4,7,10,13-tetraoxo-2,11-diphenethyl-3,6,9,12-tetraazatetradecanamido)-4-methyl-N-((S)-1-(((S)-3-methyl-1-((R)-2-methyloxiran-2-yl)-1-oxobutan-2-yl)amino)-1-oxo-3-phenylpropan-2-yl)pentanamide ;
CARFILZOMIB DIMER-2 ;
CZM71 :
(S)-4-Methyl-N-((S)-1-(((S)-4-methyl-1-(((S)-1-(((S)-4-methyl-1-((R)-2-methyloxiran-2-yl)-1-oxopentan-2-yl)amino)-1-oxo-3-phenylpropan-2-yl)amino)-1-oxopentan-2-yl)amino)-1-oxo-3-phenylpropan-2-yl)-2-((S)-2-(2-morpholinoacetamido)-4-phenylbutanamido)penta
CARFILZOMIB ENANTIOMER ;
CZM72 :
(R)-4-Methyl-N-((R)-1-((R)-4-methyl-1-((S)-2-methyloxiran-2-yl)-1-oxopentan-2-ylamino)-1-oxo-3-phenylpropan-2-yl)-2-((R)-2-(2-morpholinoacetamido)-4-phenylbutanamido)pentanamide ;
CARFILZOMIB METHOXIDE ;
CZM73 :
(S)-Methyl 2-((S)-4-methyl-2-((S)-2-(2-morpholinoacetamido)-4-phenylbutanamido)pentanamido)-3-phenylpropanoate ;
CARMUSTINE ;
CAS:154-93-8
CMS00 :
1,3-Bis(2-Chloroethyl)-1-nitrosourea ;
CARMUSTINE EP IMPURITY A ; CARMUSTINE USP RC A ;
CAS:2214-72-4
CMS01 :
1,3-Bis(2-Chloroethyl)urea ;
CARPROFEN ;
CAS:53716-49-7
CRN00 :
(2RS)-2-(6-Chloro-9H-carbazol-2-yl)propanoic acid ;
CARPROFEN EP IMPURITY A ;
CAS:252288-17-8
CRN01 :
2-(6-Chloro-9H-carbazol-2-yl)-2-methylpropanedioic acid ;
CARPROFEN EP IMPURITY B ;
CAS:52263-68-0
CRN02 :
(2RS)-2-(9H-Carbazol-2-yl)propanoic acid ;
CARPROFEN EP IMPURITY C ;
CAS:92841-21-9
CRN03 :
(1RS)-1-(6-Chloro-9H-carbazol-2-yl)ethanol ;
CARPROFEN EP IMPURITY D ;
CAS:92841-22-0
CRN04 :
1-(6-Chloro-9H-carbazol-2-yl)ethanone ;
CARPROFEN EP IMPURITY E ;
CAS:2732-25-4
CRN05 :
3-Chloro-9H-carbazole ;
CARPROFEN EP IMPURITY F ;
CAS:71208-55-4
CRN06 :
Diethyl 2-(6-chloro-9H-carbazol-2-yl)-2-methylpropanedioate ;
CARPROFEN EP IMPURITY G ; CARPROFEN ETHYL ESTER ;
CAS:52262-89-2
CRN07 :
Ethyl (2RS)-2-(6-chloro-9H-carbazol-2-yl)propanoate ;
CARPROFEN EP IMPURITY H ;
CAS:92841-23-1
CRN08 :
6-Chloro-2-ethyl-9H-carbazole ;
CARPROFEN USP RC A ; CARVEDILOL CARBAZOLE IMPURITY ;
CAS:86-74-8
CRN21 :
9H-Carbazole ;
CARVEDILOL (R)-ISOMER ; -(+)-CARVEDILOL ;
CAS:95093-99-5
CVD12R :
(2R)-1-(9H-Carbazol-4-yloxy)-3-[[2-(2-methoxyphenoxy)-ethyl]amino]propan-2-ol ;
CARVEDILOL (S)-ISOMER ; (S)-(-)-CARVEDILOL ;
CAS:95094-00-1
CVD13S :
(2S)-1-(9H-Carbazol-4-yloxy)-3-[[2-(2-methoxyphenoxy)-ethyl]amino]propan-2-ol ;
CARVEDILOL ;
CAS:72956-09-3
CVD00 :
(2RS)-1-(9H-Carbazol-4-yloxy)-3-[[2-(2-methoxyphenoxy)-ethyl]amino] propan-2-ol ;
CARVEDILOL 4-HYDROXY METABOLITE ; 4-HYDROXY CARVEDILOL ;
CAS:142227-49-4
CVD34 :
4-[2-[[3-(9H-Carbazol-4-yloxy)-2-hydroxypropyl]amino]ethoxy]-3-methoxy phenol ;
CARVEDILOL 4-HYDROXYCARBAZOLE IMPURITY ;
CAS:52602-39-8
CVD14 :
4-Hydroxycarbazole ;
CARVEDILOL BISCARBAZOLE IMPURITY ; CARVEDILOL DIETHER PROPANOL IMPURITY ;
CAS:1276477-91-8
CVD41 :
1,3-Bis(9H-carbazol-4-yloxy)-2-propanol ;
CARVEDILOL CARBAZOLE IMPURITY ;
CAS:86-74-8
CVD15 :
9H-Carbazole ;
CARVEDILOL DIPHENOXY IMPURITY ;
CAS:1076199-79-5
CVD46 :
1-(9H-Carbazol-4-yloxy)-3-[[2-hydroxy-3-[[2-(2-methoxyphenoxy)ethyl]amino]propyl][2-(2-methoxyphenoxy)ethyl]amino]-2-propanol ;
CARVEDILOL EP IMPURITY A (= USP RC A) ;
CAS:1198090-73-1
CVD01 :
1-(4-(2-Hydroxy-3-(2-(2-methoxyphenoxy)ethylamino)propoxy)-9H-carbazol-9-yl)-3-(2-(2-methoxyphenoxy)ethylamino)propan-2-ol ;
CARVEDILOL EP IMPURITY B (= USP RC B) ; CARVEDILOL BIS-CARBAZOLE IMPURITY ;
CAS:918903-20-5
CVD02 :
3,3'-(2-(2-Methoxyphenoxy)ethylazanediyl)bis(1-(9H-carbazol-4-yloxy)propan-2-ol ;
CARVEDILOL EP IMPURITY C (= USP RC C) ; N-BENZYL CARVEDILOL ;
CAS:72955-94-3
CVD03 :
1-(9H-Carbazol-4-yloxy)-3-(benzyl(2-(2-methoxyphenoxy) ethyl)amino)propan-2-ol ;
CARVEDILOL EP IMPURITY D (= USP RC D) ;
CAS:51997-51-4
CVD04 :
4-(2,3-Epoxypropoxy)carbazole ;
CARVEDILOL EP IMPURITY E (= USP RC E) ;
CAS:64464-07-9
CVD05H :
2-(2-Methoxyphenoxy)ethylamine hydrochloride ;
CARVEDILOL KETONE IMPURITY ;
CAS:933442-50-3
CVD50 :
1-(2-(2-Methoxyphenoxy)ethylamino)-3-(9H-carbazol-8-yloxy)propan-2-one ;
CARVEDILOL N-ISOPROPYL IMPURITY ;
CAS:1246819-01-1
CVD51 :
1-(9H-Carbazol-4-yloxy)-3-[[2-(2-methoxyphenoxy)ethyl](1-methylethyl)amino]-2-propanol ;
CARVEDILOL O-DESMETHYL IMPURITY ;
CAS:72956-44-6
CVD45 :
(2RS)-1-(9H-Carbazol-4-yloxy)-3-[[2-(2-hydroxyphenoxy)-ethyl] amino] propan-2-ol ;
CARVEDILOL O-DESMETHYL O-ALKYL IMPURITY ;
CAS:1346602-98-9
CVD43 :
3,3-{2,2-[1,2-Phenylenebis(oxy)]bis(ethane-2,1-diyl)}bis(azanediyl)bis(1-(9H-carbazol-4-yloxy)propan-2-ol) ;
CARVEDILOL O-DESMETHYL O-AMINOETHYL IMPURITY ;
CAS:1391052-10-0
CVD44 :
(2RS)-1-(9H-Carbazol-4-yloxy)-3-[[2-(2-(2-aminoethyl)oxyphenoxy)-ethyl] amino] propan-2-ol ;
CARVEDILOL O-DESMETHYL O-BENZYL IMPURITY ;
CAS:72955-92-1
CVD39 :
(2RS)-1-(9H-Carbazol-4-yloxy)-3-[[2-(2-benzyloxyphenoxy)-ethyl]amino] propan-2-ol ;
CARVEDILOL P-BENZYLOXY IMPURITY ; 4-BENZYLOXY CARVEDILOL ;
CAS:887352-95-6
CVD40 :
(2RS)-1-(9H-Carbazol-4-yloxy)-3-[[2-(2-methoxy-4-benzyloxyphenoxy)-ethyl]amino] propan-2-ol ;
CARVEDILOL PROPANEDIOL IMPURITY ;
CAS:123119-89-1
CVD42 :
3-(9H-Carbazol-4-yloxy)-1,2-propanediol ;
CARVEDILOL USP RC F ; 6,7,8,9-TETRAHYDRO CARVEDILOL ;
CAS:1246820-73-4
CVD26 :
1-[[2-(2-Methoxyphenoxy)ethyl]amino]-3-[(2,3,4,9-tetrahydro-1H-carbazol-5-yl)oxy]-2-propanol ;
CASPOFUNGIN (BASE) ;
CAS:162808-62-0
CSF00B :
1-[(4R,5S)-5-[(2-Aminoethyl)amino]-N2-[(10R,12S)-10,12-dimethyl-1-oxotetradecyl]-4-hydroxy-L-ornithine]-5-(threo-3-hydroxy-L-ornithine)pneumocandin B0 ;
CASPOFUNGIN ACETATE ; CASPOFUNGIN B0 ACETATE ;
CAS:179463-17-3
CSF00A :
(3S,6S,9S,11R,15S,18S,20R,21S,24S,25S)-21-(2-Aminoethylamino)-3-[3-amino-1(R)-hydroxypropyl]-6-[1(S),2(S)-dihydroxy-2-(4-hydroxyphenyl)ethyl]-18-(10,12-dimethyltetradecanamido)-11,20,25-trihydroxy-15-[1(R)-hydroxy ethyl]-1,4,7,13,16,22-hexaazatricyclo[22.
CASPOFUNGIN C0 ACETATE ;
CSF33A :
Caspofungin Acetate C0 Analog ;
CASPOFUNGIN DESMETHYL IMPURITY ; CASPOFUNGIN IMPURITY A ;
CAS:1202167-57-4
CSF34 :
(3S)-(4R,5S)-5-[(2-Aminoethyl)amino]-N2-[(10R,12S)-10,12-dimethyl-1-oxotetradecyl]-4-hydroxy-L-ornithyl-L-seryl-(4R)-4-hydroxy-L-prolyl-(4S)-4-hydroxy-4-(4-hydroxyphenyl)-L-threonyl-(3R)-3-hydroxy-L-ornithyl-3-hydroxy-L-proline ;
CASPOFUNGIN METABOLITE M1 ;
CSF41 :
(4S)-Hydroxy-4-(4-hydroxyphenyl)-L-threonine ;
CASPOFUNGIN METABOLITE M2 ;
CSF42 :
N-Acetyl-(4S)-Hydroxy-4-(4-hydroxyphenyl)-L-threonine ;
CASPOFUNGIN METABOLITE M2D ;
CSF43 :
N-acetyl-4(S)-hydroxy-4-(4-hydroxyphenyl)-L-threonine-gama-lactone ;
CASPOFUNGIN PHENYLTHIO AMIDE IMPURITY ; PNEUMOCANDIN B0 PHENYLTHIO ANALOG ;
CSF51:
(3S)-(4R,5R)-N2-[(10R,12S)-10,12-Dimethyl-1-oxotetradecyl]- 4-hydroxy-5-phenylthio-L-ornithyl-L-threonyl-(4R)-4-hydroxy-L-prolyl-(4S)-4-hydroxy-4-(4-hydroxyphenyl)-L-threonyl-(3R)-3-hydroxy-L-glutaminyl-3-hydroxy-L-proline (6?1)-lactam ;
CASPOFUNGIN PHENYLTHIO AMINE IMPURITY ; PNEUMOCANDIN B0 DEOXY PHENYLTHIO ANALOG ;
CSF52 :
(3S,6S,9S,11R,15S,18S,20R,21S,24S,25S)-21-Phenylthio-3-[3-amino-1(R)-hydroxypropyl]-6-[1(S),2(S)-dihydroxy-2-(4-hydroxyphenyl)ethyl]-18-(10,12-dimethyltetradecanamido)-11,20,25-trihydroxy-15-[1(R)-hydroxy ethyl]-1,4,7,13,16,22-hexaazatricyclo[22.3.0.0(9,1
CASPOFUNGIN PNEUMOCANDIN A0 IMPURITY ; PNEUMOCANDIN A0 ; METHYL PNEUMOCANDIN B0 ; L-671329 ;
CAS:120692-19-5
CSF01 :
N-[20-(3-amino-1-hydroxy-3-oxopropyl)-23-[1,2-dihydroxy-2-(4-hydroxyphenyl)ethyl]-2,11,12,15-tetrahydroxy-6-(1-hydroxyethyl)-16-methyl-5,8,14,19,22,25-hexaoxotetracosahydro-1H-dipyrrolo[2,1-c:2',1'-l][1,4,7,10,13,16]hexaazacyclohenicosin-9-yl]-10,12-dimet
CASPOFUNGIN PNEUMOCANDIN B0 IMPURITY ; PNEUMOCANDIN B0 ; DESMETHYL PNEUMOCANDIN A0 ; L-688786 ;
CAS:135575-42-7
CSF02 :
(3S)-(4R,5R)-N2-[(10R,12S)-10,12-Dimethyl-1-oxotetradecyl]- 4,5-dihydroxy-L-ornithyl-L-threonyl-(4R)-4-hydroxy-L-prolyl-(4S)-4-hydroxy-4-(4-hydroxyphenyl)-L-threonyl-(3R)-3-hydroxy-L-glutaminyl-3-hydroxy-L-proline (6?1)-lactam ;
CASPOFUNGIN PNEUMOCANDIN C0 IMPURITY ;
CAS:144074-96-4
CSF03 :
Pneumocandin C0 ; Pneumocandin B0 Hydroxy Isomer ;
CEDIRANIB ;
CAS:288383-20-0
CDR00 :
4-(4-Fluoro-2-methylindol-5-yloxy)-6-methoxy-7-[3-(pyrrolidin-1-yl)propoxy] quinazoline ;
CEDIRANIB 4-CHLORO IMPURITY ;
CAS:199327-69-0
CDR50 :
4-Chloro-6-methoxy-7-(3-(pyrrolidin-1-yl)propoxy)quinazoline ;
CEDIRANIB 4-FLUORO 5-HYDROXY 2-METHYLINDOLE ;
CAS:288385-88-6
CDR51 :
4-Fluoro-2-methyl-1H-indol-5-ol ;
CEDIRANIB 4-HYDROXY IMPURITY ;
CAS:199327-75-8
CDR52 :
6-Methoxy-7-(3-(pyrrolidin-1-yl)propoxy)quinazolin-4-ol ;
CEFACLOR EP IMPURITY A ; CEFALEXIN EP IMPURITY A ; D-PHENYLGLYCINE ;
CAS:875-74-1
CCL01 :
(2R)-(-)-2-Amino-2-phenylacetic acid ;
CEFACLOR EP IMPURITY B ;
CAS:53994-69-7
CCL02 :
(6R,7R)-7-Amino-3-chloro-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid ; 7-Amino-3-chloro-3-cephem-4-carboxylic acid ;
CEFACLOR EP IMPURITY C ; CEFACLOR (2S)-ISOMER ;
CAS:143059-69-2
CCL03 :
(6R,7R)-7-[[(2S)-2-Amino-2-phenylacetyl]amino]-3-chloro-8-oxo-5-thia- 1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid ;
CEFACLOR EP IMPURITY D ; CEFACLOR 3-ENE ISOMER ; DELTA-3 CEFACLOR ;
CAS:152575-13-8
CCL04 :
(2RS,6R,7R)-7-[[(2R)-2-Amino-2-phenylacetyl]amino]-3-chloro-8-oxo-5-thia-1-azabicyclo[4.2.0] oct-3-ene-2-carboxylic acid ;
CEFACLOR EP IMPURITY E ; CEFACLOR OPEN-RING IMPURITY ;
CAS:188915-50-6
CCL05 :
2-[[(2R)-2-Amino-2-phenylacetyl]amino]-2-(5-chloro-4-oxo-3,4-dihydro-2H-1,3-thiazin-2-yl)acetic acid ;
CEFACLOR EP IMPURITY F ; AMPICILLIN EP IMPURITY H ;
CAS:2882-18-0
CCL06 :
3-Phenylpyrazin-2-ol ;
CEFACLOR EP IMPURITY G ; ISOCEFALEXINE ;
CAS:37050-97-8
CCL07 :
(2RS,6R,7R)-7-[[(2R)-2-Amino-2-phenylacetyl]amino]-3-methylene-8-oxo-5-thia-1-azabicyclo[4.2.0]octane-2-carboxylic acid ;
CEFACLOR EP IMPURITY H ; N-PHENYLGLYCYL CEFACLOR ; D-PHENYLGLYCYL CEFACLOR ;
CCL08 :
(6R,7R)-7-[[(2R)-2-[[(2R)-2-Amino-2-phenylacetyl]amino]-2-phenylacetyl]amino]-3-chloro-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid ;
CEFACLOR MONOHYDRATE ;
CAS:70356-03-5
CCL00 :
(6R,7R)-7-[[(2R)-2-Amino-2-phenylacetyl]amino]-3-chloro-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid monohydrate ;
CEFADROXIL EP IMPURITY A ; CEFPROZIL EP IMPURITY A ; AMOXICILLIN EP IMPURITY I (= USP RC I) ;
CAS:22818-40-2
CDX01 :
(2R)-2-Amino-2-(4-hydroxyphenyl)acetic acid ;
CEFADROXIL EP IMPURITY B ; 7-ADCA ; CEFADROXIL EP IMPURITY B ; CEFADROXIL USP RC B ; CEFALEXIN EP IMPURITY B ;
CAS:22252-43-3
CDX02 :
(6R,7R)-7-Amino-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid ;
CEFADROXIL EP IMPURITY C ;
CAS:147103-96-6
CDX03 :
(2R,5RS)-2-[(R)-[[(2R)-2-Amino-2-(4-hydroxyphenyl)acetyl]amino]carboxymethyl]-5-methyl-5,6-dihydro-2H-1,3-thiazine-4-carboxylic acid ;
CEFADROXIL EP IMPURITY D ; L-CEFADROXIL ; CEFADROXIL USP RC D ;
CAS:144790-28-3
CDX04 :
(6R,7R)-7-[[(2S)-2-Amino-2-(4-hydroxyphenyl)acetyl]amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid ;
CEFADROXIL EP IMPURITY E ; CEFPROZIL EP IMPURITY C ;
CAS:147103-93-3
CDX05 :
(6RS)-3-(Aminomethylene)-6-(4-hydroxyphenyl)piperazine-2,5-dione ;
CEFADROXIL EP IMPURITY F ; N-HYDROXYPHENYLGLYCYL CEFADROXIL ;
CAS:147103-95-5
CDX06 :
(6R,7R)-7-[[(2R)-2-[[(2RS)-2-Amino-2-(4-hydroxyphenyl)acetyl]amino]-2-(4-hydroxyphenyl)acetyl]amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid ;
CEFADROXIL EP IMPURITY G ; CEFALEXIN EP IMPURITY D ;
CAS:34876-35-2
CDX07 :
3-Hydroxy-4-methylthiophen-2(5H)-one ;
CEFADROXIL EP IMPURITY H ; 7-ADCA PIVALAMIDE ;
CAS:146794-70-9
CDX08 :
(6R,7R)-7-[(2,2-Dimethylpropanoyl)amino]-3-methyl-8oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid ;
CEFADROXIL MONOHYDRATE ; CEFPROZIL EP IMPURITY B ;
CAS:66592-87-8
CDX00 :
(6R,7R)-7-[[(2R)-2-Amino-2-(4-hydroxyphenyl)acetyl]amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid monohydrate ;
CEFADROXIL SULFOXIDE IMPURITY ;
CAS:182290-77-3
CDX60 :
(6R,7R)-7-((R)-2-Amino-2-(4-hydroxyphenyl)acetamido)-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid 5-oxide ;
CEFADROXIL USP RC I ; CEFADROXIL DELTA-3 ISOMER ;
CAS:147103-94-4
CDX29 :
(6R,7R)-7-[(R)-2-Amino-2-(4-hydroxyphenyl)acetamido]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-3-ene-2-carboxylic acid ;
CEFALEXIN DIKETOPIPERAZINE DELTA-3 ISOMER ;
CAS:65870-52-2
CFL60B :
2-(3,6-Dioxo-5-phenyl-2-piperazinyl)-5,6-dihydro-5-methyl-2H-1,3-thiazine-4-carboxylic acid ;
CEFALEXIN DIKETOPIPERAZINE IMPURITY ;
CAS:59865-11-1
CFL50B :
2-(3,6-Dioxo-5-phenyl-2-piperazinyl)-3,6-dihydro-5-methyl-2H-1,3-thiazine-4-carboxylic acid ;
CEFALEXIN EP IMPURITY A ; CEFACLOR EP IMPURITY A ; D-PHENYLGLYCINE ;
CAS:875-74-1
CFL01 :
(2R)-2-Amino-2-phenylacetic acid ;
CEFALEXIN EP IMPURITY B ; 7-ADCA ;
CAS:22252-43-3
CFL02 :
7-Aminodesacetoxycephalosporanic acid ;
CEFALEXIN EP IMPURITY C ; D-PHENYLGLYCYL CEPHALEXIN ;
CAS:72528-40-6
CFL03 :
(6R,7R)-7-[[(2R)-2-[[(2R)-2-Amino-2-phenylacetyl]amino]-2-phenylacetyl] amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid ;
CEFALEXIN EP IMPURITY D ; CEFADROXIL EP IMPURITY G ;
CAS:34876-35-2
CFL04 :
3-Hydroxy-4-methylthiophen-2(5H)-one ;
CEFALEXIN EP IMPURITY E ; 7-ADCA PIVALAMIDE ;
CAS:146794-70-9
CFL05 :
(6R,7R)-7-[(2,2-Dimethylpropanoyl)amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid ;
CEFALEXIN EP IMPURITY F ; CEFALEXIN 3-ENE ISOMER ;
CAS:79750-46-2
CFL06 :
(2RS,6R,7R)-7-[[(2R)-2-Amino-2-phenylacetyl]amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-3-ene-2-carboxylic acid ;
CEFALEXIN MONOHYDRATE ;
CAS:15686-71-2
CFL00 :
(6R,7R)-7-[[(2R)-2-Amino-2-phenylacetyl]amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid monohydrate ;
CEFALOTIN EP IMPURITY A ; DEACETOXY CEFALOTIN ;
CAS:34691-02-6
CLS01 :
(6R,7R)-3-Methyl-8-oxo-7-[(thiophen-2-ylacetyl)amino]-5-thia-1-azabicyclo [4.2.0]oct-2-ene-2-carboxylic acid ;
CEFALOTIN EP IMPURITY B (ACID) ; DEACETYL CEFALOTIN (ACID) ;
CAS:5935-65-9
CLS02A :
(6R,7R)-3-(Hydroxymethyl)-8-oxo-7-[(thiophen-2-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
CEFALOTIN EP IMPURITY B (NA) ; DEACETYL CEFALOTIN SODIUM ;
CAS:5547-29-5
CLS02N :
(6R,7R)-3-(Hydroxymethyl)-8-oxo-7-[(thiophen-2-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid sodium salt ;
CEFALOTIN EP IMPURITY C ; CEFAZOLIN EP IMPURITY H ; CEFOPERAZONE EP IMPURITY E ; 7-AMINOCEPHALOSPORANIC ACID ; 7-ACA ;
CAS:957-68-6
CLS03 :
(6R,7R)-3-[(Acetyloxy)methyl]-7-amino-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid ;
CEFALOTIN EP IMPURITY D ; CEFALOTIN LACTONE IMPURITY ; DEACETYL CEPHALOTHIN LACTONE ; CEFOXITIN EP IMPURITY C ; CEFALONIUM DEACETYLCEPHALOTHIN LACTONE ;
CAS:10590-10-0
CLS04 :
(5aR,6R)-6-[[(Thiophen-2-yl)acetyl]amino]-5a,6-dihydro-3H,7H-azeto[2,1-b] furo[3,4-d][1,3]thiazine-1,7(4H)-dione ;
CEFALOTIN SODIUM ;
CAS:58-71-9
CLS00N :
Sodium (6R,7R)-3-[(acetyloxy)methyl]-8-oxo-7-[(thiophen-2-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate ;
CEFAMANDOLE EP IMPURITY A ;
CAS:1947364-12-6
CML01 :
(6R,7R)-7-((R)-2-(Formyloxy)-2-phenylacetamido)-3-methyl-8-oxo-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid ;
CEFAMANDOLE EP IMPURITY C ; O-ACETYLCEFAMANDOLE ;
CAS:36922-16-4
CML03 :
(6R,7R)-7-((R)-2-Acetoxy-2-phenylacetamido)-3-((1-methyl-1H-tetrazol-5-ylthio)methyl)-8-oxo-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid ;
CEFAMANDOLE EP IMPURITY D ; CEFOPERAZONE EP IMPURITY C ;
CAS:13183-79-4
CML04 :
1-Methyl-1H-tetrazole-5-thiol ;
CEFAMANDOLE EP IMPURITY E ; FORMYLMANDELOYL-7-ACA ;
CAS:87932-78-3
CML05 :
(6R,7R)-7-[[(2R)-2-(Formyloxy)-2-phenylacetyl]amino]-3-[(acetyloxy)methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid ;
CEFAMANDOLE NAFATE ;
CAS:42540-40-9
CML50N :
Sodium (6R,7R)-7-((R)-2-(formyloxy)-2-phenylacetamido)-3-((1-methyl-1H-tetrazol-5-ylthio)methyl)-8-oxo-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylate ;
CEFAMANDOLE SODIUM ;
CAS:30034-03-8
CML00N :
Sodium (6R,7R)-7-((R)-2-hydroxy-2-phenylacetamido)-3-((1-methyl-1H-tetrazol-5-ylthio)methyl)-8-oxo-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylate ;
CEFAZOLIN EP IMPURITY A ; 7-ZACA ;
CAS:30246-33-4
CZL01A :
(6R,7R)-7-Amino-3-[[(5-methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid ;
CEFAZOLIN EP IMPURITY B ; 7-PIVALAMIDO CEFAZOLIN SODIUM ;
CAS:2384108-14-7
CZL02N :
(6R,7R)-7-[(2,2-Dimethylpropanoyl)amino]-3-[[(5-methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid sodium salt ;
CEFAZOLIN EP IMPURITY C ;
CAS:56842-77-4
CZL03N :
(6R,7R)-3-Methyl-8-oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-5-thia-1-azabicyclo [4.2.0]oct-2-ene-2-carboxylic acid sodium salt ;
CEFAZOLIN EP IMPURITY D ;
CAS:27164-45-0
CZL04N :
(6R,7R)-3-[(Acetyloxy)methyl]-8-oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid sodium salt ;
CEFAZOLIN EP IMPURITY E ;
CAS:29490-19-5
CZL05 :
5-Methyl-1,3,4-thiadiazol-2-thiol ;
CEFAZOLIN EP IMPURITY F ;
CZL06 :
CEFAZOLIN EP IMPURITY G ; CEFAZOLIN LACTONE IMPURITY ;
CAS:1172998-53-6
CZL07 :
(5aR,6R)-6-[(1H-Tetrazol-1-ylacetyl)amino]-5a,6-dihydro-3H,7H-azeto[2,1-b]furo[3,4-d][1,3]thiazine-1,7(4H)-dione ;
CEFAZOLIN EP IMPURITY H ; CEFOPERAZONE EP IMPURITY E ; CEFALOTIN EP IMPURITY C ; 7-AMINOCEPHALOSPORANIC ACID ; 7-ACA ;
CAS:957-68-6
CZL08 :
(6R,7R)-3-[(Acetyloxy)methyl]-7-amino-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid ;
CEFAZOLIN EP IMPURITY I ; CEFAZOLOIC ACID ;
CZL09 :
2-[Carboxy[(1H-tetrazol-1-ylacetyl)amino]methyl]-5-[[(5-methyl-1,3,4-thia diazol-2-yl)sulfanyl]methyl]-5,6-dihydro-2H-1,3-thiazine-4-carboxylic acid ;
CEFAZOLIN EP IMPURITY J ; HYDROLYSED CEFAZOLOIC ACID ;
CZL10 :
(6R,7R)-3-[[(5-Methyl-1,3,4-thiadiazol-2-yl)sulphanyl]methyl]-8-oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxamide ;
CEFAZOLIN EP IMPURITY K ; CEFAZOLIN AMIDE ;
CAS:1322626-65-2
CZL11 :
(6R,7R)-3-[[(5-Methyl-1,3,4-thiadiazol-2-yl)sulphanyl]methyl]-8-oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxamide ;
CEFAZOLIN EP IMPURITY L ;
CZL12 :
(6R,7S)-3-[[(5-Methyl-1,3,4-thiadiazol-2-yl)sulphanyl]methyl]-8-oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid ;
CEFAZOLIN SODIUM ;
CAS:27164-46-1
CZL00N :
Sodium (6R,7R)-3-[[(5-methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl]-8-oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate ;
CEFAZOLIN TETRAZOLYLACETAMIDE ACETAL ;
CZL51 :
N-(2,2-Dihydroxyethyl)-2-(1H-tetrazol-1-yl)acetamide ;
CEFAZOLIN TETRAZOLYLACETIC ACID ;
CAS:21732-17-2
CZL50 :
2-(1H-Tetrazol-1-yl)acetic acid ;
CEFDINIR (E)-ISOMER (BASE) ; CEFDINIR EP IMPURITY R ;
CAS:178601-88-2
CFD50B :
(6R,7R)-7-[(E)-2-(2-Aminothiazol-4-yl-)-2-(hydroxyimino)acetamido]-8-oxo-3-vinyl-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid ;
CEFDINIR (E)-ISOMER (TFA SALT) ; CEFDINIR EP IMPURITY R ;
CAS:178601-88-2
CFD50T :
(6R,7R)-7-[(E)-2-(2-Aminothiazol-4-yl-)-2-(hydroxyimino)acetamido]-8-oxo-3-vinyl-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid trifluoroacetic acid salt ;
CEFDINIR ;
CAS:91832-40-5
CFD00 :
(-)-(6R,7R)-7-[2-(2-Amino-4-thiazolyl)glyoxylamido]-8-oxo-3-vinyl-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid 7-beta-(Z)-oxime ;
CEFDINIR 3-METHYL IMPURITY (USP) ; CEFDINIR IMPURITY G ;
CAS:71091-93-5
CFD53 :
(6R,7R)-7-[(Z)-2-(2-Aminothiazol-4-yl)-2-(hydroxyimino)acetamido]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid ;
CEFDINIR 7-EPIMER ;
CAS:178601-89-3
CFD67 :
(6R,7S)-7-[[(2Z)-2-(2-Amino-4-thiazolyl)-2-(hydroxyimino)acetyl]amino]-3-ethenyl-8- oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid ;
CEFDINIR DECARBOXY OPEN RING LACTONE (USP) ;
CAS:178949-04-7
CFD58B :
(Z)-2-(2-Aminothiazol-4-yl)-2-(hydroxyimino)-N-{[(2RS,5RS)-5-methyl-7-oxo-2,4,5,7-tetrahydro-1H-furo[3,4-d][1,3]thiazin-2-yl]methyl}acetamide ;
CEFDINIR DELTA-2 IMPURITY
CAS:934986-49-9
CFD52 :
(6R,?7R)?-7-?[[(2Z)?-?2-?(2-?Amino-?4-?thiazolyl)?-?2-?(hydroxyimino)?acetyl]?amino]?-?3-?ethenyl-?8-?oxo-?5-?Thia-?1-?azabicyclo[4.2.0]?oct-?3-?ene-?2-?carboxylic acid ;
CEFDINIR ISOXAZOLE ANALOG (USP) ;
CAS:1356842-10-8
CFD54 :
(6R,7R)-7-(4-Hydroxyisoxazole-3-carboxamido)-8-oxo-3-vinyl-5-thia-1-azabicyclo [4.2.0]oct-2-ene-2-carboxylic acid ;
CEFDINIR LACTONE (USP) ;
CAS:946573-41-7
CFD55 :
(Z)-2-(2-Aminothiazol-4-yl)-2-(hydroxyimino)-N-{(3RS,5aR,6R)-3-methyl-1,7-dioxo-1,3,4,5a,6,7-hexahydroazeto[2,1-b]furo[3,4-d][1,3]thiazin-6-yl}acetamide ;
CEFDINIR N-ACETYL IMPURITY ;
CFD61 :
(6R,7R,Z)-7-(2-(2-Acetamidothiazol-4-yl)-2-(hydroxyimino)acetamido)-8-oxo-3-vinyl-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid ;
CEFDINIR O-ACETYL IMPURITY ;
CAS:127770-93-8
CFD62 :
(6R,7R)-7-[[(2Z)-2-[(Acetyloxy)imino]-2-(2-amino-4-thiazolyl)acetyl]amino]-3-ethenyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid ;
CEFDINIR SULFOXIDE ;
CAS:934986-48-8
CFD60 :
(6R,7R)-7-[[(2Z)-2-(2-Amino-4-thiazolyl)-2-(hydroxyimino)acetyl]amino]-3-ethenyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid 5-oxide ;
CEFDINIR THIAZOLYLACETYL GLYCINE OXIME ACETAL IMPURITY (USP) ;
CAS:178422-40-7
CFD56 :
(Z)-2-(2-Aminothiazol-4-yl)-N-(2,2-dihydroxyethyl)-2-(hydroxyimino) acetamide ;
CEFDINIR THIAZOLYLACETYL GLYCINE OXIME IMPURITY (USP) ;
CAS:178949-03-6
CFD57 :
N-[(Z)-2-(2-Aminothiazol-4-yl)-2-(hydroxyimino)acetyl]glycine ;
CEFDINIR USP RC A ; CEFDINIR OPEN-RING LACTONE ;
CAS:178422-42-9
CFD21N :
2-[(Z)-2-(2-Aminothiazol-4-yl)-2-(hydroxyimino)acetamido]-2-[(2RS,5RS)-5-methyl-7-oxo-2,4,5,7-tetrahydro-1H-furo[3,4-d][1,3]thiazin-2-yl]acetic acid sodium salt ;
CEFDINIR USP RC B ;
CAS:79350-10-0
CFD22 :
(6R,7R)-7-[2-(2-Amino-4-thiazolyl)acetamido]-8-oxo-3-vinyl-5-thia-1-azabicyclo[4,2,0]oct-2-ene-2-carboxylic acid ;
CEFEPIME EP IMPURITY A ; CEFEPIME USP RC A ; ANTI-CEFEPIME ; CEFEPIME TRANS-ISOMER ; E-CEFEPIME ;
CAS:97164-57-3
CPM01 :
(6R,7R)-7-[[(2E)-(2-Aminothiazol-4-yl)(methoxyimino)acetyl]amino]-3-[(1-methylpyrrolidinio)methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate ;
CEFEPIME EP IMPURITY B ; CEFEPIME USP RC B ; ATA CEFEPIME ;
CPM02 :
(6R,7R)-7-[[(2Z)-[2-[[(2Z)-(2-Aminothiazol-4-yl)-(methoxyimino)acetyl] amino] thiazol-4-yl](methoxyimino)-acetyl]amino]-3-[(1-methylpyrrolidinio) methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate ;
CEFEPIME EP IMPURITY C ; CEFEPIME USP RC C ;
CAS:104301-63-5
CPM03 :
(2Z)-2-(2-Aminothiazol-4-yl)-N-(formylmethyl)-2-(methoxyimino)acetamide ;
CEFEPIME EP IMPURITY D ; CEFEPIME USP RC D ;
CAS:65872-41-5
CPM04 :
(2Z)-(2-Aminothiazol-4-yl)(methoxyimino)acetic acid ;
CEFEPIME EP IMPURITY E ; CEFEPIME USP RC E ;
CAS:103121-85-3
CPM05 :
1-{[(6R,7R)-7-Amino-2-carboxy-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-3-yl]methyl}-1-methylpyrrolidin-1-ium chloride ;
CEFEPIME EP IMPURITY F ;
CPM06 :
(6R,7R)-7-[[[(6R,7R)-7-[[(2Z)-(2-Aminothiazol-4-yl)(methoxyimino)acetyl]amino]-3-[(1-methylpyrrolidinio)methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-2-yl] carbonyl] amino]-3-[(1-methylpyrrolidinio)methyl]-8-oxo-5-thia-1-azabicyclo [4.2.0]oct-2-ene- 2-
CEFEPIME EP IMPURITY G ; N-METHYLPYRROLIDINE ;
CAS:120-94-5
CPM07 :
1-Methylpyrrolidine ;
CEFEPIME HYDROCHLORIDE ; CEFEPIME DIHYDROCHLORIDE MONOHYDRATE ;
CAS:123171-59-5
CPM00H :
1-[[(6R,7R)-7-[[(2Z)-(2-Amino-4-thiazolyl) (methoxyimino) acetyl] amino]-2-carboxy-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-3-yl]methyl]-1-methyl pyrrolidinium chloride monohydrochloride monohydrate ;
CEFIXIME EP IMPURITY A ;
CAS:1614255-90-1
CXM01 :
2-[[(Z)-2-(2-Aminothiazol-4-yl)-2-[(carboxymethoxy)imino]acetyl]amino]-2-[(2R)-5-methyl-7-oxo-1,2,5,7-tetrahydro-4H-furo[3,4-d][1,3]thiazin-2-yl]acetic acid ;
CEFIXIME EP IMPURITY B ;
CAS:1335475-19-8
CXM02A :
2-[[[(Z)-1-(2-Aminothiazol-4-yl)-2-[[[(2R,5RS)-5-methyl-7-oxo-1,2,5,7-tetrahydro-4H-furo[3,4-d][1,3]thiazin-2-yl]methyl]amino]-2-oxoethylidene] amino]oxy]acetic acid acetate salt ;
CEFIXIME EP IMPURITY C ; CEFIXIME 7-EPIMER ;
CAS:108691-83-4
CXM03 :
(6R,7S)-7-[[(Z)-2-(2-Aminothiazol-4-yl)-2-[(carboxymethoxy)imino]acetyl] amino]-3-ethenyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid ;
CEFIXIME EP IMPURITY D ; CEFIXIME E-ISOMER ;
CAS:97164-56-2
CXM04 :
(6R,7R)-7-[[(E)-2-(2-Aminothiazol-4-yl)-2-[(carboxymethoxy)imino]acetyl] amino]-3-ethenyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid ;
CEFIXIME EP IMPURITY E ;
CAS:72701-01-0
CXM05 :
(6R,7R)-7-[[(Z)-2-(2-Aminothiazol-4-yl)-2-[(carboxymethoxy)imino]acetyl] amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid ;
CEFIXIME EP IMPURITY F ; CEFIXIME ETHYL ESTER ;
CAS:79368-95-9
CXM06N :
(6R,7R)-7-[[(Z)-2-(2-Aminothiazol-4-yl)-2-[(2-ethoxy-2-oxoethoxy)imino] acetyl]amino]-3-ethenyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid sodium salt ;
CEFIXIME METHYL ESTER ;
CAS:88621-01-6
CXM51 :
(6R,7R)-7-[[(2Z)-2-(2-Amino-4-thiazolyl)-2-[(2-methoxy-2-oxoethoxy)imino]acetyl]amino]-3-ethenyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid ;
CEFIXIME SULFONE ; CEFIXIME 1,1-DIOXIDE ;
CXM52 :
(6R,7R)-7-[[(2Z)-2-(2-Amino-4-thiazolyl)-2-[(carboxymethoxy)imino]acetyl]amino]-3-ethenyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid-1,1-Dioxide ;
CEFIXIME SULFOXIDE ;
CAS:1335555-87-7
CXM53 :
(6R,7R)-7-[[(2Z)-2-(2-Amino-4-thiazolyl)-2-[(carboxymethoxy)imino]acetyl]amino]-3-ethenyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid-1-oxide ;
CEFIXIME TRIHYDRATE ;
CAS:79350-37-1
CXM00 :
(6R,7R)-7-[[(Z)-2-(2-Aminothiazol-4-yl)-2-[(carboxymethoxy)-imino] acetyl] amino]-3-ethenyl-8-oxo-5-thia-1-azabicyclo-[4.2.0]oct-2-ene-2-carboxylic acid trihydrate ;
CEFMETAZOEL DITETRAZOLYL IMPURITY ;
CAS:74228-11-8
CMZ52N :
(6R-cis)-7-Methoxy-7-[[[(1-methyl-1H-tetrazol-5-yl)thio]acetyl]amino]-3-[[(1-methyl-1H-tetrazol-5-yl)thio]methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid sodium salt ;
CEFMETAZOLE (6R,7R)-ISOMER ;
CMZ67 :
(6R,7R)-7-(2-(cyanomethylthio)acetamido)-7-methoxy-3-((1-methyl-1H-tetrazol-5-ylthio)methyl)-8-oxo-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid ;
CEFMETAZOLE (ACID) ;
CAS:56796-20-4
CMZ00A :
(6R,7S)-7-[2-[(cyanomethyl)thio]acetamido]-7-methoxy-3-[[(1-methyl-1H-tetrazol-5-yl)thio]methyl]-8-oxo-5-thia-1- azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid ;
CEFMETAZOLE LACTONE ;
CAS:70993-70-3
CMZ50 :
(5aR-cis)-2-[(Cyanomethyl)thio]-N-(1,4,5a,6-tetrahydro-6-methoxy-1,7-dioxo-3H,7H-azeto[2,1-b]furo[3,4-d][1,3]thiazin-6-yl)-acetamide ;
CEFMETAZOLE S-METHYL IMPURITY ;
CAS:68576-47-6
CMZ51 :
(6R-cis)-7-[[[(Cyanomethyl)thio]acetyl]amino]-3-[[(1-methyl-1H-tetrazol-5-yl)thio]methyl]-7-(methylthio)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid ;
CEFMETAZOLE SODIUM ;
CAS:56796-39-5
CMZ00N :
Sodium (6R,7S)-7-[2-[(cyanomethyl)thio]acetamido]-7-methoxy-3-[[(1-methyl-1H-tetrazol-5-yl)thio]methyl]-8-oxo-5-thia-1- azabicyclo[4.2.0]oct-2-ene-2-carboxylate ;
CEFOPERAZONE 7-AMINO IMPURITY ;
CFP57 :
(6R,7R)-7-Amino-3-((1-methyl-1H-tetrazol-5-ylthio)methyl)-8-oxo-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid ;
CEFOPERAZONE ACID ;
CAS:62893-19-0
CFP00A :
(6R,7R)-7-[[(2R)-2-[[(4-Ethyl-2,3-dioxopiperazin-1-yl)carbonyl] amino]-2-(4-hydroxyphenyl)acetyl]amino]-3-[[(1-methyl-1H-tetrazol-5-yl) sulfanyl]methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid ;
CEFOPERAZONE EP IMPURITY A ; CEFOPERAZONE LACTONE IMPURITY ;
CAS:73240-08-1
CFP01 :
(5aR,6R)-6-[[(2R)-2-[[(4-Ethyl-2,3-dioxopiperazin-1-yl)carbonyl]amino]-2-(4-hydroxyphenyl)acetyl]amino]-5a,6-dihydro-3H,7H-azeto[2,1-b]furo[3,4-d] [1,3] thiazine-1,7(4H)-dione ;
CEFOPERAZONE EP IMPURITY B ; CEFOPERAZONE THIOXO IMPURITY
CAS:711598-76-4
CFP02 :
(6R,7R)-7-[[(2R)-2-[[(4-Ethyl-2,3-dioxopiperazin-1-yl)carbonyl]-amino]-2-(4-hydroxyphenyl)acetyl]amino]-3-[(4-methyl-5-thioxo-4,5-dihydro-1H-tetrazol-1-yl)methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid ;
CEFOPERAZONE EP IMPURITY C ;
CAS:13183-79-4
CFP03 :
1-Methyl-1H-tetrazole-5-thiol ;
CEFOPERAZONE EP IMPURITY D ; CEFATRIZINE EP IMPURITY A ;
CAS:37539-03-0
CFP04 :
(6R,7R)-7-Amino-8-oxo-3-[(1H-1,2,3-triazol-4-ylsulfanyl)methyl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid ("7-TACA") ;
CEFOPERAZONE EP IMPURITY E ; CEFAZOLIN EP IMPURITY H ; CEFALOTIN EP IMPURITY C ; 7-AMINOCEPHALOSPORANIC ACID ; 7-ACA ;
CAS:957-68-6
CFP05 :
(6R,7R)-3-[(Acetyloxy)methyl]-7-amino-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid ;
CEFOPERAZONE EP IMPURITY F ; CEFOPERAZONE 7-EPIMER ; (6R,7S)-CEFOPERAZONE SODIUM ;
CAS:1315481-36-7
CFP06N :
(6R,7S)-7-[[(2R)-2-[[(4-Ethyl-2,3-dioxopiperazine-1-yl)-carbonyl]amino]-2-(4-hydroxyphenyl)acetyl]amino]-3-[[(1-methyl-1H-tetrazol-5-yl)sulfanyl]methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid sodium salt ;
CEFOPERAZONE SODIUM ;
CAS:62893-20-3
CFP00N :
Sodium (6R,7R)-7-[[(2R)-2-[[(4-ethyl-2,3-dioxopiperazin-1-yl)carbonyl] amino]-2-(4-hydroxyphenyl)acetyl]amino]-3-[[(1-methyl-1H-tetrazol-5-yl) sulfanyl]methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate ;
CEFOTAXIME BROMOACETYL ANALOG ;
CAS:83305-12-8
CTX50 :
(6R,7R,Z)-3-(Acetoxymethyl)-7-(4-bromo-2-(methoxyimino)-3-oxobutanamido)-8-oxo-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid ;
CEFOTAXIME EP IMPURITY A ; CEFETAMET ; DEACETOXYCEFOTAXIME ;
CAS:65052-63-3
CTX01 :
(6R,7R)-7-[[(2Z)-2-(2-Aminothiazol-4-yl)-2-(methoxyimino)acetyl]amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid ;
CEFOTAXIME EP IMPURITY B ; 3-DESACETYL CEFOTAXIME (POTASSIUM SALT) ;
CTX02K :
(6R,7R)-7-[[(2Z)-2-(2-Aminothiazol-4-yl)-2-(methoxyimino)acetyl]amino]-3-(hydroxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid potassium salt ;
CEFOTAXIME EP IMPURITY C ; N-FORMYLCEFOTAXIME ;
CAS:66403-32-5
CTX03 :
(6R,7R)-3-[(Acetyloxy)methyl]-7-[[(2Z)-2-[2-(formylamino)thiazol-4-yl]-2-(methoxyimino)acetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid ;
CEFOTAXIME EP IMPURITY D (SODIUM SALT) ; E-CEFOTAXIME SODIUM SALT ;
CAS:65715-12-0
CTX04 :
(6R,7R)-3-[(Acetyloxy)methyl]-7-[[(2E)-2-(2-aminothiazol-4-yl)-2-(methoxyimino)acetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid ;
CEFOTAXIME EP IMPURITY E ; CEFOTAXIME USP RC E ; CEFTRIAXONE EP IMPURITY B ; DEACETYLCEFOTAXIME LACTONE ; 3-DESACETYL CEFOTAXIME LACTONE ;
CAS:66340-33-8
CTX05 :
(5aR,6R)-6-[[(2Z)-2-(2-Aminothiazol-4-yl)-2-(methoxyimino)acetyl]amino]-5a,6-dihydro-3H,7H-azeto[2,1-b]furo[3,4-d][1,3]thiazine-1,7(4H)-dione ;
CEFOTAXIME EP IMPURITY F ; CEFOTAXIME DIMER ;
CTX06 :
(6R,7R)-3-[(Acetyloxy)methyl]-7-[[(2Z)-2-[2[[[(6R,7R)-7-[[(2Z)-2-(2-aminothiazol-4-yl)-2-(methoxyimino)acetyl]amino]-2-carboxy-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-2-yl]methyl]amino]thiazol-4-yl]-2-(methoxyimino)acetyl]amino]-8-oxo-5-thia-1-azabicyclo
CEFOTAXIME EP IMPURITY G ; ATA CEFOTAXIME ;
CTX07 :
(6R,7R)-3-[(Acetyloxy)methyl]-7-[[(2Z)-2-[2-[[(2Z)-2-(2-aminothiazol-4-yl)-2-(methoxyimino)acetyl]amino]thiazol-4-yl]-2-(methoxyimino)acetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid ;
CEFOTAXIME SODIUM ;
CAS:64485-93-4
CTX00N :
[6R-[6alpha,7beta(z)]]-3-[(Acetyloxy)methyl]-[[(2-amine-4-thiazolyl)(methoxyimino)acetyl]amino]-8-oxo-5-thia-1-azabicyclo[4,2,0]oct-2-ene-2-carboxylic acid monosodium salt ;
CEFOTETAN ;
CAS:69712-56-7
CTT00A :
(6R,7S)-7-[4-(Carbamoylcarboxymethylene)-1,3-dithietane-2-carboxamido]-7-methoxy-3-[[(1-methyl-1Htetrazol-5-yl)thio]methyl]-8-oxo-5-thia-1-aza bicyclo[4.2.0]oct-2-ene-2-carboxylic acid ;
CEFOTETAN 3-ENE-ISOMER ; ?-CEFOTETAN ;
CAS:1332499-75-8
CTT42A :
(6R,7S)-7-(2-(2-Amino-1-carboxy-2-oxoethylidene)-1,3-dithietane-4-carbox amido)-7-methoxy-3-((1-methyl-1H-tetrazol-5-ylthio)methyl)-8-oxo-5-thia-1-aza-icyclo[4.2.0]oct-3-ene-2-carboxylic acid ;
CEFOTETAN DISODIUM ;
CAS:74356-00-6
CTT00N :
(6R,7S)-7-[4-(Carbamoylcarboxymethylene)-1,3-dithietane-2-carboxamido]-7-methoxy-3-[[(1-methyl-1Htetrazol-5-yl)thio]methyl]-8-oxo-5-thia-1-aza bicyclo[4.2.0]oct-2-ene-2-carboxylic acid disodium salt ;
CEFOTETAN ISOTHIAZOLYL IMPURITY
CAS:69712-30-7
CTT43A :
(6R,7S)-7-[[[(4-Carboxy-2,3-dihydro-3-oxo-5-isothiazolyl)thio]acetyl]amino]-7-methoxy-3-[[(1-methyl-1H-tetrazol-5-yl)thio]methyl]-8-oxo-5-thia-1-aza bicyclo[4.2.0]oct-2-ene-2-carboxylic acid ;
CEFOTETAN LACTONE IMPURITY ;
CTT44A :
3-Amino-2-(4-(((5aR,6S)-6-methoxy-1,7-dioxo-1,3,4,5a,6,7-hexahydroazeto [2,1-b]furo[3,4-d][1,3]thiazin-6-yl)carbamoyl)-1,3-dithietan-2-ylidene)-3-oxo propanoic acid ;
CEFOXITIN EP IMPURITY A ; DECARBAMOYL CEFOXITIN SODIUM ;
CAS:54333-94-7
CXT01N :
(6R,7S)-3-(Hydroxymethyl)-7-methoxy-8-oxo-7-[[(thiophen-2-yl)acetyl] amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid sodium salt ;
CEFOXITIN EP IMPURITY B ;
CXT02N :
(2RS,6R,7S)-3-[(Carbamoyloxy)methyl]-7-methoxy-8-oxo-7-[[(thiophen-2-yl) acetyl]amino]-5-thia-1-azabicyclo[4.2.0]oct-3-ene-2-carboxylic acid sodium salt ;
CEFOXITIN EP IMPURITY C ; CEFALOTIN EP IMPURITY D ; CEFALOTIN LACTONE IMPURITY ; DEACETYL CEPHALOTHIN LACTONE ; CEFALONIUM DEACETYLCEPHALOTHIN LACTONE ;
CAS:10590-10-0
CXT03 :
(5aR,6R)-6-[[(Thiophen-2-yl)acetyl]amino]-5a,6-dihydro-3H,7H-azeto[2,1-b] furo[3,4-d][1,3]thiazine-1,7(4H)-dione ;
CEFOXITIN EP IMPURITY D ; CEFOXITIN LACTONE ;
CAS:1422023-33-3
CXT04 :
(5aR,6S)-6-Methoxy-6-[[(thiophen-2-yl)acetyl]amino]-5a,6-dihydro-3H,7H-azeto[2,1-b]furo[3,4-d][1,3]thiazine-1,7(4H)-dione ;
CEFOXITIN EP IMPURITY E ; (R)-METHOXY CEFOXITIN ;
CXT05:
(6R,7S)-3-[(Carbamoyloxy)methyl]-7-methoxy-7-[[(2R)-2-methoxy-2-(thiophen-2-yl)acetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid ;
CEFOXITIN EP IMPURITY F ; (S)-METHOXY CEFOXITIN ;
CXT06 :
(6R,7S)-3-[(Carbamoyloxy)methyl]-7-methoxy-7-[[(2S)-2-methoxy-2-(thiophen-2-yl)acetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid ;
CEFOXITIN EP IMPURITY G ; CEFOXITIN DIMER ;
CXT07 :
(6R,7S)-3-[[[[[[(6R,7S)-2-Carboxy-7-methoxy-8-oxo-7-[[2-(thiophen-2-yl)acetyl] amino]-5-thia-1-azabicyclo[4.2.0]oct-2-en-3-yl]methyl]oxy]carbamoyl]oxy]methyl]-7-methoxy-8-oxo-7-[[2-(thiophen-2-yl)acetyl]amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxy
CEFOXITIN SODIUM ;
CAS:33564-30-6
CXT00N :
Sodium (6R,7S)-3-[(carbamoyloxy)methyl]-7-methoxy-8-oxo-7-[[(thiophen-2-yl)acetyl]amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate ;
CEFPIROME SULFATE ;
CAS:98753-19-6
CFR00 :
1-[[(6R,7R)-7-[[(2Z)-(2-Amino-4-thiazolyl)(methoxyimino)acetyl]amino]-2-carboxy-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-3-yl]methyl]-6,7-dihydro-5H-cyclopenta[b]pyrindinium monosulfate salt ;
CEFPODOXIME PROXETIL ;
CAS:87239-81-4
CPD00 :
(1RS)-1-[[(1-Methylethoxy)carbonyl]oxy]ethyl (6R,7R)-7-[[(2Z)-2-(2-amino thiazol-4-yl)-2-(methoxyimino)acetyl]amino]-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate ;
CEFPODOXIME PROXETIL EP IMPURITY A ; CEFPODOXIME ; CEFPODOXIME ACID ;
CAS:80210-62-4
CPD01 :
(6R,7R)-7-[[(2Z)-2-(2-Aminothiazol-4-yl)-2-(methoxyimino)acetyl]amino]-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylicacid ;
CEFPODOXIME PROXETIL EP IMPURITY B ; ADCA-ANALOGUE OF CEFPODOXIME PROXETIL ; 3-METHYL 3-DE(METHOXYMETHYL) CEFPODOXIME ;
CAS:947692-14-0
CPD02 :
(1RS)-1-[[(1-Methylethoxy)carbonyl]oxy]ethyl (6R,7R)-7-[[(2Z)-2-(2-amino thiazol-4-yl)-2-(methoxyimino)acetyl]amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate ;
CEFPODOXIME PROXETIL EP IMPURITY C ; DELTA-2-CEFPODOXIME PROXETIL ;
CAS:339528-86-8
CPD03 :
(1RS)-1-[[(1-Methylethoxy)carbonyl]oxy]ethyl (6R,7R)-7-[[(2Z)-2-(2-amino thiazol-4-yl)-2-(methoxyimino)acetyl]amino]-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-3-ene-2-carboxylate ;
CEFPODOXIME PROXETIL EP IMPURITY D ; ANTI-CEFPODOXIME PROXETIL ;
CAS:947692-13-9
CPD04 :
(1RS)-1-[[(1-Methylethoxy)carbonyl]oxy]ethyl (6R,7R)-7-[[(2E)-2-(2-amino thiazol-4-yl)-2(methoxyimino)acetyl]amino]-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate ;
CEFPODOXIME PROXETIL EP IMPURITY E ; CEFOTAXIME PROXETIL ; ACA-ANALOGUE OF CEFPODOXIME PROXETIL ;
CAS:217803-89-9
CPD05 :
(1RS)-1-[[(1-Methylethoxy)carbonyl]oxy]ethyl (6R,7R)-3-(acetoxymethyl)-7-[[(2Z)-2-(2-aminothiazol4-yl)-2-(methoxyimino)acetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate ;
CEFPODOXIME PROXETIL EP IMPURITY F ; N-FORMYL CEFPODOXIME PROXETIL ;
CAS:96680-30-7
CPD06 :
(1RS)-1-[[(1-Methylethoxy)carbonyl]oxy]ethyl (6R,7R)-7-[[(2Z)-2-[(2-formyl amino)thiazol-4-yl)-2-(methoxyimino)acetyl]amino]-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate ;
CEFPODOXIME PROXETIL EP IMPURITY G ; N-ACETYL-CEFPODOXIME PROXETIL ;
CAS:947692-15-1
CPD07 :
(1RS)-1-[[(1-Methylethoxy)carbonyl]oxy]ethyl (6R,7R)-7-[[(2Z)-[2-(2-acetyl amino)thiazol-4-yl]-2(methoxyimino)acetyl]amino]-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate ;
CEFPODOXIME PROXETIL EP IMPURITY H ; CEFPODOXIME PROXETIL DIMER ; CEFPODOXIME PROXETIL 4,7-SECO-DIMER ;
CAS:947692-16-2
CPD08 :
1-[[(1-Methylethoxy)carbonyl]oxy]ethyl (6R,7R)-7-[[(2Z)-2-[2[[(2R)-2-[[(2Z)-2-(2-aminothiazol-4-yl)-2-(methoxyimino)acetyl]amino]-2-[(2R)-5-(methoxy methyl)-4-[[1-[[(1-methylethoxy)carbonyl]oxy]ethoxy]carbonyl]-3,6-dihydro-2H-1,3-thiazin-2-yl]acetyl]amino
CEFPROZIL (2S)-ISOMER ;
CAS:110764-35-7
CFZ52 :
(6R,7R)-7-[[(2S)-2-Amino-2-(4-hydroxyphenyl)acetyl]amino]-8-oxo-3-(1-propen-1-yl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid ;
CEFPROZIL (E)-ISOMER ;
CAS:111900-24-4
CFZ51 :
(E)-(6R,7R)-7-[[(2R)-2-Amino-2-(4-hydroxyphenyl)acetyl]amino]-8-oxo-3-(1-propen-1-yl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid monohydrate ;
CEFPROZIL (Z)-ISOMER ;
CAS:114876-72-1
CFZ50 :
(Z)-(6R,7R)-7-[[(2R)-2-Amino-2-(4-hydroxyphenyl)acetyl]amino]-8-oxo-3-(1-propen-1-yl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid ;
CEFPROZIL EP IMPURITY A ; CEFADROXIL EP IMPURITY A ; AMOXICILLIN EP IMPURITY I (= USP RC I) ;
CAS:22818-40-2
CFZ01 :
(2R)-2-Amino-2-(4-hydroxyphenyl)acetic acid ;
CEFPROZIL EP IMPURITY B ; CEFADROXIL MONOHYDRATE ;
CAS:66592-87-8
CFZ02 :
(6R,7R)-7-[[(2R)-2-Amino-2-(4-hydroxyphenyl)acetyl]amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid monohydrate ;
CEFPROZIL EP IMPURITY C ; CEFADROXIL EP IMPURITY E ;
CAS:147103-93-3
CFZ03 :
(6RS)-3-(Aminomethylene)-6-(4-hydroxyphenyl)piperazine-2,5-dione ;
CEFPROZIL EP IMPURITY D ; CEFPROZIL USP RC D ;
CAS:106447-44-3
CFZ04 :
(6R,7R)-7-Amino-8-oxo-3-[(1Z)-prop-1-enyl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid ;
CEFPROZIL EP IMPURITY E ;
CFZ05 :
(6R,7R)-7-[[(2R)-2-Amino-2-[4-[[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]oxy]phenyl]acetyl]amino]-8-oxo-3-[(1Z)-prop-1-enyl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid ;
CEFPROZIL EP IMPURITY F ; CEFPROZIL USP RC F ;
CAS:120709-09-3
CFZ06 :
(6R,7R)-7-Amino-8-oxo-3-[(1E)-prop-1-enyl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid ;
CEFPROZIL EP IMPURITY G ;
CFZ07 :
(2R)-2-[(2R)-2-Amino-2-(4-hydroxyphenyl)acetyl]amino-2-[(2R)-4-carboxy-5-[(1Z)-prop-1-enyl]-3,6-dihydro-2H-1,3-thiazin-2-yl]-acetic acid ;
CEFPROZIL EP IMPURITY H ; CEFPROZIL USP RC H ;
CFZ08 :
(6R,7R)-7-[[(2R)-2-[[(2R)-2-Amino-2-(4-hydroxyphenyl)acetyl]amino]-2-(4-hydroxyphenyl)acetyl]amino]-8-oxo-3-[(1Z)-prop-1-enyl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid ;
CEFPROZIL EP IMPURITY I ;
CFZ09 :
(2R)-2-[(2R)-2-Amino-2-(4-hydroxyphenyl)acetyl]amino-2-[(2R)-4-carboxy-5-[(1E)-prop-1-enyl]-3,6-dihydro-2H-1,3-thiazin-2-yl]-acetic acid ;
CEFPROZIL EP IMPURITY J ;
CFZ10 :
(6R,7R)-7-[[(2R)-2-[[(2R)-2-Amino-2-(4-hydroxyphenyl)acetyl]amino]-2-(4-hydroxyphenyl)acetyl]amino]-8-oxo-3-[(1E)-prop-1-enyl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid ;
CEFPROZIL EP IMPURITY K ; CEFPROZIL USP RC K ;
CFZ11 :
(3RS,6RS)-3-[(2R,5R)-5-Ethyl-7-oxo-1,2,5,7-tetrahydro-4H-furo[3,4-d][1,3]thiazin-2-yl]-6-(4-hydroxyphenyl)piperazine-2,5-dione ;
CEFPROZIL EP IMPURITY L ;
CAS:203007-73-2
CFZ12 :
2-Hydroxyethyl-(2R)-2-amino-2-(4-hydroxyphenyl)acetate ;
CEFPROZIL EP IMPURITY M ; ETHOXY CARBONYL CEFPROZIL ;
CFZ13 :
(6R,7R)-7-[[(2R)-2-Amino-2-[4-[(ethoxycarbonyl)oxy]phenyl]acetyl]amino]-8-oxo-3-[(1Z)-prop-1-enyl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid ;
CEFPROZIL EP IMPURITY N ;
CFZ14 :
(6R,7R)-7-[[(2R)-2-Amino-2-[4-(ethoxycarbonyl)oxy]phenyl]acetyl]amino]-8-oxo-3-[(1E)-prop-1-enyl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid ;
CEFPROZIL MONOHYDRATE ;
CAS:121123-17-9
CFZ00 :
(6R,7R)-7-[[(2R)-2-Amino-2-(4-hydroxyphenyl)acetyl]amino]-8-oxo-3-(1-propen-1-yl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid monohydrate ;
CEFRADINE ;
CAS:38821-53-3
CDN00 :
(6R,7R)-7-[[(2R)-Amino(cyclohexa-1,4-dienyl)acetyl]amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid ;
CEFRADINE 4',5'-DIHYDRO IMPURITY ;
CAS:37051-00-6
CDN45 :
(6R,7R)-7-((R)-2-Amino-2-cyclohexenylacetamido)-3-methyl-8-oxo-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid ;
CEFRADINE EP IMPURITY A ; CEFADROXIL EP IMPURITY B ; 7-ADCA ; CEFADROXIL USP RC B ; CEFALEXIN EP IMPURITY B ;
CAS:22252-43-3
CDN01 :
(6R,7R)-7-Amino-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid ; 7-Aminodeacetoxycephalosporanic acid '
CEFRADINE EP IMPURITY B ; D-DIHYDROPHENYLGLYCINE ; CYCLOHEXA-1,4-DIENYLGLYCINE ;
CAS:26774-88-9
CDN02 :
(2R)-Amino(cyclohexa-1,4-dienyl)acetic acid ;
CEFRADINE EP IMPURITY C ; CEFRADINE SULFOXIDE ISOMER-1 ; (PLEASE OFFER CDN34) ;
CAS:1147512-79-5/1147512-81-9
CDN03 :
(6R,7R)-7-[[(2R)-Amino(cyclohexa-1,4-dienyl)acetyl]amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid 5-oxide (Isomer-1) ;
CEFRADINE EP IMPURITY D ; CEFRADINE SULFOXIDE ISOMER-2 ; (PLEASE OFFER CDN34) ;
CAS:1147512-79-5/1147512-81-9
CDN04 :
(6R,7R)-7-[[(2R)-Amino(cyclohexa-1,4-dienyl)acetyl]amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid 5-oxide (Isomer-2) ;
CEFRADINE EP IMPURITY E ;
CAS:215172-75-1
CDN05 :
(6R,7R)-7-[[(2R)-Amino(2-hydroxyphenyl)acetyl]amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid ;
CEFRADINE EP IMPURITY F ; CEFADROXIL EP IMPURITY G ; CEFALEXIN EP IMPURITY D ;
CAS:34876-35-2
CDN06 :
3-Hydroxy-4-methylthiophen-2(5H)-one ;
CEFRADINE EP IMPURITY G ; CEFADROXIL EP IMPURITY H ; CEFALEXIN EP IMPURITY E ; 7-ADCA PIVALAMIDE ;
CAS:146794-70-9
CDN07 :
(6R,7R)-7-[(2,2-Dimethylpropanoyl)amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid ;
CEFRADINE SULFOXIDE ;
CDN34 :
(6R,7R)-7-[[(2R)-Amino(cyclohexa-1,4-dienyl)acetyl]amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid 5-oxide ;
CEFSULODIN SODIUM ;
CAS:52152-93-9
CSL00N :
Monosodium (6R,7R)-3-(4-carbamoylpyridinium-1-ylmethyl)-8-oxo-7-[(2R)-2-phenyl-2-sulfonatoacetylamino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate ;
CEFTAZIDIME EP IMPURITY A ; CEFTAZIDIME ?2-IMPURITY ; CEFTAZIDIME DELTA-3-ISOMER ;
CAS:1000980-60-8
CFT01 :
(2RS,6R,7R)-7-[[(2Z)-2-(2-Aminothiazol-4-yl)-2-[(1-carboxy-1-methylethoxy) imino]acetyl]amino]-8-oxo-3-[(1-pyridinio)methyl]-5-thia-1-azabicyclo[4.2.0] oct-3-ene-2-carboxylate ;
CEFTAZIDIME EP IMPURITY B ; CEFTAZIDIME (2E)-ISOMER ;
CAS:97148-38-4
CFT02 :
(6R,7R)-7-[[(2E)-2-(2-Aminothiazol-4-yl)-2-[(1-carboxy-1-methylethoxy) imino] acetyl]amino]-8-oxo-3-[(1-pyridinio)methyl]-5-thia-1-azabicyclo [4.2.0]oct-2-ene-2-carboxylate ;
CEFTAZIDIME EP IMPURITY C ;
CAS:3432-88-0
CFT03H :
(6R,7R)-7-Amino-8-oxo-3-[(1-pyridinio)methyl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate hydroiodide ;
CEFTAZIDIME EP IMPURITY E ; CEFTAZIDIME T-BUTYL ESTER ;
CAS:102772-66-7
CFT05 :
(6R,7R)-7-[[(2Z)-2-(2-Aminothiazol-4-yl)-2-[[2-(1,1-dimethylethoxy)-1,1-dimethyl-2-oxoethoxy]imino]acetyl]amino]-8-oxo-3-[(1-pyridinio) methyl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate ;
CEFTAZIDIME EP IMPURITY G ;
CAS:194241-83-3
CFT07N :
2-[[[(1Z)-1-(2-Aminothiazol-4-yl)-2-[(oxoethyl)amino]-2-oxoethylidene] amino] oxy]-2-methylpropanoic acid sodium salt ;
CEFTAZIDIME EP IMPURITY H ; CEFTAZIDIME METHYL ESTER ;
CAS:1354396-23-8
CFT08 :
(6R,7R)-7-[[(2Z)-2-(2-Aminothiazol-4-yl)-2-[(2-methoxy-1,1-dimethyl-2-oxoethoxy)imino]acetyl]amino]-8-oxo-3-[(1-pyridinio)methyl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate ;
CEFTAZIDIME HYDROXYETHYL IMPURITY ;
CFT50N :
(Z)-2-(((1-(2-Aminothiazol-4-yl)-2-((2-hydroxy-2-sulfonatoethyl)amino)-2-oxoethylidene)amino)oxy)-2-methylpropanoate disodium salt ;
CEFTAZIDIME PENTAHYDRATE ;
CAS:78439-06-2
CFT00H :
1-[[(6R,7R)-7-[[(2Z)-(2-Amino-4-thiazolyl)[(1-carboxy-1-methylethoxy) imino]acetyl]amino]-2-carboxy-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-3-yl]methyl]pyridinium inner salt pentahydrate ;
CEFTIOFUR SODIUM ;
CAS:104010-37-9
CTF00N :
Ceftiofur Sodium ;
CEFTRIAXONE 7-ADCA IMPURITY ;
CAS:15690-38-7
CTN57A :
7-Amino-deacetylcephalosporanic acid (7-ADCA) ;
CEFTRIAXONE DISODIUM SALT HEMIHEPTAHYDRATE ;
CAS:104376-79-6
CTN00N :
Disodium (6R,7R)-7-[[(2Z)-(2-Aminothiazol-4-yl)(methoxyimino)acetyl]amino]-3-[[(2-methyl-6-oxido-5-oxo-2,5-dihydro-1,2,4-triazin-3-yl)sulfanyl]methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate 3.5 hydrate ;
CEFTRIAXONE EP IMPURITY A ; (E)-CEFTRIAXONE ;
CAS:92143-31-2
CTN01 :
(6R,7R)-7-[[(2E)-(2-Aminothiazol-4-yl)(methoxyimino)acetyl]amino]-3-[[(2-methyl-5,6-dioxo-1,2,5,6-tetrahydro-1,2,4-triazin-3-yl)sulfanyl]methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid ;
CEFTRIAXONE EP IMPURITY B ; CEFOTAXIME EP IMPURITY E ; 3-DESACETYL CEFOTAXIME LACTONE ;
CAS:66340-33-8
CTN02 :
(5aR,6R)-6-[[(2Z)-(2-Aminothiazol-4-yl)(methoxyimino)acetyl]amino]-5a,6-dihydro-3H,7H-azeto[2,1-b]furo[3,4-d][1,3]thiazine-1,7(4H)-dione ;
CEFTRIAXONE EP IMPURITY C ; CEFTRIAXONE TRIAZINE ANALOG (USP) ; THIOTRIAZINONE ;
CAS:58909-39-0
CTN03 :
2-Methyl-3-sulfanyl-1,2-dihydro-1,2,4-triazine-5,6-dione ;
CEFTRIAXONE EP IMPURITY D ; CEFTRIAXONE BENZOTHIAZOLYL OXIME (USP) ;
CAS:80756-85-0
CTN04 :
S-Benzothiazol-2-yl (2Z)-(2-aminothiazol-4-yl)(methoxyimino)thioacetate ;
CEFTRIAXONE EP IMPURITY E ;
CAS:58909-56-1
CTN05 :
(6R,7R)-7-Amino-3-[[(2-methyl-5,6-dioxo-1,2,5,6-tetrahydro-1,2,4-triazin-3-yl)sulfanyl]methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid ;
CEFTRIAXONE IP IMPURITY E ; CEFALOTIN EP IMPURITY C ; CEFAZOLIN EP IMPURITY H ; CEFOPERAZONE EP IMPURITY E ; 7-AMINOCEPHALOSPORANIC ACID ; 7-ACA ;
CAS:957-68-6
CTN65 :
(6R,7R)-7-Amino-3-[(acetyloxy)methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid ;
CEFTRIAXONE IP IMPURITY G ;
CTN67 :
(6R,7R)-7-[(2E)-2-(2-Amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetamido]-3-{[(2-methyl-6-oxido-5-oxo-2,5-dihydro-1,2,4-triazin-3-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-3-ene-2-carboxylic acid ;
CEFUROXIME ACID ;
CAS:55268-75-2
CRS00A :
(6R,7R)-3-[(carbamoyloxy)methyl]-7-[[(Z)-2-(furan-2-yl)-2-(methoxyimino) acetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]-oct-2-ene-2-carboxylic acid ;
CEFUROXIME ACID ?2-ISOMER ;
CAS:229499-08-5
CRS42 :
(6R,7R)-3-[[(Aminocarbonyl)oxy]methyl]-7-[[(2Z)-2-(2-furanyl)-2-(methoxy imino)acetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-3-ene-2-carboxylic acid ;
CEFUROXIME ACID METHYL ESTER ;
CRS44 :
(6R,7R)-3-[(Carbamoyloxy)methyl]-7-[[(Z)-2-(furan-2-yl)-2-(methoxyimino) acetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]-oct-2-ene-2-carboxylic acid methyl ester ;
CEFUROXIME AXETIL ; CEFUROXIME 1-ACETOXYETHYL ESTER ;
CAS:64544-07-6
CRA00 :
(1RS)-1-(Acetyloxy)ethyl (6R,7R)-3-[(carbamoyloxy)methyl]-7-[[(Z)-2-(furan-2-yl)-2-(methoxyimino)acetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]-oct-2-ene-2-carboxylate ;
CEFUROXIME AXETIL DIMER ;
CAS:1202925-10-7
CRA55 :
(6R,7R)-1-(1-((6R,7R)-3-(Carbamoyloxymethyl)-7-((Z)-2-(furan-3-yl)-2-(methoxyimino)acetamido)-8-oxo-5-thia-1-aza-bicyclo[4.2.0]oct-2-enecarbonyloxy)ethoxy)ethyl 3-(carbamoyloxymethyl)-7-((Z)-2-(furan-2-yl)-2-(methoxyimino)acetamido)-8-oxo-5-thia-1-aza-bic
CEFUROXIME AXETIL EP IMPURITY A ; CEFUROXIME AXETIL ?2-ISOMER ;
CAS:123458-61-7
CRA01 :
1-(Acetyloxy)ethyl (6R,7R)-3-[(carbamoyloxy)methyl]-7-[[(Z)-2-(furan-2-yl)-2-(methoxyimino)acetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-3-ene-2-carboxylate ;
CEFUROXIME AXETIL EP IMPURITY B ; TRANS-CEFUROXIME AXETIL ;
CAS:97232-96-7
CRA02 :
(1RS)-1-(Acetyloxy)ethyl (6R,7R)-3-[(carbamoyloxy)-methyl]-7-[[(E)-2-(furan-2-yl)-2-(methoxyimino)acetyl]-amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2carboxylate ;
CEFUROXIME AXETIL EP IMPURITY C ; CEFUROXIME SODIUM EP IMPURITY D ; CEFUROXIME TRICHLOROACETYL IMPURITY ;
CAS:76598-06-6
CRA03 :
(6R,7R)-7-[[(Z)-2-(Furan-2-yl)-2-(methoxyimino)acetyl]amino]-8-oxo-3-[[[(trichloroacetyl)carbamoyl]oxy]methyl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid ;
CEFUROXIME AXETIL EP IMPURITY D ; CEFUROXIME SODIUM;
CAS:56238-63-2
CRA04N :
(6R,7R)-3-[(carbamoyloxy)methyl]-7-[[(Z)-2-(furan-2-yl)-2-(methoxyimino) acetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]-oct-2-ene-2-carboxylic acid sodium salt ;
CEFUROXIME AXETIL EP IMPURITY E ; CEFUROXIME SODIUM EP IMPURITY H ; DESCARBAMOYL CEFUROXIME LACTONE ;
CAS:947723-87-7
CRA05 :
(5aR,6R)-6-[[(2Z)-2-(Furan-2-yl)-2-(methoxyimino)acetyl]amino]-5a,6-dihydro-3H,7H-azeto[2,1-b]furo[3,4-d][1,3]thiazine-1,7(4H)-dione ;
CEFUROXIME SODIUM ;
CAS:56238-63-2
CRS00N :
(6R,7R)-3-[(carbamoyloxy)methyl]-7-[[(Z)-2-(furan-2-yl)-2-(methoxyimino) acetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]-oct-2-ene-2-carboxylic acid sodium salt ;
CEFUROXIME SODIUM EP IMPURITY A ; DESCARBAMOYL CIS-CEFUROXIME ;
CAS:56271-94-4
CRS01 :
(6R,7R)-7-[[(Z)-(Furan-2-yl)(methoxyimino)acetyl]amino]-3-(hydroxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid ;
CEFUROXIME SODIUM EP IMPURITY B ; ACETYL CIS-CEFUROXIME ;
CAS:39685-31-9
CRS02 :
(6R,7R)-3-[(Acetyloxy)methyl]-7-[[(Z)-(furan-2-yl)(methoxyimino)acetyl] amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid ;
CEFUROXIME SODIUM EP IMPURITY C ;
CAS:69822-88-4
CRS03 :
(6R,7R)-7-[[(Z)-(Furan-2-yl)(methoxyimino)acetyl]amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid ;
CEFUROXIME SODIUM EP IMPURITY D ; CEFUROXIME AXETIL EP IMPURITY C ; CEFUROXIME TRICHLOROACETYL IMPURITY ;
CAS:76598-06-6
CRS04 :
(6R,7R)-7-[[(Z)-2-(Furan-2-yl)-2-(methoxyimino)acetyl]amino]-8-oxo-3-[[[(trichloroacetyl)carbamoyl]oxy]methyl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid ;
CEFUROXIME SODIUM EP IMPURITY E ; TRANS-CEFUROXIME ;
CAS:97232-97-8
CRS05 :
(6R,7R)-3-[(Carbamoyloxy)methyl]-7-[[(E)-(furan-2-yl)(methoxyimino) acetyl] amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid ;
CEFUROXIME SODIUM EP IMPURITY F ; DESCARBAMOYL TRANS-CEFUROXIME ;
CAS:97170-19-9
CRS06 :
(6R,7R)-7-[[(E)-(Furan-2-yl)(methoxyimino)acetyl]amino]-3-(hydroxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid ;
CEFUROXIME SODIUM EP IMPURITY G ; ACETYL TRANS-CEFUROXIME SODIUM ;
CAS:97170-20-2
CRS07N :
(6R,7R)-3-[(Acetyloxy)methyl]-7-[[(E)-(furan-2-yl)(methoxyimino)acetyl] amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid sodium salt ;
CEFUROXIME SODIUM EP IMPURITY H ; CEFUROXIME AXETIL EP IMPURITY E ; DESCARBAMOYL CEFUROXIME LACTONE ;
CAS:947723-87-7
CRS08 :
(5aR,6R)-6-[[(Z)-(Furan-2-yl)(methoxyimino)acetyl]-amino]-5a,6-dihydro-3H,7H-azeto[2,1-b]furo[3,4-d][1,3]thiazine-1,7(4H)-dione ;
CEFUROXIME SODIUM EP IMPURITY I ;
CAS:97148-39-5
CRS09N :
(Z)-(Furan-2-yl)(methoxyimino)acetic acid ammonium salt ;
CELECOXIB ;
CAS:169590-42-5
CLC00 :
4-[5-(4-Methylphenyl)-3-trifluoromethyl-1H-pyrazol-1-yl]benzenesulfonamide ;
CELECOXIB 2-METHYL ANALOG ;
CAS:170569-99-0
CLC42 :
4-[5-(2-Methylphenyl)-3-trifluoromethyl-1H-pyrazol-1-yl]benzenesulfonamide ;
CELECOXIB CARBOXYLIC ACID ;
CAS:170571-01-4
CLC40 :
4-[5-(4-Carboxyphenyl)-3-trifluoromethyl-1H-pyrazol-1-yl]benzene sulfon amide ;
CELECOXIB EP IMPURITY A ; CELECOXIB USP RC A ; CELECOXIB 3-METHYL ANALOG ;
CAS:170570-01-1
CLC01 :
4-[5-(3-Methylphenyl)-3-trifluoromethyl-1H-pyrazol-1-yl]benzenesulfonamide ;
CELECOXIB EP IMPURITY B ; CELECOXIB USP RC B ;
CAS:331943-04-5
CLC02 :
4-[3-(4-Methylphenyl)-5-trifluoromethyl-1H-pyrazol-1-yl]benzenesulfonamide ;
CELECOXIB HYDROXYMETHYL ANALOG ;
CAS:170571-00-3
CLC34 :
4-[5-[4-(Hydroxymethyl)phenyl]-3-(trifluoromethyl)-1H-pyrazol-1-yl] benzene sulfonamide ;
CELIPROLOL EP IMPURITY A ;
CAS:56980-94-0
CLL01 :
1-[5-Amino-2-[(2RS)-3-[(1,1-dimethylethyl)amino]-2-hydroxypropoxy]phenyl]ethanone ;
CELIPROLOL EP IMPURITY B ; CELIPROLOL ANILINE CARBOXY DIMER ;
CAS:125579-40-0
CLL02 :
1,3-Bis[3-acetyl-4-[3-[(1,1-dimethylethyl)amino]-2-hydroxypropoxy]phenyl]urea ;
CELIPROLOL EP IMPURITY C ; N-DIDESETHYL N-TERTBUTYL CELIPROLOL ;
CAS:57471-01-9
CLL03 :
1-[3-Acetyl-4-[(2RS)-3-[(1,1-dimethylethyl)amino]-2-hydroxypropoxy]phenyl]-3-(1,1-dimethylethyl)urea ;
CELIPROLOL EP IMPURITY D ;
CLL04 :
3-[3-Acetyl-4-[(2RS)-3-(diethylamino)-2-hydroxypropoxy]phenyl]-1,1-diethylurea ;
CELIPROLOL EP IMPURITY E ;
CLL05 :
1,1'-[[(1,1-Dimethylethyl)imino]bis[(2-hydroxypropane-1,3-diyl)oxy(3-acetyl-1,4-phenylene)]]bis(3,3-diethylurea) ;
CELIPROLOL EP IMPURITY F ;
CAS:79881-89-3
CLL06 :
3-(3-Acetyl-4-hydroxyphenyl)-1,1-diethylurea ;
CELIPROLOL EP IMPURITY G ;
CAS:56980-98-4
CLL07 :
3-[3-Acetyl-4-[[(RS)-oxiranyl]methoxy]phenyl]-1,1-diethylurea ;
CELIPROLOL EP IMPURITY H ;
CAS:85045-98-3
CLL08 :
3-[3-Acetyl-4-[(2RS)-3-bromo-2-hydroxypropoxy]phenyl]-1,1-diethylurea ;
CELIPROLOL EP IMPURITY I ;
CLL09 :
1-Acetyl-1-(4-ethoxyphenyl)-3,3-diethylurea ;
CELIPROLOL HYDROCHLORIDE ;
CAS:57470-78-7
CLL00H :
3-[3-Acetyl-4-[(2RS)-3-[(1,1-dimethylethyl)amino]-2-hydroxypropoxy]phenyl]-1,1-diethylurea hydrochloride ;
CERITINIB ;
CAS:1032900-25-6
CRT00 :
5-Chloro-N2-(2-isopropoxy-5-methyl-4-(piperidin-4-yl)phenyl)-N4-(2-(isopropylsulfonyl)phenyl)pyrimidine-2,4-diamine ;
CERITINIB 2-AMINOPHENYL ISOPROPYL SULFONE ;
CAS:76697-50-2
CRT51 :
2-(Isopropylsulfonyl)benzenamine ;
CERITINIB DICHLORO IMPURITY ; CERITINIB IMPURITY 2 ;
CAS:761440-16-8
CRT52 :
2,5-Dichloro-N-(2-(isopropylsulfonyl)phenyl)pyrimidin-4-amine ;
CETIRIZINE 3-CHLORO ANALOG ; 3-CHLORO CETIRIZINE DIHYDROCHLORIDE (USP) ;
CAS:1232460-29-5
CTR43H :
(RS)-2-[2-[4-[(3-Chlorophenyl)phenylmethyl]piperazin-1-yl]ethoxy] acetic acid dihydrochloride ;
CETIRIZINE 4-CHLOROBENZHYDROL IMPURITY (USP) ; MECLIZINE EP IMPURITY B ; MECLIZINE USP RC A ;
CAS:119-56-2
CTR40 :
4-Chlorobenzhydrol ;
CETIRIZINE 4-CHLOROBENZOPHENONE IMPURITY (USP) ; HYDROXYZINE 4-CHLOROBENZOPHENONE (USP) ;
CAS:134-85-0
CTR41 :
(4-Chlorophenyl)phenylmethanone ; 4-Chlorobenzophenone ;
CETIRIZINE ALLYL ESTER ;
CTR52H :
Allyl 2-(2-(4-((4-chlorophenyl)(phenyl)methyl)piperazin-1-yl)ethoxy)acetate dihydrochloride ;
CETIRIZINE DESCARBOXYMETHYL R-ISOMER ;
CAS:705289-61-8
CTR57H :
2-[4-[(R)-(4-Chlorophenyl)phenylmethyl]piperazin-1-yl]ethanol dihydrochloride ;
CETIRIZINE DESCHLORO T-BUTYL ESTER ;
CTR53 :
tert-Butyl 2-(2-(4-benzhydrylpiperazin-1-yl)ethoxy)acetate ;